






Research Commons at the University of Waikato 
 
Copyright Statement: 
The digital copy of this thesis is protected by the Copyright Act 1994 (New Zealand). 
The thesis may be consulted by you, provided you comply with the provisions of the 
Act and the following conditions of use:  
 Any use you make of these documents or images must be for research or private 
study purposes only, and you may not make them available to any other person.  
 Authors control the copyright of their thesis. You will recognise the author’s right 
to be identified as the author of the thesis, and due acknowledgement will be 
made to the author where appropriate.  





Goat’s vs Cow’s Milk Consumption: Analysis 
of Feeding Behaviour, Brain Activation and 
Gene Expression in Laboratory Animals 
 
A thesis  
submitted in fulfilment 
 of the requirements for the degree 
of 
Doctor of Philosophy in Biological Sciences 
at 









Milk is a complex and highly nutritive food. In Western societies, cow’s milk (CM) is most 
commonly consumed, but recent years have generated interest in milk from other species, 
especially in goat’s milk (GM). Importantly, select physical and chemical properties of milk 
are species-dependent and – thus – so are the physiological consequences of consumption of 
milk sourced from specific species. For example, variation between GM and CM protein 
impacts digestibility and gastrointestinal processes. Consumption of GM vs CM differentially 
affects levels of blood hormones regulating energy balance. Furthermore, some conflicting 
results on acceptability of GM- and CM-based foods have been reported, and it is unclear to 
what extent habituation to a specific milk type underpins these parameters. To add to the 
confusion, CM and GM are typically consumed and, therefore, studied as modified milk 
products, with one of the typical compositional alterations being done to the protein fraction in 
which the natural 20:80 whey:casein ratio is changed to resemble the 60:40 ratio of human 
milk. One of the most fundamental gaps in our knowledge regarding CM vs GM relates to the 
acceptability, palatability and satiating properties of these milks and to appetite-controlling 
brain processes triggered by CM and GM consumption. Thus, in this doctoral project, I sought 
to examine whether GM and CM diets elicit unique feeding responses in laboratory rodents 
and whether the presumed appetite differences are associated with changes in neuronal 
activation and/or gene expression in key central regions regulating food intake.  
In Specific Aim 1 of the project, I conducted a comprehensive investigation of short-term 
intake and palatability profiles of GM- and CM-based liquid and solid diets in mice and rats. 
Consumption was studied in no-choice and choice scenarios, including meal microstructure. 
Feeding experiments were followed by qPCR analysis of expression of relevant genes in the 
energy balance-related hypothalamus and brain stem, and in the nucleus accumbens, which 
regulates eating for palatability. I found that GM and CM are palatable to juvenile, adult, and 
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aged rodents. Given a choice, animals prefer GM- to CM-based diets. Analysis of meal 
microstructure using licking patterns points to enhanced palatability of and, possibly, greater 
motivation toward GM over CM. Most profound changes in gene expression after GM vs. CM 
were associated with the brain systems driving consumption for reward. The results allow me 
to conclude that, while both GM and CM are palatable, GM is preferred over CM by animals, 
and this preference is driven by central mechanisms controlling eating for pleasure. 
In Specific Aim 2 of the thesis, I investigated the impact of whey enhancement in GM protein 
fraction on appetite and feeding-related brain processes. The shift from the natural whey:casein 
ratio of ~20:80 in animal milks is done to match the 60:40 ratio of human milk. Studies show 
that 20:80 versus 60:40 whey:casein milks differently affect glucose metabolism and hormone 
release. It is unknown whether the 20:80-to-60:40 ratio adjustment affects appetite and brain 
processes related to food intake. In this set of studies I focused on the impact of the 20:80 vs 
60:40 whey:casein content in GM on food intake and feeding-related brain mechanisms in 
laboratory mice. I found that the 20:80 whey:casein GM formulation was consumed less avidly 
and was less preferred than the 60:40 GM in short-term choice and no-choice paradigms. The 
qPCR analyses in the hypothalamus and brain stem revealed that the 20:80 whey:casein GM 
intake upregulated genes involved in early termination of feeding and in an interplay between 
reward and satiety, such as MC3R, OXT, POMC and GLP1R. The 20:80 versus 60:40 
whey:casein GM intake differently affected brain neuronal activation (assessed through c-Fos, 
an immediate-early gene product) in the nucleus of the solitary tract, area postrema, 
ventromedial hypothalamic nucleus and supraoptic nucleus. Overall, the findings show that 
whey enhancement in GM promotes overconsumption of GM in no-choice and choice 
scenarios and that this increased appetite for the 60:40 GM is reflected by changes in neuronal 
activation and gene expression relevant to feeding regulatory mechanisms.  
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Specific Aim 2 results showing preference for whey-enhanced GM and corresponding changes 
in c-Fos and gene expression, do not predetermine whether the preference for the 60:40 milk 
would be retained if - instead of a highly palatable GM - a somewhat less preferred CM was 
used. Thus, in Specific Aim 3, I replicated the aforementioned feeding, gene expression and c-
Fos analyses using CM with the 20:80 vs 60:40 whey:casein. I found that mice exhibited 
preference for the 60:40 over 20:80 whey:casein CM. This preference for the 60:40 CM was 
retained even when animals had simultaneous access to the 20:80 GM. Consumption of similar 
quantities of 20:80 CM vs 60:40 CM differently affected c-Fos in the paraventricular, 
dorsomedial, arcuate and lateral hypothalamic nuclei and in the nucleus of the solitary tract in 
the brain stem and relative gene expression (melanocortin and opioid transcripts). It can be 
concluded that the 60:40 whey:casein milks are more preferred regardless of the species from 
which the milk was derived, indicating that whey:casein ratio influences preference. 
Mechanistic commonalities in the whey:casein ratio changes in CM vs GM include the 
hindbrain neuronal activity changes. Differences in hypothalamic c-Fos and gene expression 
as well as differences in no-choice feeding paradigms indicate that milk type (GM vs CM) 
influences some aspects of feeding processes driven by the shift in the whey:casein ratio. 
Overall, the data presented in this thesis indicate that GM is generally more preferred and it 
has higher acceptance than CM in laboratory animal models. This phenomenon is reflected by 
unique changes in feeding-related brain processes induced by GM vs CM. Whey enhancement 
increases preference toward milk and this effect on consumption is more profound than the 
effect of the species from which the milk was derived. In a broader context, one has to consider, 
however, that whey enhancement’s impact on feeding, brain activation and molecular 
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Introduction and Aims 
Food provides the necessary nutrients required for cellular respiration and function as well as 
for tissue growth and repair. When we are low in energy or specific nutrients, internal 
physiological mechanisms, including hormonal release altering brain activity, promote the 
sensation of hunger to encourage food intake. Following intake, the digestion and absorption 
of nutrients trigger alternative endocrine and neural pathways to produce satiation and attenuate 
feeding. If a food is particularly palatable, reward-related pathways will promote intake, even 
beyond the point of satiation. Foods have different compositions providing variable nutrient 
density, digestibility and complexity, which will inform the nature of the physiological 
response experienced following their intake. A foods’ specific macronutrient content, nutrient 
bioavailability and palatability will elicit unique hormonal release influencing peripheral 
systems as well as stimulating disparate pathways in the brain. These pathways create the 
sensations of hunger, satiety and reward shaping our food intake behaviours. In this way, the 
food we eat can influence what and how much we eat. 
Milk is a nutrient-complex food, primarily providing energy, macro- and micronutrients during 
infancy but which is also consumed frequently in child and adult diets in industrialised areas 
worldwide (Feskanich et al., 2003; Drewnowski & Specter, 2004; Chevalley et al., 2008; 
Drewnowski, 2011; Vissers et al., 2011; Huth et al., 2013; Cheng et al., 2019). Cow’s milk 
(CM) predominates the western milk market, accounting for approximately 82% of global milk 
production (Food and Agriculture Organization of the United Nations, 2018). Consequently, 
the majority of our understanding of the consequences of diary intake arises from studies 
examining CM or CM-derived products. Importantly, non-bovine milks are consumed readily 
in, among others, African and Asian regions, and the emerging research on unique nutritive 
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benefits stemming from the consumption of such milks, has generated interest in incorporating 
them also in the Western diet.  
Goat’s milk (GM), popular in areas reliant on arid agriculture, has garnered interest due to 
composition variations conveying unique nutritive benefits, supporting lower allergic response 
and easier digestion (Park, 1994; Bellioni-Businco et al., 1999; Haenlein, 2007; Park & 
Haenlein, 2013). Despite accounting for only 2% of global milk production, the rate of growth 
of the dairy goat industry has surpassed that of CM production, increasing 47% between 2000 
and 2018 compared to 39% growth for CM (Food and Agriculture Organization of the United 
Nations, 2018). With the predominant focus on CM products in nutrition research, less is 
known about physiological outcomes of GM consumption. 
GM and CM differ in specific macronutrient composition conferring unique milk digestion 
kinetics and nutrient availability – notably in milk protein profiles (Ambrosoli et al., 1988; 
Glantz et al., 2010; Logan et al., 2015; Maathuis et al., 2017; Wendorff et al., 2017; 
Hodgkinson et al., 2018; Freitas et al., 2019; Wang et al., 2019; Ye et al., 2019). There is also 
an indication of altered gastrointestinal (GI) endocrine function following GM ingestion 
(Rubio-Martín et al., 2017). It has been shown beyond a reasonable doubt that both nutrients 
and hormones alter brain function to regulate feeding behaviours – however, with scarcity of 
GM nutritional research little is known regarding the effects of GM on feeding and central 
function, let alone if these are unique to that which follow CM intake. 
With CM’s abundance in our Western diets, GM is often perceived as novel, having a relatively 
“strong, smelly, salty or sweet” compared to CM with a distinct “goaty” flavour (Mowlem, 
2005; Park & Haenlein, 2013). Habituation serves to confound human studies of preference 
and acceptance (Torrico et al., 2019; Cheng et al., 2020), thus the novelty of GM could 
influence acceptability. In basic animal research, milk often forms part of test diets utilised in 
analyses of feeding behaviours and physiological responses regulating intake, such as 
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condensed milk in obesogenic diets (Martire et al., 2013; Martire et al., 2014; Gomes et al., 
2018) and milk protein enrichment of high protein diets (Semon et al., 1987; L'Heureux-
Bouron et al., 2004; Zapata et al., 2018). Laboratory animals do not exhibit cultural diet 
habituation biases and they can be introduced to milk types in a controlled manner, which 
therefore allows for more accurate assessment of dietary interventions – including GM intake 
– without prior exposure influencing feeding behaviours. In addition, use of laboratory animals 
allows finer examination of brain function at the molecular and cellular level to define 
pathways involved in shaping behaviours, otherwise unachievable in human studies.  
Another consideration in the acceptability of milks is, that in human diets, animal milk is rarely 
consumed raw. The composition of commercially available milk products is often adjusted in 
manufacturing, resulting in formulations with macronutrient levels unique to the original milk. 
Often adjustments are made to target specific consequences of milk intake, such as lowering 
allergenicity through eliminating lactose (Jelen & Tossavainen, 2003). The relative content of 
major milk proteins whey and casein are often adjusted in human milk formula diets – from 
the natural 20:80 whey to casein ratio to “whey-enhanced” formulations with a 60:40 ratio. The 
limited prior research on natural and adjusted formulations suggest this switch impacts 
digestion with altered proteolysis and gastric emptying rates as well as insulin-independent, 
hormone-mediated glycaemic control (Kung et al., 2018; El Khoury et al., 2019; Ye et al., 
2019). It would seem unsurprising that modifying whey and casein influences digestion and 
post-absorptive processes as, in isolation, these fractions have unique digestion kinetics (Mahe 
et al., 1996; Boirie et al., 1997; Calbet & Holst, 2004; Bowen et al., 2006b; Boutrou et al., 
2013; Santos-Hernandez et al., 2018) eliciting different endocrine response and central 
function (Hall et al., 2003; Bowen et al., 2006a; Bowen et al., 2006b; Veldhorst et al., 2009; 
Brennan et al., 2012; Leidy et al., 2013; Sukkar et al., 2013). The peripheral response following 
formula intake could therefore influence feeding behaviours via modulation of central function, 
something observed with long term whey and casein isolate intake (Choi et al., 2009; McAllan 
 
4 
et al., 2013; McManus et al., 2015; Andreoli et al., 2016; Nilaweera et al., 2017). However, 
this is yet to described in a systematic way.  
There is paucity in nutrition research concerning milk consumption and the central and 
behavioural changes resulting from dairy intake. This thesis will bridge some gaps in our 
understanding of this issue through examining feeding and brain function in laboratory rodent 
models following CM and GM diets. Firstly, I have examined feeding patterns of GM and CM 
indicative of acceptability and preference and the underlying central function supporting intake 
determined by analysing gene expression of relevant genes in brain pathways related to feeding 
regulation. Secondly, I have detailed how common changes to the relative whey and casein 
ratio of milk affect these behaviours and central processes. Compositional difference between 
GM and CM are most notable in the protein fraction, affecting both digestion and absorption 
processes relevant to regulation of feeding. Therefore, outcomes of modified protein in formula 
will be characterised in both GM- and CM-based formulations.  
1.1 Milk Composition Across Goat and Cow Milks: Digestion and 
Absorption 
Milk is a complex and compositionally ‘dynamic’ food which delivers all the essential nutrients 
for its primary function of supporting infant growth, though consumption often extends beyond 
infancy in adult diets. When milk is included in dietary research, or in consumer diets, there is 
often a simplistic generalisation of all milk being nutritional equivalent, that all milk conveys 
near similar outcomes in nutrition digestion, absorption and post-absorptive utilisation and 
response. However, milk composition varies according to species source, maternal diet and 
lactation period (Saarela et al., 2005; Kent et al., 2006; Park, 2007; Bauer & Gerss, 2011; 
Keikha et al., 2017; Tagliazucchi et al., 2018; Verduci et al., 2019). Furthering this, 
commercially available milks are adaptations of the natural composition of raw milk through 
manufacturing techniques or with adjustment and addition of milk ingredients (Rudloff & 
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Lönnerdal, 1992; Institute of Medicine (US) Committee on the Evaluation of the Addition of 
Ingredients New to Infant Formula, 2004; Prosser et al., 2019), thus these milks could be 
considered formulations. Variations in milk or milk formulation composition have notable 
consequences for milk digestibility and uptake (Rudloff & Lönnerdal, 1992; Lien, 2003; Wada 
& Lönnerdal, 2015; Prosser et al., 2019). Furthermore, with milk providing the sole source of 
early nutrition, and as infant growth demands differ across species, milk composition also 
varies between different mammals (Park, 2007; Tagliazucchi et al., 2018). Milk macronutrient 
composition between GM and CM influences consequences of milk ingestion with altered 
digestion, utilisation and peripheral actions – especially in the protein fraction.  
1.1.1 Milk carbohydrates: Lactose and oligosaccharides 
Lactose digestion products, glucose and galactose, provide energy through glycolysis and 
aerobic respiration or are stored glycogen utilised in hypoglycaemic states (Nordlie et al., 
1999). CM carbohydrate content is slightly higher at 4.6-4.9% of milk weight compared to 
4.1% in GM (Jenness, 1974; Malacarne et al., 2002; Park et al., 2007; Park, 2010). Milk also 
contains oligosaccharides (reviewed in Bode (2012)), chains of monosaccharides that are 
indigestible and are delivered intact to the distal small intestine and colon. These promote 
intestinal flora growth and have bioactive properties including antimicrobial and 
developmental functions.  
1.1.2 Milk fats 
Milk fats are absorbed as free fatty acids and mono- and diglycerides in chylomicrons (Park & 
Haenlein, 2013). Dietary fatty acids are catabolised via beta-oxidation, providing substrates for 
the critic cycle and aerobic respiration (Houten & Wanders, 2010). While the lipid fraction is 
3.6% and 3.8% for CM and GM respectively (Wendorff et al., 2017), GM is noted for having 
a unique fatty acid profile conferring a characteristic “goaty” flavour (Park & Haenlein, 2013). 
Short- and medium-chain fatty acid content as well as smaller fat globule size potentially 
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increases fat-derived energy availability in GM through easier lipase activity (Attaie & Richter, 
2000; Park, 2007).  
1.1.3 Milk proteins 
The nitrogenous fraction of milk is largely derived from proteins, predominately from whey 
and casein protein groups. Minor milk proteins include lactoferrin, serum albumin, 
immunoglobulins, hormones, enzymes, and mucins embedded in the fat globule membrane 
(Jensen, 1995; Park & Haenlein, 2013). Other sources of nitrogen come from non-protein 
nitrogen fraction including free amino acids and amino acid derivatives, urea, uric acid, and 
nucleotides (Jensen, 1995; Park & Haenlein, 2013). Proteinaceous digesta are absorbed as 
amino acids or short peptides, primarily serving as the precursors for tissue growth and repair 
(Gorissen & Witard, 2018). CM and GM have a similar total protein content (Park et al., 2007; 
Wendorff et al., 2017) and a 20% whey and 80% casein protein ratio (Park & Haenlein, 2013). 
However, they do vary in the specific proteins within the casein fraction which impacts protein 
digestion.  
Whey proteins are soluble whilst hydrophobic caseins form micelle structures in milk solution. 
Whey proteins are resistant to gastric digestion, staying in the liquid component of milk digesta 
that is rapidly emptied into the small intestine (Jensen, 1995). Whey proteins are then digested 
by pancreatic enzymes and intestinal brush border membrane peptidases (Tomé & Debabbi, 
1998). Casein micellar structure features a- and b-caseins precipitating with calcium 
phosphate, forming a colloid core surrounded by k-casein “hairy” layer (Dalgleish, 2011). This 
hairy layer provides steric stabilisation in solution, however, it is susceptible to gastric 
proteolytic digestion and acidic conditions (Jenness, 1980). Loss of steric stabilisation leads to 
casein aggregation into curds which slows the rate of gastric emptying of casein proteins 
compared to whey (Mahe et al., 1996; Boutrou et al., 2013; Santos-Hernandez et al., 2018). 
As a result, plasma amino acid appearance is rapid, with higher but transient peaks following 
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whey intake whereas casein intake provides slower, lower and sustained state of 
hyperaminoacidemia (Boirie et al., 1997; Calbet & Holst, 2004; Bowen et al., 2006b). 
GM and CM casein content is a determining factor in each milk’s digestibility. CM contains 
high levels of αs1-casein whereas b-casein levels are higher in GM, with little to no αs1-casein 
(Wendorff et al., 2017). Rather, GM as2-casein variant is present in higher concentrations than 
αs1-casein. Exact levels of αs1-casein are genetically determined with its polymorphic gene 
having at least 17 variants, amongst which the D, F and G alleles provide milk with low αs1-
casein levels and the “null” O1 and O2 alleles produce no αs1-casein (Grosclaude & Martin, 
1997; Carillier-Jacquin et al., 2016). Additionally, casein micelles in GM are larger than in 
CM, 260 nm (Park et al., 2007) and 83-230 nm (Donnelly et al., 1984; Farrell Jr et al., 1990; 
de Kruif & Huppertz, 2012) respectively. Lower αs1-casein levels and larger micelle size of 
GM result in looser curds during digestion (Ambrosoli et al., 1988; Glantz et al., 2010; Logan 
et al., 2015; Freitas et al., 2019; Wang et al., 2019; Ye et al., 2019). Curd density determines 
digestion rate as a more dense gel macrostructure limits enzyme access to protein substrates 
(Barbé et al., 2013). Impact of this is evident with in vitro digestion of CM and GM and formula 
diets derived from these milks, with more rapid digestion and bioavailability of GM proteins 
(Maathuis et al., 2017; Hodgkinson et al., 2018).  
Products of protein digestion are largely reflective of each milks specific protein content, i.e. 
CM higher in αs1-casein derived peptides (Hodgkinson et al., 2019). However, GM and CM 
formulations are comparable in protein quality, with similar ileal digestibility and digestible 
indispensable amino acid scores (Maathuis et al., 2017). In their piglet model, Rutherfurd et 
al. (2006b) observed comparable amino acid retention between GM and CM formulations, 
except for higher glycine and tryptophan levels with CM. They also note adequate mineral 
retention with GM formula, with differences in mineral uptake again reflective of relative 
formula composition (Rutherfurd et al., 2006a). 
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1.2 Milk intake, Endocrine Response and Regulation of Feeding 
Milk composition alters digestion and relative bioavailability of nutrients, i.e. GM’s more 
easily digestible fatty acid and casein fractions. Nutrient availability modifies endocrine 
cascades, peripheral function of the GI tract and central function of brain regions regulating 
feeding. There are three basic drivers of modified intake: hunger, satiety and reward. Below, I 
describe the general processes that underpin these three broad mechanisms at peripheral and 
central levels.  
1.2.1 General regulation of feeding by hunger, satiety and reward 
Energy intake is regulated through balanced orexigenic and anorexigenic pathways that involve 
disparate sets of endocrine and neural signals (Figure 1.1). In the fasted state, the 
enteroendocrine cells of the GI tract release ghrelin (Cowley et al., 2003). Increased systemic 
circulation of ghrelin enhances GI motility and gastric secretions in anticipation of food intake 
and induces a feeling of hunger. The latter is due to interactions with ghrelin receptors, growth 
hormone secretagogue receptors (GHSR), expressed in the brain.  
The hypothalamic arcuate nucleus (ARC) is a key feeding-related region affected by ghrelin. 
The blood brain barrier prevents transit of peripheral molecules from the cerebrospinal fluid 
directly into the brain parenchyma, thus ghrelin and other peripheral hormones act indirectly 
upon the ARC (Morita-Takemura & Wanaka, 2019). Communication to the ARC concerning 
the energy status is mediated, in part, by tanycytes. These specialised glial cells of the 
ependymal layer line the third ventricle allowing active transport of hormones into the brain 
parenchyma (Collden et al., 2015; Balland et al., 2014). Additionally, the neighbouring median 
eminence mediates diffusion of hormones, including ghrelin, across the blood brain barrier due 
to more permeable fenestrated capillaries (Schaeffer et al., 2013). Peripheral factors entering 
the median eminence, either passively diffused or actively transported via tanycytes projecting 
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to the median eminence, interact with projections of the ARC to modify subsequent signalling 
(Morita-Takemura & Wanaka, 2019). 
The ARC itself contains two subpopulations of neurones that synthesise appetite regulating 
neuropeptides belonging to the melanocortin system (a major pathway regulating energy 
intake) (Sohn et al., 2013). One subpopulation of ARC neurones produces pro-
opiomelanocortin (POMC) which is processed into a-melanocyte stimulating hormone (a-
MSH). Interactions with a-MSH and melanocortin receptors 3 and 4 (MC3R; MC4R) of the 
hypothalamic paraventricular nucleus (PVN) lead to activation of anorexigenic projections to 
the brainstem and subsequent top-down attenuation of feeding (Browning et al., 2017). 
Countering this, ARC neuropeptide Y (NPY) and Agouti-related protein (AGRP) co-
expressing neurones increase feeding through tonic inhibition of POMC neurons, antagonism 
of MC3/4R in the PVN and suppression of PVN neurones (Sohn et al., 2013; Morton et al., 
2014). Ghrelin acts upon the ARC to stimulate NPY/AGRP neurones while suppressing POMC 
neurones, increasing feeding. 
Following food intake, the presence of food in the GI tract prompts release of an alternative set 
of hormones promoting satiety. These hormones induce peripheral actions promoting insulin 
release and modulating GI function, slowing gastric emptying through the “ileal brake” 
mechanism that slows nutrient transit through the GI tract to maximise absorption (Van Citters 
& Lin, 1999). Cholecystokinin (CCK) temporarily inhibits gastric emptying and acid secretion 
while stimulating pancreatic and gall bladder secretion (Raybould, 2007). Glucagon-like 
protein 1 (GLP-1) and glucose dependent insulinotropic polypeptide (GIP) are incretins that 
stimulate pancreatic b cells to secrete insulin (Seino et al., 2010). GLP-1 supresses glucagon 




Figure 1.1: Simplified orexigenic and anorexigenic neuro-endocrine signalling pathways controlling feeding for energy. Hypothalamic arcuate nucleus 
(ARC) neurones express pro-opiomelanocortin (POMC), processed into a-melanocyte stimulating hormone (a-MSH). a-MSH binds melanocortin 
receptors (MCRs) of the paraventricular nucleus (PVN) to suppress food intake. Alternatively, ARC neurones co-expressing neuropeptide Y (NPY) and 
agouti-related protein (AGRP) inhibit POMC neurones and PVN activity and antagonise MC3R/4R to increase intake. The brainstems nucleus of the 
solitary tract (NTS) receives hypothalamic projections, mediating top-down regulation of feeding behaviours. These systems are modulated by peripheral 
hormones. Ghrelin released from the GI tract stimulates AGRP/NPY function and inhibits POMC to increase feeding. After food intake, the GI tract 
releases cholecystokinin (CCK), peptide YY (PYY), glucagon-like protein 1 (GLP-1) and glucose dependent insulinotropic polypeptide (GIP). GI 
hormones can stimulate vagal projections to the brainstems dorsal vagal complex, terminating in the NTS, dorsal motor nucleus (DMV) and area postrema 
(AP). Brainstem projections relay signals to higher brain regions – including the hypothalamus. GI hormones, insulin and leptin, secreted by adipose, act 
at the ARC to stimulate POMC neurones and inhibit NPY/AGRP neurones, suppressing feeding.
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stomach acid secretion and emptying as well as pancreatic exocrine secretion (Takei et al., 
2015).  
Satiation occurs with the culmination of anorexigenic post-ingestive signalling, beginning with 
peripheral processes of gastric distension, GI hormone release and nutrient absorption. These 
factors communicate status of internal milieu to the brain, subsequently altering appetite and 
feeding. This is mediated by vagus nerve stimulation, with stomach stretch triggering 
mechanoreceptors on vagal efferents while hormones and nutrients bind respective receptors 
(Jordi et al., 2013; Browning et al., 2017). These fibres project into the brainstem dorsal vagal 
complex, synapsing with neurones of the nucleus of the solitary tract (NTS), the dorsal motor 
nucleus (DMV) or area postrema (AP) and relaying status of internal milieu onto higher brain 
regions regulating feeding behaviours such as the hypothalamus and amygdala (Saper et al., 
2002; Marc et al., 2014). Additionally, the circulating hormones and absorbed nutrients act at 
third ventricle tanycytes and the median eminence to alter brain function. CCK and GLP-1 
stimulate POMC neurones (Fan et al., 2004; Shah & Vella, 2014) while PYY interacts with 
presynaptic Y2 receptors of AGRP/NPY neurones, inhibiting their action thereby disinhibiting 
POMC neurones (Holzer et al., 2012). Insulin, release stimulated by GLP-1 and GIP incretins, 
and leptin, released from adipocytes proportionally to fat mass, activates the POMC pathway 
and inhibits NPY/AGRP signalling (Cowley et al., 2001; Begg & Woods, 2013). Hormone-
mediated elevation of POMC activity leads to termination of food intake.  
Reward-driven food intake is to a large extent regulated by a disparate set of pathways from 
the aforementioned ones that control energy intake. Intake of palatable foods, as determined 
by their macronutrient composition or pleasant taste (regardless of calorie content), stimulates 
dopamine, opioid, serotonin and endocannabinoid signalling in reward-related brain regions, 
from lower brainstem regions to higher-order orbitofrontal cortex, ventral palladium and 
nucleus accumbens (NAcc) (Berridge & Kringelbach, 2015). Reward is often separated into 
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three processes, “liking” (hedonic reaction to tastants), “wanting” (incentive salience, the 
transformation of neutral stimuli into attractive and “wanted” stimuli) and associative learning 
bridging the two (Berridge & Kringelbach, 2015). Opioid signalling mediates hedonic 
responses, with opioid signalling raises the reward value of foods (Olszewski et al., 2011). 
Administration of opioid or receptor agonists increases “liking” behaviours in rats (tongue 
protrusions and paw licking). Opioid receptor agonism increases intake of palatable tastants 
including sugars, fats, non-caloric but sweet saccharin solutions as well as preferred caloric 
foods (Peciña & Berridge, 2000; Naleid et al., 2007). Antagonism, commonly done in many 
experimental trials through non-selective receptor antagonists naloxone and naltrexone, 
attenuates overconsumption of palatable foods (Lynch, 1986; Olszewski et al., 2011), and the 
anorexigenic effect is affected much more by palatability than energy density/content of a diet 
(Giraudo et al., 1993; Levine et al., 1995; Weldon et al., 1996; Glass et al., 2001). Dopamine 
signalling within the mesolimbic system, originating in the ventral tegmental area (VTA) and 
encompassing ventral striatal structures including the NAcc (Pandit et al., 2011), produces the 
“wanting” aspect of reward-driven intake (Wyvell & Berridge, 2000). “Wanting”, or incentive 
salience, is the transformation of neutral stimuli into attractive and “wanted” ones through 
associative learning (Berridge & Robinson, 2003). NAcc dopamine is involved in this process, 
with increased dopamine in the NAcc increasing incentive salience and motivation for 
palatable tastants (Evans & Vaccarino, 1986; Wyvell & Berridge, 2000; Di Chiara, 2002).  
1.2.2 Impact of milk consumption on signalling pathways regulating food 
intake 
Milk intake has largely been reported to effect pathways regulating feeding for energy, whereas 
its effects on specific mechanisms related to reward remain less known. CM has been found to 
be satiating and more effective in suppressing appetite and reducing subsequent ad libitum 
intake than other common caloric beverages like fruit juice or soft drinks (Dove et al., 2009; 
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Rumbold et al., 2015; Onvani et al., 2017). Intake is accompanied by release of GLP-1 and 
GIP (Maersk et al., 2012), incretins that stimulate insulin release, which in turn can promote 
central POMC function. However, central changes following milk intake have not been 
described – except for serotonergic and melanocortin signalling following milk proteins, 
further described in Table 1.  
Importantly, the alterations in endocrine signalling described above were documented 
following CM intake. Few studies have examined the comparative efficacy of different species 
milks in appetitive and physiological responses. Thus far, two studies have investigated GM 
and CM formulations post-absorptive endocrine response and appetitive effects. Milan et al. 
(2018) found fortified GM vs CM drinks induced similar gastric emptying rates and 
postprandial amino acid absorption accompanied by GLP-1, CCK, and insulin release. 
Participants reported no difference in hunger, fullness or desire to eat between the CM and GM 
diets. Appetite ratings relative to pre-intake baseline were supressed continuously for 75 
minutes with the CM formulation, whereas appetite suppression after GM was found at 45 
minutes then again at 90 minutes. Rubio-Martín et al. (2017) reported GM ingestion may 
support stronger satiety and suppression of hunger when compared with CM intake. Study 
participants were supplied with a breakfast of semi-skimmed milk, cheese – sourced from 
either GM or CM – with white bread. The GM breakfast reduced desire to eat and subjective 
hunger. This difference was potentially mediated by enhanced GI hormone release: GLP-1 area 
under the curve (AUC) was inversely associated with AUChunger and AUCdesire-to-eat. 
Considering the differences in hunger and satiety perception, potentially mediated by GI 
endocrine signalling, GM may elicit a unique central response in energy intake regulating brain 
regions.  
Whilst milk nutrition research has emphasised satiety and hunger following milk intake, little 
has been reported regarding milk palatability or processes related to reward system function. 
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A tastants palatability can be derived from its nutrient composition, from one macronutrient – 
such as sweet sucrose solutions (Levine et al., 2003), or through multiple nutrient constituents 
– primarily carbohydrates and fats but also proteins (Martire et al., 2013; Martire et al., 2014; 
Chaumontet et al., 2018). Milk has both a high concentration of lactose and other nutrients 
suggesting potential for high palatability. Additionally, milk is often incorporated into 
rewarding diets with condensed milks in tasty, obesogenic cafeteria diets (Martire et al., 2013; 
Martire et al., 2014) or delivered alone as a highly palatable tastant (Larson et al., 2002; 
Deacon, 2011). However, reward processes following milk have not been documented, let 
alone contrasted between GM and CM.  
In Chapter 2 of this thesis, I have examined the differences in feeding behaviours with skim 
GM and CM consumption and characterise the associated central changes related to energy and 
reward-driven intake regulation rodent models. Systematic evaluations of short- and long-term 
exposure to liquid or solid diets performed accurately assess impact of different species’ milk 
on palatability, acceptability and energy intake. With GM and CM composition altering 
digestion kinetics and observations by Rubio-Martín et al. (2017) suggesting GM may elicit 
different GLP-1 response and satiety level, these two milk types could alter brain function 
related to satiety processes. Milk also has the potential to be highly palatable, with its nutrient 
dense composition and prior use in rewarding diets. Therefore, central activity and gene 
expression in reward-related and energy regulating regions was profiled following CM and 
GM consumption. This was done in laboratory rodent models, eliminating habituation biases 
that skew human taste preferences. 
1.3 Compositional changes in milk-based diets and their 
consequences on feeding-related processes 
Whilst milk constitutes a large portion to human diets, it is rarely consumed raw (Ministry of 
Health, 2003; University of Otago & Ministry of Health, 2011). Milk composition is modified 
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during manufacturing processes or intentionally altered to exploit specific nutritive aspects of 
milk. For example, protein content of milks is often targeted in human milk diets to capitalise 
on specific health benefits – satiation of milk-based beverages or milk protein supplementation 
in weight management strategies (Tahavorgar et al., 2014; Hector et al., 2015; Verreijen et al., 
2015; Maher et al., 2019; Rafey et al., 2020), muscle development in exercise (Elliot et al., 
2006; Wilkinson et al., 2007; Reitelseder et al., 2011) and in sarcopenia (Burd et al., 2012; 
Hidayat et al., 2018) or improved immunological function, with enhanced immune response 
with modified milk diets (Rutherfurd-Markwick et al., 2005) or antioxidant production with 
milk proteins intake (Parodi, 2007).  
A common modification to milk proteins for human nutrition is the adjustment of the natural 
whey and casein profile. CM and GM naturally contain a ratio of 20:80 whey to casein (Park 
et al., 2007; Park & Haenlein, 2013) and during manufacture whey is added to increase whey 
content to reach a 60:40 ratio. This is a common adjustment attempting to match human milks 
whey to casein ratio (Rudloff & Kunz, 1997). Whey and casein proteins are known to effect 
endocrine release, GI motility and absorption and central signalling in the brain – largely 
demonstrated in adult human and also rodent studies (Hall et al., 2003; Bowen et al., 2006a; 
Bowen et al., 2006b; Choi et al., 2009; Veldhorst et al., 2009; Brennan et al., 2012; Leidy et 
al., 2013; McAllan et al., 2013; Sukkar et al., 2013; McManus et al., 2015; Andreoli et al., 
2016; Nilaweera et al., 2017). The current literature on this switch from the 20:80 whey:casein 
ratio to the adjusted 60:40 does suggest altered in vitro digestion, glycaemic control and post-
prandial hormone release in adults. (Kung et al., 2018; El Khoury et al., 2019; Ye et al., 2019) 
1.3.1 Alteration in energy intake regulation processes with whey and casein 
intake 
As described in Section 1.1.3, whey and casein digestion kinetics differ, with whey passing 
rapidly through the stomach to be quickly absorbed in the small intestine whereas casein 
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micelles being destabilised in the stomach, causing protein aggregation and slowing digestion 
and plasma amino acid absorption (Mahe et al., 1996; Boutrou et al., 2013; Santos-Hernandez 
et al., 2018). Following ingestion, whey and casein elicit release of CCK, GLP-1 and PYY 
(Bowen et al., 2006a; Bowen et al., 2006b; Brennan et al., 2012; Leidy et al., 2013). Whey 
stimulates GIP release (Hall et al., 2003) and – in direct comparison of whey and casein – 
elicits a larger secretory response of GI hormones (Hall et al., 2003; Veldhorst et al., 2009; 
Sukkar et al., 2013). Potency of the endocrine response following whey intake potentially 
relates to digestion rate. Enhancing delivery speed of casein amino acids with a constituent free 
amino acid mixture, Dangin et al. (2001) observed more pronounced insulin release than whole 
casein, though not quite to the level of whey. Further slowing of casein digestion diminishes 
endocrine response. Juvonen et al. (2011) compared low-viscosity whey and viscous casein to 
a solid gel created by cross linking casein with transglutaminase. Pronounced peaks in insulin 
and CCK followed the first two diets, whereas the gel produced a lower and sustained CCK 
release.  
Hormones released after intake of whey and casein fractions affects central processes 
regulating energy-driven food consumption. Consequently, whey and casein have been 
reported to influence relevant serotonergic and melanocortin pathways in the brain. 
Serotonergic function is modified with variation in central amino acid availability following 
whey and casein diets. Amino acids can be taken up directly into the brain across the blood 
brain barrier via facilitative transporters on neural capillaries membranes (Hawkins et al., 
2006), proportionally to dietary intake (Peters & Harper, 1985; Currie et al., 1995; Choi et al., 
1999). Choi et al. (2009) examined tryptophan (TRP) availability following protein diets 
including casein and a-lactalbumin (a whey protein) and fluctuations in serotonin synthesis. 
Whey proteins do contain higher TRP content (Sindayikengera & Xia, 2006) which was 
reflected in serum and cortical TRP levels being higher following a-lactalbumin (Choi et al., 
2009). Subsequently, cortical, hypothalamic and hippocampal serotonin synthesis rates were 
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higher following a-lactalbumin. While serotonin is an anorexigen acting through POMC 
neurons (Fang et al., 2013), whey’s potential contributing effect to satiation remains elusive as 
studies on the functional link between whey intake and serotonin system’s response have thus 
far largely focussed on the anxiolytic effect whey produces via enhanced serotonin production 
(Markus et al., 2000; Orosco et al., 2004; Scrutton et al., 2007; Vekovischeva et al., 2013).  
Altered melanocortin signalling has only been described following long-term exposure to whey 
and casein isolate diets, which may explain the heterogeneity in signalling patterns observed 
as detailed in Table 1.  
Andreoli et al. (2016) report central signalling changes which indicate that whey promotes 
satiety. Rats maintained on an obesogenic diet were transitioned onto a whey-enriched variant 
of the diet. This led to higher POMC expression within the hypothalamus, and it was 
accompanied by a reduction in food intake. Others have observed hypothalamic expression 
patterns that are typical of hyperphagia following high whey intake such as lowered POMC 
production and elevated expression of other genes that stimulate AGRP/NPY neurones. Long-
term whey consumption modifies intestinal absorption capacity, with reduced intestinal weight 
and length and expression of glucose, fatty acid and amino acid transporters (McAllan et al., 
2015; McManus et al., 2015; Nilaweera et al., 2017; Boscaini et al., 2019). This appears to 
elicit compensatory increases in food intake with a concurrently reduced hypothalamic POMC 
expression (McManus et al., 2015; Nilaweera et al., 2017), even when energy-dense high-sugar 
diets were used by Nilaweera et al. (2017). When these diets were reduced in energy content 
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Table 1: Central gene expression and physiological changes occurring with whole whey, specific whey protein or casein maintenance diets. 
Study Diet paradigm Central changes and notable physiological changes after diet exposure 
Nilaweera et al. (2017) Fifteen weeks of high or low sugar 
diet with whey enrichment 
Reduced expression of POMC, increased intake. Compensatory mechanism for 
reduced intestinal absorption efficiency occurring with whey consumption (McAllan 
et al., 2015; Nilaweera et al., 2017; Boscaini et al., 2019). Lowering sugar content of 
diet exacerbated response, in addition to elevating hypothalamic ghrelin. 
McManus et al. (2015) Thirteen weeks of low fat, casein 
enriched diet or high fat diets 
enriched with casein or lactoferrin, 
a serum protein.  
Lower hypothalamic POMC with lactoferrin enrichment, no changes in NPY or 
leptin receptor expression. Lower circulating leptin levels and increased expression 
of jejunal fatty acid transporters.  
Body weight gain was delayed with lactoferrin enrichment, however both high fat 
diet variants had higher bodyweight at thirteen weeks than the low-fat diet. 
McAllan et al. (2013) Eight weeks of high fat diet 
enriched with whey or casein 
Reduced hypothalamic expression of insulin and leptin receptors and carnitine 
palmitoyltransferase-1 (CPT1b).  
Reduced insulin and leptin receptor expression associated with insulin and leptin 
resistance and development of metabolic disorders.  
CPT1b mediates fatty acid uptake for mitochondrial b-oxidation. Reduction in 
expression leads to fatty acid accumulation (Lam et al., 2005), which has 
anorexigenic effect with central nutrient sensing, AGRP/NPY production and 
appetite suppression (Obici et al., 2003; Lam et al., 2005). 
Andreoli et al. (2016) Ten weeks preexposure to 
obesogenic phytoestrogen-free diet, 
followed by six weeks of 
phytoestrogen-free diet enriched 
with whey. 
Increased POMC expression lowered energy intake, compared to rats maintained on 
phytoestrogen free diet. However, after six weeks, both phytoestrogen free diets had 




via lowering their sugar content, the orexigenic signalling patterns were exacerbated with 
enhanced ghrelin release (Nilaweera et al., 2017). The hunger hormone ghrelin stimulates NPY 
and AGRP expression to increase feeding (Cowley et al., 2003). McAllan et al. (2013) report 
dichotomous hypothalamic expression characteristic of both appetite stimulation and 
suppression. A high-fat diet enriched with whey given to rodents for eight weeks 
downregulated hypothalamic carnitine palmitoyltransferase-1 (CPT1b), a fatty acid 
transporter, but also insulin and leptin receptors transcript levels (McAllan et al., 2013). 
Reduction of CPT1b leads to the accumulation of central fatty acids (Lam et al., 2005) which 
prompts nutrient sensing neurones to reduced AGRP/NPY activity suppressing intake (Obici 
et al., 2003; Lam et al., 2005). However, insulin and leptin receptor suppression are of 
characteristic insulin and leptin resistance (Martin et al., 2000; Obici et al., 2002). These 
conditions lead to hyperphagia, dyslipidaemia and metabolic disorders including diabetes and 
obesity (Obici et al., 2002; Grillo et al., 2007; Gruzdeva et al., 2019). The heterogeneity of 
melanocortin system function in these reports likely relates to the long-term exposure to whey 
or casein and the associated intestinal remodelling. Changes in central function immediately 
following milk protein intake are yet to be reported, though altered satiety perception with 
whey and casein would suggest some involvement of these systems. Whey is often observed 
to be more satiating than casein (Hall et al., 2003; Diepvens et al., 2008; Potier et al., 2009; 
Pal et al., 2014), with higher compensation in energy intake following intake (Hall et al., 2003). 
However, others report fractions induce similar satiety (Marsset-Baglieri et al., 2014) or that 
casein is even more effective in reducing appetite and energy intake (Abou-Samra et al., 2011). 
Variation in appetite have also been seen with test diets that utilise the combined whey/casein 
fractions. Lorenzen et al. (2012) reported no differences in participant appetite given whey 
(36g), casein (34g) or skim milk (28g casein, 7g whey) drinks followed with an ad libitum 
lunch. However, prior milk intake lowered overall energy consumption during lunch. Diepvens 
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et al. (2008) examined efficacy of different protein types in shake meals in suppressing 
appetite, finding that the whey protein increased perceived satiety and fullness more effectively 
than a mix milk-protein diet (80% casein, 20% whey). Interestingly, hormone patterns 
observed did not support a more satiating effect of whey ingestion. The mixed milk proteins 
elicited higher postprandial CCK and GLP-1 response than whey alone, though whey intake 
produced a positive correlation with insulin and both CCK and GLP-1. Importantly, diets of 
with combined whey and casein fractions elicit unique endocrine activity to isolate diets 
(Diepvens et al., 2008; Lorenzen et al., 2012), which may alter central signalling systems 
regulating feeding given GI hormone interact with and modified select brain regions expressing 
relevant receptors (Cowley et al., 2001; Fan et al., 2004; Holzer et al., 2012; Begg & Woods, 
2013; Shah & Vella, 2014) and also the impact milk protein isolates have on serotonergic and 
melanocortin systems (Choi et al., 2009; McAllan et al., 2013; McManus et al., 2015; Andreoli 
et al., 2016; Nilaweera et al., 2017).  
1.3.2 Satiety processes effected by whey and casein adjustments 
Despite extensive knowledge of how whey and casein influence satiety and hunger responses, 
there has been little documentation on how these processes are affected by adjustment of whey 
and casein ratio in milk. Given that mixed diets of milk protein produce unique effects 
compared to protein isolate diets, it cannot be assumed that consequences are exactly 
proportional to the whey or casein ratio in a diet.  
Digestion kinetics and protein bioavailability of 60:40 whey:casein formulations vary from the 
natural ratio. Protein digestion kinetics are altered in milks with the adjusted ratio. Ye et al. 
(2019) examine in vitro digestion of proteins in both CM and GM-based formulations with the 
60:40 and 20:80 whey to casein ratios. Increasing casein content increased particle size due to 
casein micellar aggregation. Higher casein content slowed gastric casein digestion of the 20:80 
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CM formula, though species differences in casein curd properties and digestion speed were 
noted in smaller particle size with GM formulations and equivalent hydrolysis rate between 
20:80 and 60:40 GM formulations. As noted with whey and casein, speed of protein digestion 
and plasma amino acid appearance can impact strength of enteroendocrine cells release of GI 
hormones (Dangin et al., 2001; Juvonen et al., 2011). Another consideration in formula protein 
alteration is that whey addition lowers protein quality with increased the abundance of 
indigestible protein products following thermal manufacturing process. Pasteurization and 
ultra-high temperature processing, intended to reduce milks microbial load to extend shelf life, 
can alter milk protein structure and bioavailability. The tertiary structure of whey proteins is 
easily destabilised with heat and form novel aggregates after thermal treatment (Jean et al., 
2006; Patel et al., 2006). Additionally, Maillard reactions of proteins glycating with reducing 
sugars block proteins lysine residues, limiting proteolytic action on glycation products and 
lowering protein availability (Wada & Lönnerdal, 2015; van Lieshout et al., 2020). Indigestible 
products remain intact through the GI tract (Sillner et al., 2019; Sillner et al., 2020) promoting 
growth of aberrant microflora (Seiquer et al., 2014; Bui et al., 2020). Added whey in formula 
diets increases the abundance of these glycation products (Prosser et al., 2019), potentially 
reducing digestibility. Proteins that are more easily digested and more readily absorbed – such 
as pre-digested hydrolysates (Calbet & Holst, 2004; Diepvens et al., 2008; Koopman et al., 
2009)– enhance hormonal release and stronger satiety. 
Changes in post-prandial glycaemia were reported in studies by Kung et al. (2018) and El 
Khoury et al. (2019) with milk drinks with modified protein ratios that were consumed 
alongside high carbohydrate cereal breakfast (Kung et al., 2018; El Khoury et al., 2019). 
Healthy adult participants were given high- or low-protein (3.1% and 9.3% of weight 
respectively) milk formulations with either 20:80 or whey-added 60:40 whey to casein ratios. 
All treatments reduced blood glucose before ad libitum pizza lunch, however intake was not 
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modified. Whey to casein ratio affected pre-lunch blood glucose, with a lower peak with the 
60:40 formulation and reduced appetite with the 20:80 milk (Kung et al., 2018). Changes in 
blood glucose were insulin independent, with treatments not eliciting changes in insulin or c-
peptide levels (El Khoury et al., 2019). Rather, elevated hormonal responses included elevated 
premeal GLP-1 with the high protein concentration and 60:40 ratio as well as enhanced pre-
meal CCK release with high protein formulations and lowered ghrelin post-meal with the 60:40 
ratio. The authors suggest that gastric emptying speed, modified by post-prandial hormones, 
determined the rate of carbohydrate intestinal delivery and absorption to produce the changes 
in blood glucose response.  
Investigations of protein in infant milk formula – which is heavily modified both in total 
content and specific protein composition to attempt to match breastfed infant growth and 
metabolism – have found negligible effects of this switch with similar growth patterns across 
infancy (Grant et al., 2005; Koletzko et al., 2009; Weber et al., 2014; Zhou et al., 2014; 
Gruszfeld et al., 2016; Totzauer et al., 2018). Janas et al. (1987) reported that formulations 
with 18:82 or 34:66 whey to casein ratio not only produced similar anthropomorphic measures 
but also similar plasma amino acid fluctuations. Importantly, these studies span across infancy, 
not detailing variation in immediate feeding responses.  
These changes in digestion and endocrine response with varying relative whey and casein 
content are unsurprising when considering that these processes are uniquely modified 
following whey and casein isolate intake. However, unlike literature concerning these milk 
protein isolates, effects on satiety and hunger central control systems has not been investigated. 
El Khoury et al. (2019) noted altered release of GI hormones GLP-1 and CCK, which, as 
described in section 1.2.1, typically stimulate POMC pathways, promoting satiety. 
Interestingly, milk diets with varied whey and casein content have not been reported to modify 
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appetite perception, despite difference in acute whey and casein satiety response and variation 
that comes with mixed milk protein intake. Kung et al. (2018) and El Khoury et al. (2019) do 
not report differences in appetite response following the modified milk and cereal breakfast 
despite changes in hormones known to regulate appetite (Kung et al., 2018; El Khoury et al., 
2019). They suggest satiety to be confounded by intestinal discomfort with high lactose content 
of milks or the meal’s high energy content. How adjustments to whey and casein ratios in milk 
formulations has not been accurately assessed, nor is it known how post-prandial endocrine 
release impacts related feeding behaviours. 
1.3.3 Impacts of modified protein content on milk product palatability  
Aside from feeding related to energy status, foods can be consumed for their palatability. 
Modifications made to milk composition are reported to impact milk product taste, however, 
this is limited to flavour assaying or side observations in larger studies of physiological 
parameters with little understanding of how feeding or reward-related central activity is 
impacted. 
Whey and casein content have been reported to influence the palatability of milk products. 
Flavour assaying of yoghurts by Tomaschunas et al. (2012) indicated increased protein content 
and lower casein content produced less flavourful products with a yellowy appearance and 
grainier texture. These poorer sensory attributes were mitigated by increasing fat content. 
Cheng et al. (2019) similarly assessed sensory properties of increased protein and variable milk 
serum proteins (whey and other soluble minor milk proteins) and casein content in milk 
beverages. Similarly, increased serum protein concentration increased aroma, sweet aromatic, 
cooked and sulphur and cardboard/doughy flavours and yellowness. Increased casein content 
increased drink viscosity. Potier et al. (2009) gave women “cheesy” snacks with casein alone 
or a mixed snack with 66:33 whey to casein. While this study focussed more so on the energy 
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compensation following intake, with reduced intake of an ad libitum lunch and in total daily 
energy intake following snacks, authors also note participants rated the mixed snack as more 
palatable with better taste, texture and appearance. Variability in sensory attributes across 
ranges of macronutrient concentrations – including whey and casein content – emphasises the 
need for balancing composition to ensure diet acceptability.  
Altered intake and palatability of isolated factions and mixed diets are also noted in animal 
models, specifically in obese rats utilised by Pezeshki et al. (2015). Feeding patterns and 
metabolic consequences of long-term consumption of whey, casein or mixed milk protein diets 
were unique, with intake, body weight and fat mass declining more rapidly on isolate diets. 
This could in part due to alterations in circulating hormones, with the whey diet producing 
higher GLP-1 levels and insulin sensitivity than the mixed diets, but also due to relative 
palatability of isolate versus mixed protein diets. When diets were simultaneously presented 
with a lower protein control diet containing only 14% protein energy from egg white, 
consumption of mixed diet was near that of the control and significantly lowered across early 
timepoints for both isolate diets, indicating mixed protein had iso-palatability with the control 
whilst isolate diets were less palatable.  
Diet palatability varies across milk formulations, milk product and diets with variable whey, 
casein or mixed milk protein content. Importantly, palatability of milk formulations with 
adjustment of whey and casein content impacts flavour. However, it is unknown how the 
reported sensory attributes influence the control of feeding behaviours. Relative palatability of 
mixed protein diets and isolate diets appears relevant in animal modelling, impacting energy 
intake and contributing to alterations in body composition (Pezeshki et al., 2015). Thus, 
adjusting relative whey and casein content could impact palatability, and therefore 
acceptability, of milk formulations.  
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With the modifications in endocrine release following milk formulations of variable whey and 
casein content – and changes to melanocortin and serotonergic function following whey and 
casein isolates – it would not be surprising if altering the relative ratios of whey and casein in 
milk diets would impact central circuitry regulating intake for energy. Additionally, adjusting 
milk protein content impacts the palatability of milk diets, which could alter processes 
underlying feeding for reward. Thus, in understanding physiological outcomes in the switch 
from the natural 20:80 whey to casein ratio to the adjust 60:40 ratio, it would seem obvious to 
investigate if acute feeding behaviours are modified by changing whey:casein ratios and what 
central pathways underly these responses. In Chapters 3 and 4 I address this line of enquiry. 
Acceptability and preference for milk formulations containing the natural 20:80 and whey-
enhanced 60:40 ratios were examined in adult mouse models. Expanding upon this, the 
accompanying changes in activity and expression of relevant genes in energy intake-regulating 
regions of the brain were also described. These experiments were performed with both GM 
and CM derived-formulations. The species difference in whey and casein profiles, digestive 
properties and initial reports of modified post-absorptive hormonal response indicated that 





The overarching aim of this doctoral research was to examine whether milk-based diets 
derived from GM or CM elicit unique feeding patterns in rodent models and whether 
differences in appetite response are mediated by central processes regulating intake. This 
project encompassed three aims: 
Specific aim one: To determine whether GM and CM based diets (liquid and solid chow) 
produced variable appetitive behaviours of acceptance and preference in mouse and rat models. 
To examine whether behaviours are accompanied by changes in expression of key genes 
associated with hedonic and homeostatic feeding regulation within relevant brain regions 
controlling intake (Chapter 2).  
Specific aim two: To determine whether adjustment of milk protein content (ratio of whey and 
casein) of GM-based infant formulations modify acute feeding behaviours (acceptance and 
preference) in the mouse model. To examine whether changes in intake of diets with variable 
protein content are accompanied by changes in neuronal activation (c-Fos) and gene expression 
of key regulatory genes in brain regions associated with appetite regulation (Chapter 3). 
Specific aim three: To determine whether adjustment of protein content (ratio of whey and 
casein) of CM-based infant formulations modify acute feeding behaviours (acceptance and 
preference) and whether adjustments to protein content alter interspecies milk diet preferences 
in the mouse model. To examine if divergent feeding patterns between CM formulations are 
accompanied by changes in neuronal activation and gene expression of key regulatory genes 
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Palatability of goat’s versus cow’s milk: insights 
from the analysis of eating behaviour and gene 
expression in the appetite-relevant brain circuits in 
laboratory animal models 
2.1 Abstract 
Goat’s (GM) and cow’s milk (CM) are dietary alternatives with select health benefits shown 
in human and animal studies. Surprisingly, no systematic analysis of palatability or preference 
for GM vs. CM has been performed to date. Here, I present a comprehensive investigation of 
short-term intake and palatability profiles of GM and CM in laboratory mice and rats. 
Consumption was studied in no-choice and choice scenarios, including meal microstructure, 
and by using isocaloric milks and milk-enriched solid diets. Feeding results are accompanied 
by qPCR data of relevant genes in the energy balance-related hypothalamus and brain stem, 
and in the nucleus accumbens, which regulates eating for palatability. GM and CM were found 
palatable by juvenile, adult, and aged rodents. Given a choice, animals prefer GM- to CM-
based diets. Analysis of meal microstructure using licking patterns points to enhanced 
palatability of and, possibly, greater motivation toward GM over CM. Most profound changes 
in gene expression after GM vs. CM were associated with the brain systems driving 
consumption for reward. It is concluded that, while both GM and CM are palatable, GM is 
preferred over CM by laboratory animals, and this preference is driven by central mechanisms 




Milk is a widely consumed, affordable, and highly nutritive food, which serves as a key source 
of, among others, protein, calcium, potassium, magnesium, and vitamins (especially A and D) 
in industrialised countries (Feskanich et al., 2003; Drewnowski & Specter, 2004; Chevalley et 
al., 2008; Drewnowski, 2011; Vissers et al., 2011; Huth et al., 2013). In Western societies, 
cow’s milk (CM) products represent the largest share of dairy available on the market, and 
cow’s skim milk varieties have become common. However, recent years have generated 
interest in milk from other species, such as goat’s milk (GM). The use of GM as an alternative 
to CM has been driven by the findings in humans and laboratory animals showing potential 
beneficial nutritive consequences of GM intake and differences in physiological responses to 
GM or CM consumption, (for review, see (Haenlein, 2007)). For example, Bellioni-Businco et 
al. (1999) reported that individuals with a CM allergy were able to drink five times more GM 
than CM before the symptoms of an allergic response appeared (Bellioni-Businco et al., 1999). 
In studies utilising rodent models, Barrionuevo et al. demonstrated that GM increases 
utilization of copper, zinc, and selenium (Barrionuevo et al., 2003). Bioavailability of iron and 
copper was found to be improved in GM-fed rodents suffering from malabsorptive syndrome 
and in healthy controls (Barrionuevo et al., 2002; Barrionuevo et al., 2003). Finally, GM 
improved bone turnover in iron-deficient rats compared to rats fed CM (Diaz-Castro et al., 
2011; Diaz-Castro et al., 2012).  
Surprisingly, little is known about GM’s acceptance and preference relative to the main dairy 
product in today’s food environment in the Western world. There is no systematic analysis of 
propensity to ingest GM and CM or relative palatability of GM vs. CM in either humans or in 
laboratory animal models. Consequently, our understanding of acceptance and palatability of 
GM compared to CM is still mainly based on anecdotal evidence and on market availability, 
both heavily influenced by local cultural or environmental aspects (such as in Western vs. 
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Asian countries) and habituation-driven intake of a specific milk type (Silanikove et al., 2010). 
This is a major gap in knowledge as palatability affects, among others, the amount of food 
eaten in a single meal, the rate of consumption, food anticipation, and satiety. It has a profound 
effect on activity of brain circuits responsible for processing energy intake (including the 
hypothalamus and brain stem) and reward (such as the nucleus accumbens; NAcc) (Olszewski 
et al., 2008; Gosnell & Levine, 2009; Olszewski et al., 2011). These parameters can, in turn, 
impact a plethora of mechanisms outside the central nervous system (CNS), via neural and 
hormonal interactions linking the brain and peripheral tissues (Agusti et al., 2018; de Kloet & 
Herman, 2018; Schwartz, 2018).  
Here, I present a comprehensive investigation of short-term intake and palatability profiles of 
GM and CM in laboratory rodent models (mice and rats) using skim milks. Consumption data 
details the acceptance (no-choice) and preference (choice) scenarios of calorie-matched milks 
and milk-enriched solid diets. Consumption data are accompanied by the analysis of expression 
of appetite-related genes in the hypothalamus and brainstem, two brain regions predominantly 
involved in energy balance control, and in the NAcc, a key site that regulates eating for 
palatability (Olszewski et al., 2008; Olszewski et al., 2011). Relative mRNA levels of genes 
involved in promoting consumption, such as those encoding neuropeptide Y (NPY), Agouti-
related protein (AGRP), ghrelin receptor, orexin, opioid peptides/receptors, and gap junction 
protein, connexin 36 (Cx36), were analysed via RT-qPCR. The analysis also included 
transcripts related to decreased appetite and termination of consumption, such as oxytocin, 
melanocortin receptors 3 (MC3R) and 4 (MC4R), and proopiomelanocortin (POMC). 
Typically, presentation of tastants that differ in palatability and composition, among other 
traits, evokes some changes in expression within this subset of genes, reflecting a different 
propensity of an animal to ingest specific diets (Olszewski et al., 2008; Olszewski et al., 2009). 
A number of physiological functions by the brain vary with age, including appetite. Weight is 
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typically gained throughout early and middle age, followed by gradual, age-associated 
anorexia. In line with that, a drive to consume food (and responsiveness to palatability) is high 
during the earlier stages of life, whereas in aged animals, anhedonia and decreased 
responsiveness to rewarding diets and to drugs that promote eating for pleasure ensue (e.g., see 
(Gosnell et al., 1983; Morley, 2013; Zink et al., 2014)). Therefore, in the following feeding 
experiments, rodents belonging to three distinct age groups: adolescents, adults, and aged 
animals, were used. It should also be noted that rats and most mammals, other than select 
groups of humans, poorly digest lactose post-weaning. Though lactase activity in adult rats is 
residual, rats fed as much as 30% lactose in their daily diet from post-weaning to day 98 had 
normal body growth or body weight course (their body weight was somewhat lower) (van de 
Heijning et al., 2015). However, in this current study focused on short-term rather than long-




2.3 Material and Methods 
2.3.1 Animals 
Male Sprague-Dawley rats and C57Bl mice (all weaned on day 21) used in these studies were 
single-housed in a temperature-controlled (22 °C) animal facility with a 12:12-h LD cycle 
(lights on at 07:00). Standard chow (Diet 86, Sharpes Stock Feed, Wairarapa, New Zealand) 
and water were available ad libitum unless indicated otherwise. The University of Waikato 
animal ethics committee had approved the procedures (ethics approval numbers: 1020, 1043, 
and 1057), and they are compliant with the NIH Guide for the Care and Use of Laboratory 
Animals (NIH Publ., no. 80–23, rev. 1996). Feeding experiments were performed in separate 
cohorts of animals (weight-matched) unless specified otherwise. The age of animals included 
in the adolescent (5–6 weeks), adult (3–5 months), and aged (25–27 months) categories was 
based on previous publications pertaining to the aging process in rodents (McCutcheon & 
Marinelli, 2009). It should be noted that despite poor digestibility of lactose post-weaning, no 
signs of gastrointestinal discomfort or sickness were observed, which is in line with previous 
studies showing that rats fed as much as 30% lactose in their daily diet (thus, more than given 
here) for several weeks displayed good tolerance of the carbohydrate (van de Heijning et al., 
2015).  
2.3.2 Skim milk diets 
Milk diets (Dairy Goat Cooperative, Hamilton, New Zealand) were stored as powder and 
prepared immediately before use by being reconstituted in water. Composition of the milks are 
shown in Table 2.1. GM- or CM-enriched chows (Dairy Goat Cooperative, Hamilton, New 
Zealand) were refrigerated and brought to room temperature prior to administration. See 






Table 2.1 CM and GM milk powder composition 
 Protein Fat Carbohydrate Ash Moisture 
CM 37.1 1.1 51 6.5 4.3 
GM 36.1 0.9 49.9 9.5 3.6 
 
2.3.3 Feeding studies 
Diet treatments given either species’ adult, adolescent and aged cohorts and the energy status 
(sated/deprived) are outlined in Table 2.2.  
Table 2.2 Schematic of skim milk diet treatment paradigms across age, energy status and 
species 
 
2.3.3.1 Episodic Intake of Individually Presented GM and CM in Sated Adult Mice and Rats 
Protocol were based on previous studies assessing episodic intake of palatable tastants 
(Olszewski et al., 2010; Herisson et al., 2014; Herisson et al., 2016). Individually housed mice 
and rats were accustomed (in homecages) to receiving one of the four isocaloric (0.6 kcal/g) 
solutions for 2 h/day on 2 days (10:00–12:00) prior to the experiments using their usual 250 
mL sized water bottles (used for all bottle scenarios) to avoid neophobia(mice: n = 8–9/group; 
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rats: 8–10/group): GM, CM, an energy-equivalent 15% sucrose solution (a reference palatable 
solution), or a 15% cornstarch suspension (a negative control for palatability; as cornstarch is 
insoluble in water, 0.3% xanthan gum was added to this liquid in this experiment as described 
previously in (Bonacchi et al., 2010)). On the experimental day, bottles with the solutions (at 
room temperature) were placed in the cages and water and chow were removed for the 2-h 
experimental session. Spillage (g) from each individual bottle was recorded before placement 
into cage. Intakes were measured after 2 h using a digital scale and expressed in grams per 
gram of body weight. This feeding experiment was conducted in a separate cohort of animals.  
2.3.3.2 Energy Deprivation-Induced Intake of Individually Presented GM and CM in Mice 
and Rats 
Mice and rats previously exposed in their homecages to GM, CM, cornstarch, and sucrose were 
deprived of standard chow overnight (food taken away at 16:00). On the next day (10:00), 
water bottles were removed and replaced with bottles (at room temperature) containing one of 
the four treatments (mice: n = 8–10/group; rats: 7–8/group). Spillage (g) from each individual 
bottle was recorded before placement into cage. Intakes were measured using a digital scale 
after 2 h and expressed in grams per gram of body weight. This feeding experiment was 
conducted in a separate cohort of animals. 
2.3.3.3 Episodic Intake of Individually Presented GM- and CM-Enriched Chow in Sated 
Adult Mice and Rats 
Rats and mice were given episodic access to the chow enriched with GM or CM according to 
the protocol described above, where, instead of GM or CM, a GM- or CM-enriched chow  was 
presented for 2 h (10:00). Standard chow pellets were removed during this 2-h meal, but water 
was left in the cages. Intake of chow pellets (at room temperature) was measured using a digital 
scale after 2 h and expressed in grams per gram of body weight. In order to assess baseline 
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intake, a control group of animals had a fresh batch of the standard chow placed in the hopper 
for 2 h (n = 7–8/group for both mice and rats). This feeding experiment was conducted in a 
separate cohort of animals.  
2.3.3.4 Energy Deprivation-Induced Intake of Individually Presented GM- and CM-Enriched 
Chow in Adult Mice and Rats 
Rats and mice previously exposed to GM- and CM-enriched chow (pre-exposure to both chow 
types was simultaneous) were deprived of standard chow overnight (food taken away at 16:00). 
On the next day (10:00), animals received either standard chow, GM- or CM-enriched pellets 
(mice: n = 7–8/group; rats: n = 8–9/group) at room temperature. Intakes were measured using 
a digital scale after 2 h and expressed in grams per gram of body weight. This feeding 
experiment was conducted in a separate cohort of animals. 
2.3.3.5 Episodic Intake of Individually Presented GM and CM in Sated Adolescent and Aged 
Rodents 
Mice and rats aged 5–6 weeks (n = 9–11/group for each species) were used in the study on 
adolescent animals, whereas 25-month old mice and 26-month old rats (n = 8–9/group for each 
species) were used as the aged cohorts. The feeding experiments utilising individually 
presented cornstarch, sucrose, GM, and CM solutions followed the protocol described above 
for the relevant studies in adult sated rodents that received one of the four solutions for 2 h. 
This feeding experiment was conducted in a separate cohort of animals. 
2.3.3.6 Episodic Intake of GM and CM Presented Simultaneously in Sated Adolescent, Adult, 
and Aged Rodents 
Mice (n = 20) and rats (n = 21) aged 5–6 weeks were used in the study on adolescent animals, 
16–18-week old mice (n = 10) and rats (n = 12) were included in the study on adults, whereas 
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25-month old mice (n = 12) and 26-month old rats (n = 11) were used as the aged cohorts. 
Adult and adolescent rats and mice had been previously exposed to GM and CM (pre-exposure 
to both milk types was simultaneous). The aged animals came from the cohorts described above 
in section 2.3.3.5, however, a week-long ‘washout’ period was allowed between the previous 
experiment and this study. First, the animals were accustomed to simultaneously receiving GM 
and CM as a two-bottle choice (bottles placed next to each other; random order) for circa 1 h 
per day on two days in their homecage. Then, on the experimental day, chow and water were 
removed from cages and GM and CM (at room temperature) were given to the animals for 2 h 
(11:00–13:00). Spillage (g) from each individual bottle was recorded before placement into 
cage. Intakes were measured using a digital scale after 2 h and expressed in grams per gram of 
body weight. This feeding experiment was conducted in a separate cohort of adolescent and 
adult animals. 
2.3.3.7 Episodic Intake of GM- and CM-Enriched Chow Presented Simultaneously in Sated 
Adult and Aged Rodents 
Mice and rats aged 18–20 weeks old mice (n = 8) and rats (n = 8) were included in the study 
on adults, whereas 25-month old mice (n = 9) and 27-month old rats (n = 10) were used as the 
aged cohorts. Adult rats and mice had been previously exposed to GM and CM chow (pre-
exposure to both chow types was simultaneous). The aged animals came from the same cohort 
as in section 2.3.3.5, again with a two-week-long washout period. First, the animals were 
accustomed to receiving simultaneously CM- and GM-enriched chow in a subdivided hopper 
in their homecages (placement of GM/CM pellets was random; standard chow was removed) 
for ~1 h per day on two days. Then, on the experimental day, after removal of standard chow, 
CM- and GM-enriched pellets (at room temperature) were given to the animals for 2 h (10:00–
12:00). Intakes were measured using a digital scale after 2 h and expressed in grams per gram 
of body weight. This feeding experiment was conducted in a separate cohort of adult animals. 
 
49 
2.3.3.8 Lickometer-Assessed Preference for Simultaneously Presented GM and CM in Sated 
Adult Rats 
Six 12-week old male rats were housed individually in cages equipped with bottles attached to 
lickometers (Lafayette Instruments, Lafayette, IN, USA). The animals were previously given 
GM and CM to prevent neophobia (the pre-exposure was simultaneous). They were 
accustomed to receiving a choice between GM and CM on two separate days for 30 min 
(random order of bottles) in lickometer cages. On the experimental day, standard chow and 
water were removed from the cages and animals were given simultaneous access to GM and 
CM (room temperature) for 30 min. The number of licks on each bottle was counted and 
analysed (Scurry Activity Monitoring software, Lafayette, IN, USA), both as total number of 
licks as well as number of licks per 5-minute interval. We also assessed the cluster number 
(number of bouts of licking—each bout was defined as continuous licking interspaced by no 
more than 0.5 s between each other) and an average cluster length (bout duration measured in 
seconds) of GM vs. CM. This feeding experiment was conducted in a separate cohort of 
animals. 
2.3.3.9 72-h Cumulative Intake of Simultaneously Presented CM- and GM-Enriched Chow 
in Adult Rats 
First, the animals were accustomed to receiving two types of chow pellets (room temperature) 
simultaneously in a subdivided hopper in their homecage (placement of pellets was random) 
for circa 2 h per day on two days. On the experimental day 1 (17:00), animals received a choice 
of either standard/CM chow (n = 9), standard/GM chow (n = 10), or GM/CM chow for 72 h 
(pellets were exchanged daily; n = 16). Cumulative 72-h intakes were recorded in grams. This 
feeding experiment was conducted in a separate cohort of animals. 
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2.3.4 Effect of 24-h CM vs. GM Consumption on Feeding-Related Gene 
Expression in the Brain Circuit 
In order to assess the effect of 24-h intake of GM and CM solutions on the expression of 
feeding-related genes in the brain, mice were given CM or GM (at room temperature) as the 
only tastant (starting at 10:00). Animals given water served as baseline controls. At 10:00 on 
the subsequent day (thus, 24 h after milk presentation), the animals were sacrificed via cervical 
dislocation. Brains were dissected out and the hypothalamus, NAcc, and brain stem excised 
and stored in RNAlater at −80 ° C until further processing. This experiment was conducted in 
a separate cohort of animals. 
Tissues were homogenised in Trizol (Ambien), 1 mL per 0.1 g tissue. 0.2 mL chloroform was 
added and samples were centrifuged at room temperature for 10 min at 10,000× g. The clear 
phase containing RNA was isolated and 0.5 mL of isopropanol was added. RNA was 
precipitated in an ice bath for 10 min then centrifuged at 4 °C for 20 min at 10,000× g. Aqueous 
phase was removed from the pellets, which were then resuspended in 0.3 mL of ethanol and 
centrifuged at 4 °C for 10 min at 10,000× g. Liquid was removed and pellets were air-dried. 
Pellets were dissolved in 8 µL DEPC water and 1 µL DNAse buffer (dNature). Samples were 
then incubated with 1 µL DNAse (dNature) at 37 °C for 30 min. DNAse was inactivated via 
addition of stop buffer (dNature) and incubation at 67 °C for 10 min. Removal of DNA was 
confirmed via PCR using HOT FIREPol Blend Master Mix (dNature), followed with agarose 
gel electrophoresis. Concentrations of RNA were measured with a nanodrop. 
cDNA was synthesised from RNA samples with iScript Advanced cDNA synthesis kit 
(BioRad). Synthesis of cDNA was confirmed with PCR followed by agarose gel 
electrophoresis. Quantitative RT-PCR (qPCR) was used to determine relative expression levels 
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of housekeeping genes (ActB, GAPDH, β-tubulin) and of genes of interest. Reactions 
contained 4 µL of 25 ng/μL sample cDNA, 1 µL of each forward and reverse primers (5 µM), 
10 µL iTaq Universal SYBR Green Supermix (BioRad) and 4 µL MilliQ water. qPCR 
experiments were performed in duplicates alongside negative controls of MilliQ water for each 
primer pair. Amplification protocol was initiated at 95 °C for 15 min, followed by 45 cycles of 
15 s at 95 °C, 15 s at the primer-specific annealing temperature and 30 s at 72 °C. Primers used 
are detailed in Table 2.3.  
2.3.5 Data Analysis 
Analyses of qPCR data utilised BioRad CFX Manager software (BioRad); one-way ANOVA 
followed by Bonferroni’s test with the correction for multiple comparisons was used, with p < 
0.05 set as criterion of statistical significance. Feeding data from studies comparing two groups 
were analysed using a t-test, whereas comparisons between three or more groups were done 
with ANOVA followed by Bonferroni’s post-hoc test, with differences considered significant 




Table 2.3 Forward and reverse primers for housekeeping and target genes used in RT-qPCR 
analyses of hypothalamic, brainstem and NAcc relative gene expression following GM and 
CM consumption 
Gene Forward Reverse 
GADPH 5′-AAGGTCATCCCAGAGCTGAA-3′ 5′-CTGCTTCACCACCTTCTTGA-3′ 
βTUB 5′-CGGAAGGAGGCGGAGAGC-3′ 5′-AGGGTGCCCATGCCAGAGC-3′ 
ActB 5′- GTGTGACGTTGACATCCGT-3′ 5′-TGCTAGGAGCCAGAGCAGTA-3′ 
POMC 5′-CCTTGTGGGTCTGTTTGA-3′ 5′-AGCAGCCTCCCGAGACA-3′ 
AGRP 5′-GGATCTGTTGCAGGAGGCTCAG-3′ 5′-TGAAGAAGCGGCAGTAGCACGT-3′ 
NPY 5′-GGTCTTCAAGCCGAGTTCTG-3′ 5′-AACCTCATCACCAGGCAGAG-3′ 
MC4R 5′-CTTATGATGATCCCAACCCG-3′ 5′-GTAGCTCCTTGCTTGCATCC-3′ 
GHSR 5′-TCCGATCTGCTCATCTTCCT-3′ 5′-GGAAGCAGATGGCGAAGTAG-3′ 
ORX 5′-GCCGTCTCTACGAACTGTTGC-3′ 5′-CGCTTTCCCAGAGTCAGGATA-3′ 
OXT 5′-CCTACAGCGGATCTCAGACTG-3′ 5′-TCAGAGCCAGTAAGCCAAGCA-3′ 
OXTR 5′-TCTTCTTCGTGCAGATGTGG-3′ 5′-CCTTCAGGTACCGAGCAGAG-3′ 
PENK 5′-CGACATCAATTTCCTGGCGT-3′ 5′-AGATCCTTGCAGGTCTCCCA-3′ 
DYN 5′-GACAGGAGAGGAAGCAGA-3′ 5′-AGCAGCACACAAGTCACC-3′ 
MOR 5′-CCTGCCGCTCTTCTCTGG-3′ 5′-CGGACTCGGTAGGCTGTAAC-3′ 
KOR 5′-CACCTTGCTGATCCCAAAC-3′ 5′-TTCCCAAGTCACCGTCAG-3′ 
PNOC 5′-AGCACCTGAAGAGAATGCCG-3′ 5′-CATCTCGCACTTGCACCAAG-3′ 
ORL1 5′-ATGACTAGGCGTGGACCTGC-3′ 5′- GATGGGCTCTGTGGACTGACA-3′ 
GLP1R 5′-ATGGCCAGCACCCCAAGCCTCC-3′ 5′-TCAGCTGTAGGAACTCTGG-3′ 






In the non-choice acceptance tests, sated adult mice and rats showed very low levels of 
consumption of a ‘bland’ cornstarch emulsion, whereas intakes of the GM (mice, F(3,30) = 
62.8, p < 0.001; rats, F(3,32) = 25.5, p < 0.001) and CM (mice, p < 0.001; rats, p < 0.001), as 
well as of the sucrose solution (mice, p < 0.001; rats, p < 0.001), were several times higher than 
of cornstarch. Energy-deprived animals had a higher baseline intake of cornstarch, but 
consumed significantly more sucrose (mice, F(3,32) = 9.77, p ≤ 0.001; rats, F(3,26) = 5.5, p = 
0.039), GM (mice, p < 0.001; rats, p = 0.0023), and CM (mice, p = 0.034; rats, p = 
0.0083; Figure 2.1 A–D). Similarly, both deprived and sated adult individuals ate more GM- 
and CM-enriched pellets than standard chow (sated mice: F(2,19) = 5.9, GM, p = 0.029 and 
CM, p = 0.011; sated rats: F(2,19) = 20.5, GM, p < 0.001 and CM, p = 0.0011; deprived 
mice: F(2,19) = 6.5, GM, p = 0.0058 and CM, p = 0.034; deprived rats: F(2,22) = 10.8, 
GM, p < 0.001 and CM, p = 0.0442; Figure 2.1E–H). Adolescent and aged sated mice and rats 
(Figure 2.2A,B,E,F) given episodic 2-h access to one of the solutions, consumed more GM 
(adolescent mice, F(3,35) = 42.7, p < 0.001; rats, F(3,36) = 16.9, p < 0.001; aged mice, F(3,29) 
= 31.2, p < 0.001; rats, F(3,29) = 18.9, p < 0.001), CM (adolescent mice, p < 0.001; rats, p < 
0.001; aged mice, p < 0.001; rats, p < 0.001) and sucrose (adolescent mice, p < 0.001; rats, p < 




Figure 2.1 Episodic 2-h consumption of individually presented (acceptance) cornstarch, 
sucrose, GM, and CM isocaloric solutions (A–D), and of standard, GM- and CM-enriched 
chow (E–H) in sated (nondeprived) and energy-deprived mice (left panel) and rats (right 





Figure 2.2: Episodic 2-h consumption of individually presented cornstarch, sucrose, GM, and 
CM isocaloric solutions (A,B,E,F: acceptance) and simultaneously given GM and CM 
(C,D,G,H: preference) in adolescent and aged sated mice (left panel) and rats (right panel). 
*, p ≤ 0.05; ***, p ≤ 0.001.  
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When given a 2-h episodic choice between GM and CM, all age cohorts of rats (adolescent, p < 
0.001; adult, p < 0.001; aged, p < 0.001) and adult and aged mice (p = 0.012 and 0.011, 
respectively) preferred GM (Figure 2.2C,D,G,H and Figure 2.3A,B). During a brief, 30-min 
exposure to both GM and CM in cages equipped with lickometers, adult rats exhibited a more 
robust response to GM cumulatively over that period (p = 0.01) as well as during the first (p = 
0.037) and second (p = 0.05) 5-min time interval of the meal (Figure 2.3C,D). There was a 
trend approaching significance (p = 0.088) toward an increase in the cluster number (number 
of licking bouts) of GM over CM, and a significantly greater cluster length of each GM than 
CM bout (p = 0.022; Figure 2.3E,F). In choice experiments involving GM- and CM-enriched 
chow, adult and aged rats (p = 0.009 and 0.023, respectively) and adult mice (p = 0.028) 
preferred GM chow, whereas in aged mice, a trend toward GM preference was detected (p = 
0.059) (Figure 2.4A,B). Adult rats given a 72-h uninterrupted access to a choice between GM 
and CM chow preferred GM chow (p < 0.001), while both GM (p = 0.015) and CM pellets (p < 




Figure 2.3: Episodic consumption of simultaneously presented GM and CM over 2-h in sated 
mice (A) and rats (B), lickometer activity during a 30-min exposure ((C): 0–30 min; (D): 5-
min intervals), the number of GM over CM licking bouts (cluster number) (E), and the cluster 




Figure 2.4 Consumption of simultaneously presented GM- and CM-enriched chow in adult and 
aged sated mice (A) and rats (B) over 2 h and simultaneously presented pellets (standard vs. 
GM; standard vs. CM, and GM vs. CM) over 72 h in adult rats (C).*, p ≤ 0.05; **, p ≤ 0.01; 
***, p ≤ 0.001.  
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Real-time PCR analysis after consumption of the two milk formulations (GM: 19.27 +/− 0.18 
g; CM: 18.44 +/− 0.17 g) revealed that GM upregulated in the NAcc PNOC (p = 0.0164), 
ORL1 (p = 0.0042), Cx36 (p = 0.0017), GLP1R (p = 0.0015), MC4R (p = 0.002), OXT (p < 
0.001), and GHSR (p < 0.001) genes, whereas mRNA levels of PENK were lower (though it 
did not reach significance with a p value of 0.01), compared with CM consumption. In the 
hypothalamus, MOR (p = 0.045) and KOR (p = 0.017) transcript levels were higher after GM 
consumption, and in the brain stem there was a trend toward upregulation of the MC4R (p = 
0.099) and the MC3R was upregulated (p = 0.0275; Figure 2.5). Compared to water controls, 
in the NAcc, GM affected expression of ORL1 (p = 0.012), Cx36 (p = 0.0052), GLP1R (p = 
0.0042), MC4R (p = 0.0053), OXT (p = 0.0149), and GHSR (p < 0.001); in the hypothalamus, 
ORX (p = 0.0164), KOR (p = 0.0399), and MC4R (p = 0.0403). On the other hand, 






Figure 2.5: Relative expression of feeding-related genes in the nucleus accumbens (A), 
hypothalamus (B), and brain stem (C) of mice maintained for 24 h on GM or CM. Water served 
as a baseline tastant. a – significantly different from the water group; b – significantly different 
from the CM group. Analysis performed with ANOVA followed by Bonferroni’s test and 




Enhanced motivation to eat in the absence of an immediate need to replenish calories or 
continuation of a meal beyond levels that restore energy balance typically occur when an 
individual is given access to food that is highly palatable. In laboratory animal models, 
similarly to what is observed in humans, a variety of tastants are perceived as palatable. Those 
include ingestants whose palatability is derived mainly from the flavour and/or postabsorptive 
effects of either a single macronutrient (e.g., sucrose-sweetened solutions) or from the complex 
contribution of multiple nutritive components (e.g., in meat rich in protein and fat) (Levine et 
al., 2003; Martire et al., 2013; Martire et al., 2014). Calorie density of food (especially when 
coupled with high energy needs of an organism) is an additional factor that affects the liking 
of and preference for a given food (Drewnowski, 1998; Olszewski et al., 2011).  
The current set of studies show that both GM and CM and milk-enriched solid diets are highly 
palatable. In no-choice acceptance paradigms, energy non-deprived rats and mice of all age 
groups (adolescent, adult, and aged) consumed GM and CM as avidly as the calorie-matched 
15% sucrose solution (used here as a positive control for a highly palatable tastant in rodents 
(for review, see (Levine et al., 2003)), while ingesting only minimal amounts of the ‘bland’ 
cornstarch. A similar phenomenon was observed in energy-deprived animals, although the 
amount by which GM, CM, and sucrose intakes exceeded that of cornstarch was not as 
pronounced as in sated rodents. That was due to the vigorous energy deficit-driven 
consumption of cornstarch and a ‘ceiling effect’ that prevents ingestion of large amounts of the 
solutions during the brief refeeding period. Importantly, GM and CM enrichment of laboratory 
chow stimulated intake in both hungry and sated animals well above the level of standard 
pellets. It indicates that both GM- and CM-derived palatability is a generalised phenomenon, 
not limited to liquid milks, but extending to solid foods that contain milk powder. This is in 
concert with the ability of other palatable tastants (including, but not limited to, fat, sucrose, 
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and select amino acids) to have a positive gustatory effect when presented as a component of 
both liquid and solid foods (Moran & Ladenheim, 2016). The fact that not only adolescent and 
adult animals, but also the aged ones, readily consume GM and CM suggests that age-related 
decline in hedonic processing (Gosnell et al., 1983; Landi et al., 2016; Tenk et al., 2017; Tomm 
et al., 2018) does not completely abolish a drive to eat milk-based diets. Instead, a slightly 
depressed intake of GM and CM at an old age parallels that reported for sweet solutions, as 
shown here and by other authors (Shin et al., 2012; Inui-Yamamoto et al., 2017; Sakai et al., 
2017). This finding is particularly relevant from the standpoint of being able to use palatable 
GM or CM as nutritionally superior alternatives to, e.g., sucrose-sweetened tastants in aged 
individuals (Morley, 2013). That adolescent rodents also consume large quantities of both milk 
types indicates that prolonged dietary habituation is not required to develop the liking of either 
GM or CM. In fact, the amounts of GM and CM ingested by juveniles were as high as the 
volume of sucrose (readily consumed in large quantities by young animals, e.g., see (Naneix 
et al., 2016)) even though the individuals had had only two brief exposures to these solutions 
prior to the experiment. 
The single-tastant scenarios above strongly suggest a high acceptance level for both GM and 
CM indicating they are palatable, but as these no-choice paradigms produced fairly similar 
feeding responses, choice studies were needed to define relative preference for these two milk 
types. Simultaneous 2-h exposure to two bottles containing GM and CM showed that adult and 
aged mice and rats as well as adolescent rats exhibit a marked preference for GM (adolescent 
mice were the only cohort in which GM and CM were iso-palatable). The preference for GM 
did not appear to be related to whether the animals’ pre-exposure to the specific diets was 
simultaneous (such as in adolescents and adults) or sequential (aged rodents). This finding was 
further expanded by employing the 30-min lickometer analysis in adult rats. It showed 
approximately four times as many licks at the bottle containing GM compared to CM during 
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the first 5 min of the meal, and twice as many licks at the GM bottle in the subsequent 5-min 
interval. Overall, the licking activity at both bottles occurred within the same timeframe with 
neither milk type being ingested in a prolonged fashion. It increases our confidence in that 
motivation to consume palatable GM rather than maintenance of a meal (due to, e.g., delayed 
satiation (Glass et al., 2001)) is the main reason for avid intake of GM. The analysis of the 
licking bouts provides additional support for this notion. The cluster number (total number of 
bouts) neared significance for GM, possibly reflecting the incentive motivational properties of 
the food stimulus; importantly, the relationship of motivation and this measure reflects post-
ingestive negative feedback (Davis & Smith, 1992; Higgs & Cooper, 1998; D'Aquila, 2010; 
Dwyer, 2012; Mendez et al., 2015). On the other hand, the average cluster length—
significantly greater for the GM formulation—typically parallels the hedonic properties 
(mainly, orosensory pleasure) of ingestive stimuli (as reviewed, e.g., in (Dwyer, 2012)). In this 
case, it is the length of clusters that appears to be the main driver for the preference for GM. A 
good example of the significance of licking bout length versus number in the context of neural 
regulation of food intake comes from studies on the endogenous opioid system. Ostlund et al. 
found that mu opioid receptor (MOR) knockout (KO) mice show alterations in sucrose licking: 
while energy-deprived wild-type mice increased burst length, relative to the nondeprived 
condition, this aspect of licking was insensitive to changes in food deprivation in MOR KOs. 
The rate of sucrose and sucralose licking in KOs was lower than in wildtype animals, providing 
evidence that the MOR was involved in processing palatability (Ostlund et al., 2013). Mendez 
and colleagues reported that proenkephalin (PENK) KOs given a sucrose solution exhibited 
fewer bouts of licking (though the length did not differ) than wild type controls, indicating a 
diminished motivation to eat (Mendez et al., 2015). Finally, studies on the involvement of 
nociceptin/orphanin FQ (NOC) revealed that NOC administration initiates new bouts of licking 
for sweet solutions, which is in line with the notion of its potential relationship to motivational 
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aspects of feeding. Interestingly, energy-deprived NOC receptor KO mice given sucrose 
showed longer bouts of licking than wild types, suggesting that, under hungry conditions, NOC 
may also affect hedonics of consumption (Mendez et al., 2016). 
The notion that satiety is not delayed by GM intake is supported by the experimental work 
exploring satiating effects of a CM- versus GM-based meal in humans. In their study, Rubio-
Martín et al. presented healthy adults with GM-based or CM-based breakfast after an overnight 
fast and obtained blood samples and appetite ratings from the subjects just before and up to 5 
h after completion of the meal. They found that that the ‘desire to eat’ rating was significantly 
lower and hunger rating tended to be lower after the GM breakfast. Interestingly, the area under 
the curve (AUC) for a satiety hormone glucagon-like peptide-1 was inversely associated with 
the AUChunger and AUCdesire-to-eat after the GM meal (Rubio-Martín et al., 2017). 
The aforementioned data obtained in human observations combined with the current results of 
our experiments in animal models suggest that even though composition differences between 
GM and CM are relatively minor, they are sufficient to significantly affect appetite-related 
parameters. It remains to be elucidated whether these effects are produced by a specific 
macronutrient component, a combination of nutritive components, and/or some physico-
chemical characteristics of each milk type (e.g., micelle structures in GM vs. CM differ in 
diameter, hydration, and mineralization) (Park et al., 2007). 
The analysis of mRNA levels of feeding-related genes sheds more light on neural processing 
underlying enhanced preference for GM over CM. One of the most striking outcomes is the 
fact that, unlike in the NAcc, which showed an increase in multiple mRNA profiles after GM 
over CM, there are relatively few significant differences in gene expression in the 
hypothalamus and brain stem. Those two brain areas serve as the foundation for the control of 
energy homeostasis and consumption-related changes in the internal milieu associated with 
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plasma osmolality, stomach distension, and defence from exposure to food-borne toxins 
(Klockars et al., 2019). In this network, the brain stem acts as the relay station between the 
periphery and the central nervous system, whereas the hypothalamus plays an endocrine role 
(by releasing, e.g., anorexigenic hormones, such as oxytocin (OXT) via the neurohypophysis) 
and innervates a number of central target sites (it includes the reciprocal connectivity with the 
brain stem, as well as multiple pathways with, among others, nigrostriatal and hippocampal 
structures). It is noteworthy that, despite the same level of intake of GM and CM over the 24-
h period, the hypothalamic expression of NPY and orexin (ORX) was lower in the GM group. 
Both ORX and NPY in the hypothalamus enhance consumption chiefly by increasing hunger 
and motivating intake of energy-dense tastants (Levine et al., 2004; Nixon et al., 2012). Thus, 
these data suggest that enhanced preference for GM over CM of the shorter choice and no-
choice scenarios does not stem from the stimulation of neural mechanisms that lead to hunger-
driven feeding. In line with the aforementioned conclusion from feeding experiments that the 
increased preference for GM vs. CM in choice scenarios is unlikely to be related to suppressed 
satiety signalling, we found that the brain stem expression of satiation promoting melanocortin 
receptors (Wirth et al., 2001; Girardet & Butler, 2014) is elevated after consumption of GM (it 
remained the same in the hypothalamus). This change in the receptor mRNA level coupled 
with the lack of a difference in the melanocortin ligand precursor gene expression 
(proopiomelanocortin, POMC) as well as in the anorexigenic OXT gene (Olszewski et al., 
2010; Olszewski et al., 2016) suggests the lack of impairment in central satiety processing after 
GM (and, surprisingly, even a somewhat greater sensitivity of the molecular network 
promoting satiety in response to GM consumption). 
Interestingly, the hypothalamic genes whose expression was elevated by GM intake were those 
encoding the MOR and kappa (KOR) opioid receptors (MOR and KOR brain stem and 
accumbal mRNA levels were also higher, though the difference did not reach statistical 
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significance). Furthermore, in the NAcc, we found overexpression of genes coding for opioid-
related NOC and this peptide’s receptor, ORL1. Opioid receptors are directly implicated in the 
regulation of feeding for reward (Glass et al., 2001; Gosnell & Levine, 2009). They are part of 
a dispersed network that includes the NAcc as one of the key sites mediating hedonic aspects 
of eating behaviour. They are also expressed throughout the ‘homeostatic’ components of the 
feeding-related circuit (Olszewski et al., 2008), including the hypothalamus and brain stem, 
where they are theorised to promote excessive consumption of palatable tastants by delaying 
meal termination. The magnitude at which opioid receptor agonists, such as butorphanol 
tartrate, dynorphin and beta-endorphin, stimulate consumption parallels the relative palatability 
of foods (Gosnell et al., 1986; Gosnell & Levine, 2009). Conversely, opioid receptor 
antagonists, e.g., naltrexone and naloxone, are particularly effective at reducing intake of tasty 
ingestants (Giraudo et al., 1993). Hence, higher expression of the MOR and KOR mRNA after 
GM is in line with the observed preference for the GM over CM. Changes in expression of 
additional NAcc genes that underscore the functional relationship between GM intake and 
reward processing include upregulation of Cx36 mRNA, as Cx36 ensures proper synchrony of 
dopaminergic pathways (Steffensen et al., 2011), and of the growth hormone secretagogue 
receptor (GHSR) mRNA, considering that the GHSR in the NAcc has been found to mediate 
hedonics of ingestive behaviour (Skibicka et al., 2013). Again, as in the case of the 
hypothalamic gene expression analysis, genes encoding molecules that promote satiety – such 
as OXT, melanocortin receptor 4, and glucagon-like peptide-1 receptor (Kanoski et al., 2016) 
– were upregulated after GM, which points to the heightened reward processing rather than 
impaired satiation as the factor propelling preference toward GM over CM. 
2.6 Conclusions 
In laboratory animal models, GM and CM are highly palatable when presented as liquids and 
as components of solid diets. Diet choice paradigms reveal preference for GM over CM in mice 
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and rats belonging to different age groups. Feeding studies and analyses of gene expression in 
the feeding-relevant brain circuit point to feeding reward as the main factor underlying 
preference for GM. The complex nutritional profile of milk varies between species. With the 
use of skim milk with low lipid content, macronutrient variation eliciting preference for GM 
over CM would be attributed to either lactose or milk protein fractions. Incorporation of milk 
into human diets comes with modification of milk composition, often with adjustment of the 
protein fraction. The predominance of CM in western societies is reflected in a bias in literature 
concerning acceptance and postprandial effects of whey and casein fractions, the two major 
milk proteins, in which CM proteins are widely utilised over other species milks. There is 
suggestion that modifying protein fractions in milk diets alters digestive and post-absorptive 
consequences. However, with differences in protein compliments between CM and GM and 
the variation in acceptance and preference observed here, little is known regarding acceptance 
of modified whey and casein content across species milks with altered patterns of intake, 
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Changes in feeding and related brain activity and 
gene expression in mouse model following 
consumption of goat’s milk formulations with 
variable whey and casein content.  
3.1 Abstract 
In the previous chapter, preference for goat’s milk (GM) over cow’s milk (CM) was shown in 
laboratory animal models in choice scenarios. Across different ages, animals exhibited avid 
consumption of GM-based liquid and solid diets. Preference was driven with reward-related 
signalling in opioidergic and dopaminergic systems. In this chapter, I describe the 
modifications to feeding behaviours and central signalling following GM-derived formulations 
with natural and adjusted whey to casein content. Adjustment of protein content in animal milk-
based formulations is done to modify protein and energy levels, to ensure adequate amino acid 
intake and to affect satiety. The shift from the natural whey:casein ratio of 20:80 in animal milk 
formulations for adults and for infants is oftentimes done to reflect the 60:40 whey:casein ratio 
of human milk. Recent studies show altered digestion and metabolic parameters accompany 
modified whey:casein – in vitro and adult studies showed that 20:80 versus 60:40 whey:casein 
milks differently affect casein proteolysis rate, glucose metabolism and hormone release; these 
data are supported by animal model findings. Importantly, it is unknown whether the 
adjustment from the 20:80 to 60:40 ratio affects appetite and brain processes related to food 
intake. The current set of studies therefore focused on the impact of the 20:80-to-60:40 
whey:casein content shift in GM-derived formulation on food intake and feeding-related brain 
processes in the adult organism. In laboratory mice the 20:80 whey:casein GM formulation 
was consumed less avidly and was less preferred than the 60:40 formulation in short-term 
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choice and no-choice feeding paradigms. Appetite changes were reflected by altered hindbrain 
and hypothalamic mRNA expression of genes relevant to feeding, including the melanocortin 
system. They were also associated with changes in brain neuronal activation patterns assessed 
by the analysis of an immediate early gene product, c-Fos, in the nucleus of the solitary tract, 
area postrema, ventromedial hypothalamic nucleus and supraoptic nucleus. It is concluded that 
the shift from the 20:80 to 60:40 whey:casein ratio in GM-derived formulations affects short-
term feeding and relevant brain processes. 
3.2 Introduction 
In Chapter 2, variation in intake of goat’s milk (GM) and cow’s milk (CM) was described in 
laboratory animals. Rat and mice models exhibited avid consumption of GM over CM in both 
liquid and solid diets and across a range of ages. Analysis of relative gene expression in key 
brain regions regulating feeding noted altered expression of reward-related genes in 
opioidergic, dopaminergic and oxytocin-related pathways. Elevated consumption of GM 
driven by reward reinforces species difference in consummatory outcomes, previously 
described in variable digestion and peripheral post-absorptive nutrient and hormone status. 
Chapter 2 serves as the first description of modified acceptance and preference with GM and 
CM, expanded upon in the next two chapters examining impact of modifying protein content 
of milk on appetitive behaviours.  
Milk and dairy products constitute a significant proportion of a typical diet and the nutritional 
benefits associated with their consumption stem from, among others, the macronutrient profile 
of milk, including the unique protein composition (Anderson & Moore, 2004; Chen et al., 
2014; Hirahatake et al., 2014; Pasiakos, 2015). Milk proteins consist primarily of whey and 
casein (Jahan-Mihan et al., 2011). Unlike the 60:40 whey:casein ratio of human milk, the 
protein fraction of animal milks (such as bovine and caprine milk predominantly available on 
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the consumer market) has the natural whey:casein ratio of approximately 20:80 (Park & 
Haenlein, 2013); and thus milk formulations used in human nutrition – most commonly infant 
formulas – are often whey-enhanced to match the 60:40 ratio (Goedhart & Bindels, 1994; 
Lönnerdal, 2003; Heird, 2007).  
It is well established that proteins, including those present in milk, affect appetite, body weight 
and metabolic parameters (Anderson & Moore, 2004; Zemel, 2004; Jahan-Mihan et al., 2011). 
Importantly, data show that whey and casein generate distinct physiological and appetitive 
responses by interacting with specific transporters and receptors in the gut, affecting nutrient 
absorption, modifying gastric emptying and gastrointestinal (GI) hormone release (Boirie et 
al., 1997b; Dangin et al., 2003; Anderson & Moore, 2004; Jahan-Mihan et al., 2011). Whey 
and casein have unique digestion kinetics and post-absorptive effects. Digestion of whey is 
rapid compared to casein: casein proteins aggregate into curds (Luiking et al., 2016; Wang et 
al., 2018), delaying delivery of constituent metabolites to the intestine (Boirie et al., 1997b; 
Marsset-Baglieri et al., 2014; Meyer et al., 2015; Dalziel et al., 2017). Plasma amino acid 
levels reflect digestion speed, with whey intake inducing higher, immediate increases in 
circulating amino acids (Boirie et al., 1997a; Hall et al., 2003; Calbet & Holst, 2004) and casein 
having delayed and lower but sustained hyperaminoacidemia (Boirie et al., 1997a).  
Consequently, whey and casein differentially influence the release of some consumption-
regulating hormones, which – in turn - likely produces a unique downstream central nervous 
system response, including activity of relevant brain systems that control appetite. While both 
fractions produce hypophagia via peptide YY (PYY) and its interaction with the Y2 receptor 
(Reidelberger et al., 2013; Zapata et al., 2018), whey is a much more potent enhancer of 
cholecystokinin (CCK), glucagon-like protein 1 (GLP-1) and glucose dependent insulinotropic 
polypeptide (GIP) release (Hall et al., 2003; Marsset-Baglieri et al., 2014; Hoefle et al., 2015; 
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El Khoury et al., 2019). As plasma amino acids and gastrointestinal hormones influence 
feeding either through direct or vagal-mediated action on central pathways (Gietzen et al., 
1989; Blouet et al., 2009; Gartner et al., 2018a; Gartner et al., 2018b; Heeley et al., 2018), 
scarce prior literature indeed suggests differing effects of whey and casein at central feeding-
related circuits, with e.g. whey more effectively modulating serotoninergic activity (Orosco et 
al., 2004; Choi et al., 2009) and expression of select energy homeostasis regulatory genes 
(Potier et al., 2009; Andreoli et al., 2016; Nilaweera et al., 2017). Altered feeding patterns 
resulting from consumption of either fraction alone have been reported (Hall et al., 2003; 
Marsset-Baglieri et al., 2014; Pal et al., 2014; Singh et al., 2016).  
While evidence delineating the physiological responses to individually presented whey and 
casein exists, human or laboratory animal studies evaluating the physiological impact of those 
fractions ingested in milk formulations in two commonly encountered ratios, i.e., whey:casein 
60:40 and 20:80, are very scarce. This gap in knowledge is particularly surprising considering 
that these are common ratios in both adult and infant dairy-based nutrition, and one should not 
simplistically assume that the effect of combined whey and casein in milk formulation would 
be either negligible or merely ‘proportional’ to their adjusted content. In their 2019 study, (El 
Khoury et al., 2019) found that in healthy adults given a 60:40 versus 20:80 whey:casein milk 
beverage, a higher whey:casein ratio milk ingested along with high-carbohydrate cereal 
decreased postprandial glycemia in an insulin-independent manner, primarily through delayed 
gastric emptying (El Khoury et al., 2019). The authors also observed the preprandial glucose 
peaks to be lower and GLP-1 plasma levels to be elevated after ingestion of milk with the 60:40 
ratio. In line with that, obese rats showed greater improvements in glucose tolerance when fed 
whey than those given whey plus casein (Nilsson et al., 2007; Pezeshki et al., 2015). 
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Even though the search for an improved whey:casein ratio has been largely spurred by the 
intent to improve eating behavioural, nutritional and metabolic consequences of protein 
consumption, surprisingly, very little is known about potential appetite-related feeding and 
neural consequences that the departure from the natural 20:40 toward 60:40 whey:casein 
protein ratio in animal milk formulation may produce. This gap in knowledge is particularly 
critical since it can be presumed that the distinct feeding and neuroendocrine effects shown for 
whey and casein alone likely contribute to unique appetite-related changes induced by 
consumption of a formulation containing whey:casein combination at the ratio of 20:80 versus 
(whey-enhanced) 60:40. Surprisingly, the potential effects of such modification have never 
been studied. Therefore, the current study utilising adult laboratory mice was designed to 
determine whether an adjustment of the whey:casein ratio in protein-matched milk formulation 
from 20:80 to 60:40 (a) affects palatability and acceptability of the milk formulation in short-
term feeding paradigms, (b) whether it evokes a different pattern of activity in feeding-related 
brain sites after ingestion of the matched amount of one of the formulas, and (c) whether it 
promotes changes in expression of hypothalamic and brainstem genes critical in food intake 
regulation. Given the fractions’ differences in post-ingestive effects, it was speculated that 
appetite changes come through central mechanisms uniquely affected by modifications in 
whey-to-casein content. A standard caprine milk-based formula with the 20:80 versus 60:40 




3.3 Material and Methods 
3.3.1  Animals  
Adult male C57Bl mice were single-housed in a temperature-controlled (22 °C) room with a 
12:12 hour LD cycle (lights on 0900). Animals had ad libitum access to standard chow (Diet 
86, Sharpes Stock Feed, Wairarapa, New Zealand) and tap water unless stated otherwise. 
Groups were weight-matched. The procedures were approved by the University of Waikato 
animal ethics committee (approval #1057).  
3.3.2 Milk formulations 
The formulations were GM-based (Dairy Goat Cooperative, Hamilton, New Zealand). The 
control GM formula contained the natural protein ratio of 20% whey and 80% casein (20:80 
GM) whereas the novel formula had 60% whey and 40% casein (60:40 GM). They were stored 
as powder and prepared immediately before use by being reconstituted in water. All animals 
were pre-exposed to the formulas prior to the trials in order to prevent neophobia. Composition 
of formulations are detailed in Table 3.1.  
Table 3.1: Nutritional composition of GM formulations per 100 ml 
 kJ Protein (g) Whey protein (%) Fat 
(g) 
Carbohydrate (g) 
20:80 GM 278.1 1.3 20.0 3.5 7.5 
60:40 GM 275.5 1.4 60.0 3.5 7.1 
 
3.3.3 Feeding studies 




Table 3.2: Schematic of GM-based formulation treatment paradigms in adult mice 
 
3.3.3.1 Preference for the simultaneously presented GM formulas  
Mice (n=7-8/group) were acclimatised to two-bottle presentation of the formulations on two 
separate occasions one week prior to the trial. On the experimental day at 10:00, chow and 
water were removed from the cages and mice were simultaneously given access to two bottles, 
one containing the 20:80 GM formulation and the other, the 60:40 GM solution. Intake was 
measured after 2 hours by weighing the bottles and the data were expressed in grams. 
3.3.3.2 Energy deprivation-induced 2-hour intake of each GM formulation presented 
individually along with standard chow  
Mice (n=10/group) were deprived overnight of chow; water was available during that time. At 
10:00 they were given access to standard chow and a bottle containing either the 20:80 GM 
formulation or the 60:40 GM solution for 2 hours. Water was removed during the 2-hour meal 
as the formulas were the source of both calories and water. In an additional control scenario, 
in order to determine the impact of the formulations on consumption of standard chow, another 
group of mice (n=10) was refed with chow, but instead of either formulation, they received a 
bottle of water. Chow and fluid consumption was determined at the end of the 2-hour meal. 
 
79 
3.3.3.3 Intake of the formulas presented independently for 24 hours 
During a 24-hour pre-exposure period, to reduce neophobia, a water bottle in each cage was 
replaced with a bottle containing either the 20:80 GM formulation or the 60:40 GM test solution 
(chow was available). On the experimental day, both chow and water were removed (start at 
09:00) and a bottle containing either the 20:80 or the 60:40 GM formulation was placed in the 
cage. The formulations were the only source of both calories and fluid for the next 24 hours. 
Afterwards, formulation intake was measured in grams.  
3.3.4 Neuronal activation in feeding-related hypothalamic and brainstem 
areas after consumption of the same amount of the 60:40 GM versus 
20:80 GM formulation.  
Protooncogene c-fos is an immediate gene product elevated during activation of the neurone, 
with peak expression 30-60 minutes post-stimuli (Morgan & Curran, 1991), allowing tracing 
of central activity following food intake. The purpose of this experiment was to assess whether 
consumption of the same amount of the 60:40 GM formula induces a different pattern of 
neuronal activation in areas of the hypothalamus and brain stem that are crucial in the 
regulation of food intake compared to the 20:80 GM formula. 
Water and standard chow were removed from the cages and animals were presented with either 
20:80 or the 60:40 GM formulation (n=8) for 1 hour and allowed to drink ~1 g/g BW . Mice 
were then anaesthetised with intraperitoneal 35% urethane and perfused with saline (10 ml) 
followed by 50 ml of 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (pH 7.4) one 
hour after termination of diet exposure. Brains were dissected and postfixed in PFA at 4 °C 
overnight. Coronal 60 μm vibratome (Leica, Germany) sections were processed for c-Fos 
immunostaining. The sections were incubated in 3% H2O2 in 10% methanol (in tris-buffered 
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saline (TBS); pH 7.4) for ten minutes, then overnight in rabbit anti-c-Fos antibody (1:3000; 
Synaptic Systems, Goettingen, Germany) at 4 °C. Then sections were incubated for 1 hour in 
the secondary biotinylated goat-anti-rabbit antibody (1:400; Vector Laboratories, USA) and 
for 1 hour in avidin-biotin complex (1:800; Vector Laboratories, USA) at room temperature. 
0.05% DAB, 0.01% H2O2 and 0.2% nickel sulphate (Sigma, USA) were used to visualise cFos-
positive nuclei. All incubation utilised a mixture of 0.25% gelatin and 0.5% Triton X-100 
(Sigma, USA) in TBS. TBS was also used for intermediate rinsing. Sections were mounted 
onto gelatinised slides, dried and dehydrated in ascending concentrations of ethanol, soaked in 
xylene and embedded in and embedded in Entellan (Merck, Germany). Manual counting of c-
Fos immunoreactive nuclei was performed bilaterally in all regions (4-5 sections/animal) by a 
person blinded to group allocations at 10x and 40x magnifactions on Nikon microscope. 
Densities of c-Fos positive nuclei/mm2 were averaged per group.  
3.3.5 Hypothalamic and brainstem gene expression following 24-hour 
exposure to the 20:80 GM vs 60:40 GM formula  
Upon completion of the 24 hour 20:80 or 60:40 GM formula exposure (as described in Section 
3.3.3.3), the animals were sacrificed at 09:00 by cervical dislocation and the brain stem and 
hypothalamus were dissected. They were stored in 1 ml RNALater (Invitrogen, USA) at room 
temperature for 1 hour and then at -80°C until processing. 
Upon thawing, the tissue was transferred from RNALater to TRIzol (Life Technologies, USA; 
1ml/100mg tissue) and mechanically homogenised. Chloroform (0.2ml/100mg tissue) was 
added and samples were centrifuged at 4 °C for 20 minutes at 10,000× g. The clear phase 
containing RNA was siphoned, 0.5ml isopropanol was added and samples were put on ice for 
10 minutes. Samples were centrifuged again at 4 °C for 20 minutes at 10,000× g. The aqueous 
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phase was removed from the pellets which were resuspended in 0.3ml ethanol and centrifuged 
at 4°C for 10 minutes at 10,000× g. Ethanol was removed and the pellets were air-dried. 
8 µL of DEPC H2O and 1 µl of DNAse buffer (dNature, New Zealand) was added to the pellets. 
These were incubated with 1 µl DNAse (dNature, New Zealand) at 37 °C for 30 minutes. 
DNAse was inactivated with 1 µl stop buffer (dNature, New Zealand) addition and incubation 
at 67°C for 10 minutes. Removal of genomic DNA was confirmed via PCR using HOT 
FIREPol Blend Master Mix (dNature, New Zealand), then agarose gel electrophoresis. RNA 
concentrations were measured with a nanodrop. 
cDNA was synthesised from RNA using iScript Advanced cDNA synthesis kit (BioRad, New 
Zealand), confirmed with PCR followed by agarose gel electrophoresis. RT-qPCR determined 
relative expression levels of housekeeping genes (ActB, β-tubulin, H3B) and genes of interest. 
Reactions contained 4 µl of 25 ng/μl sample cDNA, 1 µl of each forward and reverse primers 
(5 µM), 10 µl iTaq Universal SYBR Green Supermix (BioRad, New Zealand) and 4 µl MilliQ 
water. Reactions were performed in duplicates alongside MilliQ water negative controls for 
each primer pair. Amplification protocol was initiated at 95 °C for 15 minutes, followed by 45 
cycles of 15 seconds at 95°C, 15 seconds at the primer-specific annealing temperature and 30 
seconds at 72 °C. Primers used are detailed in Table 3.3.  
Table 3.3: Forward and reverse primers for housekeeping and target genes used in RT-qPCR 
analyses of hypothalamic and brainstem relative gene expression following GM formulations 
Gene Forward Reverse 
ACTB 5′-AGTGTGACGTTGACATCCGT-3′ 5′-TGCTAGGAGCCAGAGCAGTA-3′ 
BTUB 5′-CGGAAGGAGGCGGAGAGC-3′ 5′-AGGGTGCCCATGCCAGAGC-3′ 
H3B 5′-CCTTGTGGGTCTGTTTGA-3′ 5′-CAGTTGGATGTCCTTGGG-3′ 
MC4R 5′-CTTATGATGATCCCAACCCG-3′ 5′-GTAGCTCCTTGCTTGCATCC-3′ 
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POMC 5′-GACACTGGCTGCTCTCCAG-3′ 5′-AGCAGCCTCCCGAGACA-3′ 
NPY 5′-GGTCTTCAAGCCGAGTTCTG-3′ 5′-AACCTCATCACCAGGCAGAG-3′ 
KOR 5′-CACCTTGCTGATCCCAAAC-3′ 5′-TTCCCAAGTCACCGTCAG-3′ 
MOR 5′-CCTGCCGCTCTTCTCTGG-3′ 5′-CGGACTCGGTAGGCTGTAAC-3′ 
DYN 5′-GACAGGAGAGGAAGCAGA-3′ 5′-AGCAGCACACAAGTCACC-3′ 
OXT 5′-CCTACAGCGGATCTCAGACTG-3′ 5′-TCAGAGCCAGTAAGCCAAGCA-3′ 
ORX 5′-GCCGTCTCTACGAACTGTTGC-3′ 5′-CGCTTTCCCAGAGTCAGGATA-3′ 
PNOC 5′-AGCACCTGAAGAGAATGCCG-3′ 5′-CATCTCGCACTTGCACCAAG-3′ 
OPRL1 5′-ATGACTAGGCGTGGACCTGC-3′ 5′-GATGGGCTCTGTGGACTGACA-3′ 
 
3.3.6 Statistical analyses 
Food intake and immunohistochemistry data were analysed with unpaired student’s t-test for 
two-group comparisons. In the case of the feeding study where three groups were compared 
with each other, a one-way ANOVA followed by Tukey’s post-hoc test with a correction for 
multiple comparisons was used. Analyses of qPCR data were performed with BioRad CX 
Manager software (BioRad, New Zealand), followed by unpaired student’s t test. Differences 
were considered statistically significant at p < 0.05. 
3.4 Results 
During a 2-hour two-bottle test in which the animals had a choice between the 20:80 and 60:40 
GM formulations, mice showed a significantly lower preference for the 20:80 formulation 
(Figure 3.1, p<0.0001), When the formulations were given independently (no choice between 
the formulas) along with the standard chow for 2 hours to overnight-deprived mice, the animals 
that had access to the 60:40 solution drank more than the mice given the 20:80 formula (Figure 
3.2, p=0.019). Chow intake did not differ between the two groups. Importantly, the comparison 
with the group that received water instead of a formula revealed that both formulas were 
preferred over water (F(2,27)=15.40; water vs 20:80 GM – p=0.034; water vs 60:40 GM – 
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p<0.001). Chow intake was lower in the formula groups than in water-given mice showing a 
strong trend approaching significance (water vs 20:80 GM – p=0.058; water vs 60:40 GM – 
p=0.065). Finally, in the 1-hour and 24-hour no-choice exposure to the 20:80 versus 60:40 GM 
formulations, mice drank equal volumes during the 1-hour exposure and less of the 20:80 GM 
solution in 24-hour exposure (Figure 3.3, P<0.001). 
 
Figure 3.1 Non-deprived animals consume less of the 20:80 whey:casein formulation than of 
the 60:40 GM formula during a 2-h episodic exposure of simultaneously presented diets. *** 
P ≤ 0.001. 
 
Figure 3.2: Mice overnight-deprived of food and refed for 2 h with 20:80 whey:casein GM 
formula + chow or with the 60:40 whey:casein GM formulation + chow or with water + chow 
most avidly ingested the 60:40 formula followed by the 20:80 GM solution and water. a – 
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significantly different from water intake; b – significantly different from 60:40 GM formula; c 
– significantly different the 20:80 GM formula intake. Significant when p<0.05. 
 
Figure 3.3: Mice given for 1 hour (left) or 24 hours (right) a single bottle of 20:80 or adjusted 
60:40 GM formulations avidly consumed the 60:40 formula during the 24 hour period. *** - 
P ≤ 0.001. 
A decrease in cFos immunoreactivity was observed in the hypothalamic supraoptic nucleus 
(SON; P=0.025) as well as the ventromedial hypothalamus (VMH; P=0.008) and the rostral 
nucleus of the solitary tract (rNTS; P=0.0308) after 1-hour exposure to the 20:80 whey:casein 
GM formula compared to the 60:40 diet (Figure 3.4). Increases in cFos IR were noted in the 
area postrema (AP, P=0.0066) and the caudal portion of the nucleus of the solitary tract (cNTS; 
P=0.0165). 
Real-time PCR analyses showed an increase in brainstem relative expression of the 
melanocortin receptor 3 (MC3R; p=0.03), orexin (ORX; p=0.028), oxytocin (OXT; p=0.003) 
and pro-opiomelanocortin (POMC; p=0.014) genes following consumption of the 20:80 GM 
formulation compared to the 60:40 formula (Figure 3.5). Increased expression of glucagon-like 
peptide-1 receptor (GLP-1R; p=0.033) and ORX (p=0.027) in the hypothalamus was also 






Figure 3.4: c-Fos immunoreactivity in brain sites related energy homeostasis increased in the supraoptic nucleus (SON), ventromedial 
hypothalamus (VMH) and rostral nucleus of the solitary tract (rNTS) and decreased in the area postrema (AP) and caudal nucleus of the solitary 
tract (cNTS) following the intake of the 60:40 versus 20:80 whey:casein GM formulation in mice that ingested equal volume of fluid during a 1-
hour session. Photomicrographs depict c-Fos in hypothalamic (A, B) and hindbrain (C-E) areas with significant change was noticed (20:80 GM 
formula: left panels; 60:40 formula: right panels). PVN – paraventricular nucleus; DMH – dorsomedial hypothalamic nucleus; ARC - arcuate 
nucleus; LHA – lateral hypothalamic area; DMV - dorsal motor nucleus of the vagus; iNTS – intermediate nucleus of the solitary tract; otr – optic 






Figure 3.5: Relative expression of feeding-related genes in the brain stem (top) and 
hypothalamus (bottom) after 24-hour consumption of the 20:80 whey:casein GM formulation 
versus the 60:40 whey:casein test solution. Lower brainstem expression of melanocortin 
receptor 3 (MC3R), orexin (ORX), oxytocin (OXT) and pro-opiomelanocortin (POMC) was 
observed after the 60:40 formulation consumption. Lower expression of glucagon-like protein 
1 receptor (GLP-1R) and ORX was noted in the hypothalamus after exposure to this diet. * - 





While adequate protein intake ensures availability of amino acids, especially the essential ones, 
and thus supports basic functioning of the organism, excessive protein load may promote 
adverse effects, such as acidosis or hypercalciuria potentially resulting in kidney disease. It is 
not surprising, therefore, that intake of protein is a highly regulated process. On the one hand, 
hunger increases a drive to seek all macronutrients, including protein. However, ingestion of 
high-protein food triggers early termination of consumption by promoting rapid satiation; and 
diets very high in protein are perceived as less palatable and their acceptability is relatively 
low. Although the phenomenon of protein intake control has been well described in human and 
laboratory animal studies, surprisingly little is known about the impact of modifications in 
protein fraction ratios on appetite. This lack of information is particularly critical in the context 
of adjusting whey:casein ratios from 20:80 content (i.e., closely resembling animal milks 
predominant on the consumer market, such as bovine and caprine) to 60:40 in milk 
formulations.  
The current study shows for the first time that a shift from the 20:80 to 60:40 whey:casein ratio 
in a formulation affects short-term consumption. Also intake of the 60:40 whey:casein milk 
produces a different neuronal activation pattern in feeding-related brain areas and a different 
expression of genes regulating food consumption in the hypothalamus and brain stem than does 
the 20:80 whey:casein standard formulation.  
Notably, in both the 2-hour and 24-hour exposure paradigms, regardless of the presence of 
other tastants, the 60:40 whey:casein formulation was consumed in larger quantities and it was 
preferred over the 20:80 ratio. This consistent outcome across the paradigms employed in this 
basic research project serves as compelling evidence in that a shift from the 20:80 to 60:40 
whey:casein ratio influences acceptability of and preference for milk formula in the short-term 
and it may potentially translate to long-term consequences for energy homeostasis. Structural 
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differences between whey and casein and, thus, disparate digestive and postabsorptive 
responses they evoke, to some extent explain how a change in the proportion of these two 
fractions contributes to feeding. Casein micelles coalesce in the stomach and form a curd, 
whereas whey passes through the stomach intact (Luiking et al., 2016; Wang et al., 2018). The 
relative speed of whey digestion is reflected in absorptive processes where more rapid 
availability of amino acids increases rate of uptake. Whey produces rapid transient peaks in 
plasma amino acid content whereas delayed gastric emptying of caseins produces a slower but 
prolonged elevation of amino acids (Boirie et al., 1997a; Hall et al., 2003; Calbet & Holst, 
2004). Whey-enhanced formulations are more susceptible to heat-induced protein 
glycation (Meyer et al., 2011; Prosser et al., 2019) that may reduce their digestibility (Wada & 
Lönnerdal, 2015) and perturb the gut bacteria (Seiquer et al., 2014). Not surprisingly, 
anorexigenic hormone levels vary upon whey versus casein consumption (Blouet et al., 2009; 
Potier et al., 2009; Pal et al., 2014; Meyer et al., 2015; Andreoli et al., 2016; Singh et al., 
2016). For example, addition of whey to diets fed to obese rats increases PYY mRNA 
expression and secretion as well as feeding; and the reduction in food intake is reversed by 
PYY receptor-2 antagonists. Changes in brain activity have been noted in serotonergic and 
energy regulating pathways (Semon et al., 1987; Travers, 2002; Seiquer et al., 2014; Stratford 
et al., 2017; Jinno et al., 2020), though the latter ensues after long-term feeding.  
In the context of the general understanding of whey and casein influence on feeding-related 
mechanisms, the data obtained here further support the notion that while each of the protein 
fractions alone specifically alters appetite and appetite-related physiological parameters, actual 
effects of the combined fractions cannot be simplistically extrapolated as proportional to the 
mere whey:casein ratio. In fact, generalization of appetitive and metabolic effects of whey and 
casein may be far from possible unless studied in conjunction with specific ratios and with 
specific foods in which these fractions are used. Indeed, data obtained in previous reports in 
which only one fraction or the other was added to diets or administered as a preload, are 
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confusing and oftentimes contradictory. For example, some authors suggested that whey might 
be suppressing food intake more effectively than casein (Hall et al., 2003; Pal et al., 2014). On 
the other hand, Marsset-Baglieri et al. (2014) found that a liquid snack of whey or casein alone 
or in combination was effective in suppressing appetite in overweight subjects compared to a 
maltodextrin control snack, however, there was no difference in satiation potency between the 
protein groups (Marsset-Baglieri et al., 2014). Potier et al. (2009) gave adult subjects a cheesy 
snack containing either casein or whey+casein (66:33) as a meal preload (Potier et al., 2009). 
While the preloads lowered intake at the subsequent meal, no differences were observed 
between the casein and whey+casein groups.  
In order to identify the feeding-related physiological consequences of the departure from the 
conventional 20:80 to the ‘whey-enhanced’ 60:40 ratio, activation and neuronal activation 
changes were examined in the hypothalamic and hindbrain circuits relevant to appetite 
regulation. In the brainstem, c-Fos immunoreactivity was increased in the rostral nucleus of 
the solitary tract (rNTS) and decreased in the area postrema (AP) and caudal nucleus of the 
solitary tract (cNTS). Immediate response to the 60:40 whey:casein content appears to 
incorporate gustatory-related signalling through increased rNTS activation, a region with 
significant gustatory and sensory input (Rinaman, 2010). The rNTS displays enhanced activity 
following oral delivery of strong flavoured tastants, such as sweet sucrose, bitter quinine, or 
sour citric acid (Harrer & Travers, 1996; King et al., 1999; Travers, 2002; Stratford et al., 
2017). Additionally, activity in the cNTS suggests a role of visceral input contributing to 
appetitive behaviours. Vagal efferents terminating in the cNTS and the relative permeability of 
the blood brain barrier in the brain stem allow the combined visceral sensation and circulating 
nutrients to modulate activity of broader brain pathways (Horst et al., 1989; Rinaman, 2010). 
The NTS projects extensively to energy homeostasis-related and appetite regulating regions 
including the PVN, LHA and DMH (Horst et al., 1989). 
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In the hypothalamus, the 20:80 whey:casein formulation intake was associated with reduced 
neuronal activity in the supraoptic nucleus (SON) and the ventromedial hypothalamus (VMH). 
The reduced Fos in these two areas may at first seem counterintuitive. Classically, the SON 
has been linked with satiety processing as it is targeted by appetite suppressing cocaine-
amphetamine-regulated-transcript, CCK and GLP-1 and it releases – among others - 
anorexigenic oxytocin (Marsset-Baglieri et al., 2014; Stanstrup et al., 2014; Hoefle et al., 
2015). However, it should be noted that a greater level of c-Fos immunoreactivity in the SON 
has been linked with palatable high-sugar diet consumption (Hume et al., 2017). Furthermore, 
oxytocin has been also suggested to be relevant to hedonic feeding and food preferences, 
particularly in relation to sugar consumption. As for the VMH, neurons in this area are able to 
sense glucose, with some being excited by an increase in glucose concentration, while others 
inhibited by it, the phenomenon specific to subdivisions of this hypothalamic region (Kang et 
al., 2004). It is important to note that an increase in the activity of VMH neurons has been 
observed in rats upon sweet taste receptor stimulation with palatable caloric sucrose and non-
caloric saccharin solutions (Rao & Prabhakar, 1992). Therefore, it is possible that the higher c-
Fos levels observed in the VMH and SON in animals exposed to the 60:40 formula is a 
consequence of enhanced palatability of the whey-enhanced formulation. 
The relative gene expression analyses in the hypothalamus and brain stem following 24-hour 
exposure to the standard 20:80 versus 60:40 formulation revealed that the 20:80 ratio produced 
higher mRNA expression levels of anorexigenic genes such as MC3R, OXT and POMC in the 
brainstem and GLP1R in the hypothalamus. This suggests that consumption of the 20:80 
whey:casein formula is associated with changes in expression in the melanocortin, OXT and 
GLP-1 systems, the key players in ensuring early termination of food intake (and in the case of 
OXT – a possible interplay between the rewarding and satiating effects of the diets that differ 
in the whey:casein ratio; a hypothesis to follow up on with direct manipulation of OXT 




Feeding behaviours in mouse laboratory models is affected with the switch from the 20:80 to 
60:40 whey:casein in GM-based formulations. The latter is more readily accepted and preferred 
in choice scenarios. Altered feeding is accompanied by unique central function following either 
ratio. Notably, hindbrain activity suggests a strong gustatory and visceral response to formula 
intake. Different activity and expression of genes in hypothalamic structures suggest heighten 
satiety signalling with elevated melanocortin, OXT and GLP-1 system function with 20:80 
intake – and a potential link of OXT signalling and SON and VMH activity to sweet tastant 
ingestion.  
This set of studies focussed solely on response to GM-derived formulation. However, the 
variation in whey and casein profiles between GM and CM alters related peripheral processes. 
GM-specific casein content creating a looser curd in gastric conditions, facilitating easier 
proteolysis and accelerated gastric emptying compared to CM. Gastric digestion patterns of 
GM and CM formulations with modified whey:casein also exhibit species difference, with slow 
digestion of high casein CM formula mitigated in high casein GM formulations. However, 
comparative description of post-absorptive differences is scarce, with limited description of 
altered endocrine and circulating nutrient levels following these species milk intake. Chapter 3 
extends the current observations of altered feeding with GM formulations to examine response 
of the mice model to CM-derived formulations with the natural 20:80 and adjusted 60:40 
whey:casein ratios. I also re-examine GM preference in cross-species presentations described 
in Chapter 2, giving animals choice of formulations with the same or different ratio but sourced 
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Whey:casein adjustment in cow’s milk from 20:80 to 
60:40 affects food intake, brain stem and 
hypothalamic gene expression and neuronal 
activation whilst superseding preference for goat’s 
over cow’s milk. 
4.1 Abstract 
As described in Chapter 3, rodents display higher preference for whey-enhanced goat’s milk 
(GM) formulations (i.e., with a 60:40 whey:casein ratio) over a 20:80 whey:casein GM. 
Changes in feeding-related brain activity (defined through c-Fos mapping) and relative 
expression of genes accompanied this enhanced preference. However, it is unknown whether 
the heightened preference for the 60:40 milk would be retained if - instead of a highly palatable 
and preferred GM - a somewhat less preferred (albeit, still palatable) cow’s milk (CM) was 
used. Thus, in this chapter, I replicated feeding paradigms and analyses of brain gene 
expression and c-Fos IR with CM formulations with the natural 20:80 and adjusted 60:40 
whey:casein ratios. Mice given CM formulations exhibited higher preference for the 60:40 over 
20:80 whey:casein CM ratio. This elevated preference from the 60:40 CM was retained even 
when animals had simultaneous access to the 20:80 GM formulation. Consumption of similar 
quantities of 20:80 vs 60:40 CM differently affected cFos IR (in the paraventricular, 
dorsomedial, arcuate and lateral hypothalamic nuclei and in the nucleus of the solitary tract in 
the brain stem) and relative gene expression (the melanocortin and opioid system transcripts). 
It can be concluded that the 60:40 whey:casein milk formulations are palatable and they are 
more preferred regardless of the species from which the milk was derived, indicating that whey 
enhancement is a potent driver of milk overconsumption. Mechanistic commonalities in the 
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whey:casein ratio changes in CM versus those described for GM in Chapter 3 include the 
observed hindbrain neuronal activity changes. Differences in hypothalamic c-Fos IR and gene 
expression patterns as well as minor differences in no-choice feeding paradigms indicate that 
the species from which milk was derived modifies some feeding-related processes driven by 
the shift in the whey:casein ratio.  
4.2 Introduction 
As described in detail in the introductory section to Chapter 3 of this thesis, not only is the 
protein content of a diet important, but so is the actual composition of the protein fractions. In 
milk-based diets, two protein fractions are of particular significance: whey and casein. Apart 
from their presence alone, it is in fact their ratio that impacts on a number of ingestive and post-
ingestive processes related to, among others, gut, (neuro)endocrine, and metabolic functions 
(Kung et al., 2018; El Khoury et al., 2019; Ye et al., 2019). This altered physiological response 
to different whey:casein ratios is intuitive, given the outcomes of whey and casein intake are 
disparate – “fast” whey passes through the stomach and is absorbed quickly producing rapid, 
high peaks of plasma amino acids accompanied by strong hormonal release (Hall et al., 2003; 
Veldhorst et al., 2009; Sukkar et al., 2013) whilst “slow” casein clots in the stomach, extending 
digestion and amino acid absorption and – consequently - producing an (arguably) weaker 
hormonal response (Mahe et al., 1996; Boirie et al., 1997; Hall et al., 2003; Calbet & Holst, 
2004; Bowen et al., 2006; Choi et al., 2009; Veldhorst et al., 2009). Ye et al. (2019) observed 
altered gastric digestion with natural and adjusted milk formulations. Higher casein content in 
20:80 whey:casein cow’s milk (CM) formulations resulted in larger casein aggregates, slowing 
gastric digestion of proteins (Ye et al., 2019). Studies involving blood analyses (e.g. Kung et 
al. (2018); El Khoury et al. (2019)) have found altered hormonal response following cereal 
breakfasts served with CM with the natural versus adjusted whey:casein ratios. When given 
prior to ad libitum lunch, the 60:40 whey:casein milk produced lower blood glucose levels 
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whereas the 20:80 ratio, lower appetite (Kung et al., 2018). Lower blood glucose was insulin-
independent, likely being a result of delayed gastric emptying and post-prandial release of 
GLP-1, CCK.  
Furthermore, changes in whey and casein content affect the brain. It has been shown that post-
meal brain processing, particularly in serotonergic pathways, in individuals given milk protein 
(Choi et al., 2009; McManus et al., 2015; Andreoli et al., 2016; Nilaweera et al., 2017) is 
modified when whey and casein fractions are given in combination (Diepvens et al., 2008; 
Potier et al., 2009; Lorenzen et al., 2012; Marsset-Baglieri et al., 2014; Pezeshki et al., 2015). 
In my data presented in Chapter 3,I found that the whey-enhanced GM was more avidly 
consumed than the 20:80 GM formulation and that this was associated with unique gene 
expression and c-Fos immunoreactivity (IR) changes in feeding-related circuits. Specifically, 
intake of the 20:80 GM formulation downregulated melanocortin receptor 3 (MC3R), pro-
opiomelanocortin (POMC) and oxytocin (OXT) transcripts in the hypothalamus and glucagon-
like peptide 1 (GLP-1) receptor (GLP1R) mRNA in the hindbrain. Brainstem c-Fos in the 
rostral and caudal nucleus of the solitary tract (rNTS; cNTS) and hypothalamic ventromedial 
nucleus (VMH) were impacted by the whey:casein ratio shift. 
One has to consider, however, that the appetite and brain processing changes (presented in 
Chapter 3) upon an adjustment of the whey:casein ratio from the natural 20:80 to 60:40 as well 
as the previous report on whey/casein effects on the serotonergic system, do not take into 
account whether a similar response would be achieved if the whey:casein adjustment was done 
in a milk derived from another species. In other words, a plausible scenario that should be taken 
into account is that the milk ‘vehicle’ for whey:casein may affect a plethora of mechanisms 
induced by the two protein fractions. This is particularly important since GM formulations have 
different digestion patterns, with natural and adjusted ratios having comparable hydrolysis rates 
with smaller particulates than the 20:80 CM formulation (Ye et al., 2019). GM has relatively 
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lower concentrations of as1-casein, thus forms a looser curd in gastric conditions which is more 
easily digested (Ambrosoli et al., 1988; Glantz et al., 2010; Logan et al., 2015; Freitas et al., 
2019; Wang et al., 2019; Ye et al., 2019). As a consequence, post-absorptive and satiety 
response to GM intake is unique to that of CM. In line with that, a greater reduction in the 
desire to eat and subjective hunger has been shown in individuals given GM- than CM-based 
breakfast (Rubio-Martín et al., 2017), and this outcome was speculated to be related to GLP-1 
signalling and circulating triglyceride levels. Furthermore, as described in Chapter 2 of this 
thesis, central processes and feeding behaviours also differ in response to GM vs CM in 
laboratory rodents: Mice and rats prefer GM-based diets and expression of several feeding-
related genes is affected by consumption of those milk types. 
Given that variations in appetite for GM vs CM are underpinned by unique central processing 
following ingestion of each milk type, in the current Chapter of the thesis, I ask whether the 
heightened preference for the 60:40 whey:casein ratio in GM reported in Chapter 3 would 
persist if, instead of the GM, a CM-based formulation was given to the animals. Therefore, this 
chapter examines the response in animals fed with CM rather than GM formulations with 
natural 20:80 whey-to-casein ratio (control), vs the adjusted 60:40 ratio to examine (a) whether 
the modification of the whey:casein ratio affects palatability- and acceptability-related feeding 
parameters, (b) whether amount-matched consumption of either formulation elicits unique c-
Fos IR in feeding-related brain sites, and (c) whether 20:80 vs 60:40 whey:casein CM 
consumption leads to changes in expression of key regulatory genes in the hypothalamus or 
brainstem. Finally, animals’ preference for GM over CM (described in Chapter 2) was re-
evaluated in the context of the two whey:casein ratios to understand whether these ratios 




4.3 Material and Methods 
4.3.1 Animals 
Adult male C57Bl mice (AgResearch, Hamilton, New Zealand) were single-housed in a 
temperature-controlled room (22°C) with a 12:12 LD cycle (lights on at 0900). Animals had 
ad libitum access to standard chow (Diet 86, Sharpes Stock Feed, Wairarapa, New Zealand) 
and tap water unless stated otherwise. Groups were weight-matched. The studies were 
approved by the University of Waikato animal ethics committee (ethics approval number 
1057).  
4.3.2 Milk formulations  
CM- or GM-based milk formulations (Dairy Goat Cooperative, Hamilton, New Zealand) had 
the natural ratio of 20% whey and 80% casein (control solutions: 20:80 CM; 20:80 GM), 
whereas experimental formulations contained 60% whey and 40% casein (60:40 CM; 60:40 
GM). For composition, refer to Table 4.1. Formulations were powdered and reconstituted in 
tap water immediately before exposure. All animals were pre-exposed to the diets prior to the 
feeding trials to prevent neophobia. 
Table 4.1: Nutritional composition of prepared CM and GM formulations per 100 mL 
 kJ Protein (g) Whey protein (%) Fat (g) Carbohydrate (g) 
20:80 CM 286.5 1.6 20.0 3.8 7.3 
60:40 CM 273.5 1.4 60.0 3.4 7.2 
20:80 GM 278.1 1.3 20.0 3.5 7.5 
60:40 GM 275.5 1.4 60.0 3.5 7.1 
 
4.3.3 Feeding studies 
CM-based formulation treatment paradigms for adult mice are outlined in  
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Table 4.2  
 
102 
Table 4.2: Schematic of CM-based formulation treatment paradigms in adult mice 
 
4.3.3.1 Preference for simultaneously presented CM formulations 
Mice (n=7/group) were acclimatised to the two-bottle presentations in two separate sessions 
one week prior to the trial. On the experimental day at 10:00, chow and water were removed 
from cages and mice were given access to two bottles, containing either 20:80 or 60:40 CM 
formulations. Formulation intake after two hours was measured in grams. 
4.3.3.2 Preference of CM or GM formulations with 20:80 or 60:40 whey:casein ratios  
The two-bottle scenario in Section 4.3.3.1 was repeated, with mice (n=7/group) receiving 
access to CM or GM formulations with the control vs adjusted whey:casein ratio (20:80 CM 
vs 60:40 GM; 60:40 CM vs 20:80 GM) or with the same whey:casein ratio (20:80 CM vs 20:80 
GM; 60:40 CM vs 60:40 GM). Formulation intake after two hours was measured in grams. 
4.3.3.3 Intake of CM formulations in a 1-hour exposure paradigm 
Mice (n=8/group) had water and chow removed from cages at 08:00, and animals were then 
given a single bottle of control 20:80 adjusted 60:40 CM for one hour. Formulation intake was 
measured in grams. 
4.3.3.4 Intake of individually presented CM formulations in a 24-hour exposure paradigm 
On the experimental day, both chow and water were removed (at 09:00) and a bottle containing 
either the control 20:80 or the whey-adjusted 60:40 CM formulation was placed in the cage 
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(n=8/group). The formulations were the only source of both calories and fluid for the next 24 
hours. Afterwards, intake was measured in grams.  
4.3.4 Neuronal activation in feeding-related hypothalamic and brainstem 
areas after consumption of the same amount of the 60:40 versus 20:80 
CM formulation.  
The purpose of this experiment was to assess whether consumption of the same amount of the 
20:80 vs 60:40 whey:casein CM milk formulation (as described in described in 4.3.3.1 and akin 
to the c-Fos experiment presented in the previous chapter pertaining to GM) induces a different 
pattern of neuronal activation in the hypothalamus and brain stem, areas that are crucial in the 
regulation of food intake.  
One hour after exposure to the 20:80 or 60:40 CM formulation, mice were anaesthetised with 
35% urethane i.p. Animals were perfused with saline (20 mL) followed by 50 mL of 4% 
paraformaldehyde (PFA) in 0.1 M phosphate buffer (pH 7.4). Brains were removed and 
postfixed overnight in PFA at 4 °C. Coronal 60 μm sections created via vibratome (Leica, 
Germany) were processed for c-Fos immunostaining. Sections were incubated in 3% H2O2 in 
10% methanol (in TBS; pH 7.4) for ten minutes, then overnight in rabbit anti-Fos antibody 
(1:3000; Synaptic Systems, Goettingen, Germany) at 4°C. Tissues were incubated in goat-anti-
rabbit secondary antibody (1:400; Vector Laboratories, USA) then in avidin-biotin complex 
(Vector Laboratories, USA) at room temperature for an hour each. Peroxidase was visualised 
with 0.05% DAB, 0.01% H2O2 and 0.2% nickel sulfate (Sigma, USA). All incubation solutions 
utilised 0.25% gelatin and 0.5% Triton X-100 (Sigma, USA) in TBS. Intermediate washes 
were in TBS. Sections were mounted on gelatinised slides, dried and dehydrated with 
ascending concentrations of ethanol followed by xylene and subsequently embedded with 
Entellan (Merck, Germany). c-Fos IR nuclei were counted manually and bilaterally in all 
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regions (4-5 sections/animal) by a person blinded to group allocations at 10x and 40x 
magnifactions on Nikon microscope. Densities recorded as c-Fos positive nuclei/mm2 were 
averaged per group.  
4.3.5 Hypothalamic and brainstem gene expression following 24-hour 
exposure to the 20:80 CM vs 60:40 CM formulations  
Following 24-hour individual exposure to 20:80 or 60:40 CM formulation that results in the 
consumption of the same amount of the milk solutions (as described in section 4.3.3.4, 
n=8/group), mice were sacrificed via cervical dislocation at 09:00 and the brain stem and 
hypothalamus were dissected and stored for one hour in 1mL RNAlater (Invitrogen, USA) at 
room temperature and then at -80°C until processing. 
Thawed samples were transferred from RNAlater into TRIzol (Life Technologies, USA; 
1mL/100mg tissue). Following mechanical homogenisation, chloroform was added 
(0.2ml/100mg tissue). Samples were centrifuged for 20 minutes, 10,000× g at 4 °C. The clear 
phase was siphoned and RNA was precipitated with addition of 0.5mL of isopropanol with 
10minute ice bath incubation. Samples for were centrifuged again at 4°C for 20 minutes at 
10,000× g. Pellet was retained and washed in 0.3mL of ethanol and centrifuged at 4°C for 10 
minutes at 10,000× g. The ethanol was removed and pellet air dried.  
1 µL of DNAse buffer (dNature, New Zealand), 1 µL DNAse (dNature, New Zealand) and 8 
µL of DEPC water was added to the pellet and incubated at 37°C for 30 minutes, followed by 
67°C for 10 minutes with 1 µL stop buffer (dNature, New Zealand). Absence of DNA was 
confirmed with HOT FIREPol Blend Master Mix (dNature, New Zealand) PCR and agarose 
gel electrophoresis. RNA concentrations were determined with a nanodrop. 
Reverse transcription synthesised cDNA with iScript Advanced cDNA synthesis kit (BioRad, 
New Zealand) and was confirmed with PCR and gel electrophoresis.  
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RT-qPCR determined relative expression of housekeeping genes (ActB, β-tubulin, H3B) and 
genes of interest. Reaction mixes containing 4 µL of 25 ng/μL sample cDNA, 1 µL each of 
forward and reverse primers (5 µM), 10 µL iTaq Universal SYBR Green Supermix (BioRad, 
New Zealand) and 4 µL MilliQ water. Reaction were run in duplicate with MilliQ water 
negative controls for each primer pair. Amplification protocol was 95 °C for 15 minutes, 
followed by 45 cycles of 15 seconds at 95°C, 15 seconds at the primer-specific annealing 
temperature and 30 seconds at 72°C. Primers sequences used are detailed in Table 4.3.  
4.3.6 Statistical analyses 
Unpaired Student’s t test for two-group comparisons was used to analyse food intake and 
immunohistochemistry data. Analyses of qPCR data were performed with BioRad CX 
Manager software (BioRad, New Zealand), followed by unpaired Student’s t test. Differences 
were considered statistically significant at p < 0.05. 
Table 4.3: Forward and reverse primers for housekeeping and target genes used in RT-qPCR 
analyses of hypothalamic and brainstem relative gene expression following CM formulations 
Gene Forward Reverse 
ACTB 5′-AGTGTGACGTTGACATCCGT-3′ 5′-TGCTAGGAGCCAGAGCAGTA-3′ 
BTUB 5′-CGGAAGGAGGCGGAGAGC-3′ 5′-AGGGTGCCCATGCCAGAGC-3′ 
H3B 5′-CCTTGTGGGTCTGTTTGA-3′ 5′-CAGTTGGATGTCCTTGGG-3′ 
MC4R 5′-CTTATGATGATCCCAACCCG-3′ 5′-GTAGCTCCTTGCTTGCATCC-3′ 
POMC 5′-GACACTGGCTGCTCTCCAG-3′ 5′-AGCAGCCTCCCGAGACA-3′ 
NPY 5′-GGTCTTCAAGCCGAGTTCTG-3′ 5′-AACCTCATCACCAGGCAGAG-3′ 
KOR 5′-CACCTTGCTGATCCCAAAC-3′ 5′-TTCCCAAGTCACCGTCAG-3′ 
MOR 5′-CCTGCCGCTCTTCTCTGG-3′ 5′-CGGACTCGGTAGGCTGTAAC-3′ 
DYN 5′-GACAGGAGAGGAAGCAGA-3′ 5′-TCAGAGCCAGTAAGCCAAGCA-3′ 
OXT 5′- CCTACAGCGGATCTCAGACTG-3′ 5′-TCAGAGCCAGTAAGCCAAGCA-3′ 
ORX 5′-GCCGTCTCTACGAACTGTTGC-3′ 5′-CGCTTTCCCAGAGTCAGGATA-3′ 
PNOC 5′-AGCACCTGAAGAGAATGCCG-3′ 5′-CATCTCGCACTTGCACCAAG-3′ 
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OPRL1 5′-ATGACTAGGCGTGGACCTGC-3′ 5′-GATGGGCTCTGTGGACTGACA -3′ 
 
4.4 Results 
Mice given a choice between the 20:80 and 60:40 whey:casein ratio CM formulations more 
avidly consumed the whey-enhanced formulation (P<0.0001,Figure 4.1). This was also 
observed in milk cross-species (i.e., GM vs CM) simultaneous presentations of formulations 
with different whey:casein ratios (20:80 CM vs 60:40 GM; 60:40 CM vs 20:80 GM), where 
the 60:40 ratio was preferred regardless of species from which milk was derived (P<0.0001; 
Figure 4.2AB). When presented with formulations of the same whey:casein ratio (20:80 CM 
vs 20:80 GM; 60:40 CM vs 60:40 GM), GM formulations were preferred, significantly so for 
the 60:40 GM over 60:40 CM (P=0.0112) and with a trend approaching significance in the case 
of the 20:80 CM/GM combination (P=0.1210; Figure 4.2CD). In non-choice scenarios 
involving 1-hour and 24-hour tastant availability, there was no difference in the intake of 20:80 
and 60:40 CM formulations (Figure 4.3). 
 
Figure 4.1 Non-deprived animals consume less of the 20:80 CM whey:casein formulation than 
of the 60:40 CM formulation during a 2-h episodic exposure of simultaneously presented diets. 











Figure 4.2: Two bottle choice tests of CM or GM formulations. In milk cross-species 
presentation with different whey:casein ratios (A: 20:80 CM vs 60:40 GM; B: 60:40 CM vs 
20:80 GM), the adjusted 60:40 ratio formulations were consumed avidly regardless of species. 
In cross species presentation with the same whey:casein ratios (C: 20:80 CM vs 20:80 GM; D: 
60:40 CM vs 60:40 GM), the GM formulation were preferred in 60:40 choice. * - P ≤ 0.05; 
*** P ≤ 0.001 
 
Figure 4.3: Individual presentation of cow’s milk formulations for 1-hour (left) and 24-hour 




Intake of a similar amount of 20:80 vs 60:40 CM formulation over a 1-hour meal affected c-
Fos IR in 6 out of 13 sites following one-hour exposure to 20:80 or 60:40 CM formulations 
(Figure 4.4). Animals that consumed the 60:40 formulation had fewer c-Fos positive nuclei in 
the hypothalamic paraventricular nucleus (PVN; P=0.0046), dorsomedial hypothalamic 
nucleus (DMH; P=0.024), arcuate nucleus (ARC; P<0.001), lateral hypothalamic area (LHA; 
P<0.001), and in the caudal nucleus of the solitary tract (cNTS; P=0.0063) compared to the 
20:80 whey:casein CM-fed conspecifics. Higher c-Fos IR in the 60:40 than 20:80 whey:casein 
CM group was found in the rostral portion of the NTS (rNTS; P=0.0081).  
Mice consuming the 60:40 whey:casein CM formulation for 24 hours had increased brainstem 
expression of the melanocortin receptor 3 (MC3R; P=0.006) and opioid-like receptor 1 
(OPRL1, P=0.005) genes as well as reduced hypothalamic expression of neuropeptide Y (NPY) 
(Figure 4.5). Decreases in hypothalamic melanocortin receptor 4 (MC4R; P=0.067) and orexin 
(ORX; P=0.056) expression following 60:40 CM approached, but did not reach, significance.  
 
Figure 4.4: cFos immunoreactivity was higher in the rostral nucleus of the solitary tract (rNTS) 
and lower in the paraventricular nucleus (PVN), dorsomedial hypothalamic nucleus (DMH), 
the arcuate nucleus (ARC), lateral hypothalamic area (LHA) and caudal nucleus of the solitary 
tract (cNTS) following intake of the CM formulation with the natural 20:80 whey:casein (20:80 
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CM) compared to whey-adjusted 60:40 whey:casein ratio (60:40 CM). SON – supraoptic 
nucleus; VMH – ventromedial hypothalamic nucleus; NacS – nucleus accumbens shell; NacC 
– nucleus accumbens core; DMNV – dorsal motor nucleus of the vagus; AP – area postrema; 
iNTS – intermediate nucleus of the solitary tract; * - P ≤ 0.05; ** - P ≤ 0.01; *** - P ≤ 0.001. 
 
Figure 4.5: Brain stem (top) and hypothalamic (bottom) relative gene expression following 24 
hour consumption of the control 20:80 vs 60:40 CM formulation. 60:40 CM formulation intake 
was associated with increased expression of the melanocortin receptor 3 (MC3R) and opioid-
like receptor 1 (OPRL1) mRNA in the brainstem and reduced neuropeptide Y (NPY) gene 




Data presented in the previous Chapter 3 showed that laboratory mice more avidly consume 
GM with the adjusted 60:40 compared to the natural 20:80 whey:casein ratio and that this is 
associated with unique changes in feeding-related circuitry in terms of c-Fos immunoreactivity 
and expression of feeding-related genes. The studies included in the current Chapter expand on 
these findings by determining that the whey-enhanced ratio is more preferred to 20:80 even in 
another type of milk, namely in the bovine formulation, the milk known for gustatory and 
ingestive characteristics distinct from GM. Acute appetitive impacts with the shift from the 
natural to adjusted ratio in the CM-based formulation are accompanied by changes in neuronal 
activity in feeding regulatory regions and in relative expression of genes in relevant signalling 
pathways.  
Milk, including CM, is a palatable tastant and animals readily consume it even in the absence 
of energy needs (as shown, e.g., in Chapter 2). However, this set of data indicates that a 
whey:casein ratio modification in the protein fraction of CM affects preference for CM. In the 
feeding experiment that involved a choice between CM formulations containing the 20:80 vs 
60:40 whey:casein ratios, laboratory mice consumed approximately four times more of the 
whey-adjusted CM than of the natural 20:80 formulation. This profound preference for the 
60:40 CM was achieved in the paradigm that relied on merely 2 hours of the formulation 
presentation, thereby reflecting a greatly heightened drive to consume this solution. This level 
of the difference is indeed high: for example previous studies employing short-term, 
simultaneous presentations of isocaloric and isopalatable liquids containing fat vs sugar or 
different types of sweet solutions have shown differences within 10% of the consumed volume 
(Olszewski et al., 2010; Herisson et al., 2014), and a potent pharmacological treatment 
specifically aimed at affecting preference was able to make animals consume twice as much of 
one solution than the other (Herisson et al., 2014). Elevated consumption of the 60:40 
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formulation over the 20:80 ratio was similarly observed with GM-based formulations in 
Chapter 3, where mice also strongly preferred the adjusted GM formulation to a similar degree. 
Repetition of this pattern reaffirms the importance of whey:casein ratio on the palatability of 
milk formulations regardless of the species source.  
It should be noted that in the feeding experiment involving a non-choice presentation of CM 
containing either 20:80 or 60:40 whey:casein, we did not see a significant difference in 
consumption. However, a difference in intake is less frequently seen in paradigms that rely on 
a single tastant presentation than in choice paradigms. This is the case even with highly 
palatable tastants (e.g. sweet and fat solutions (Olszewski et al., 2010; Herisson et al., 2014)) 
or in fasted, and thus highly motivated, states (Kimura et al., 2003).  
The fact that short-term intake volumes of individually presented formulations were similar to 
the total volume consumed in choice paradigms as well as to the short-term palatable sucrose 
solution intake in Chapter 2 and in previous studies from our laboratory (Gartner et al., 2018), 
indicates that CM formulations regardless of their whey:casein ratio are palatable. 
Interestingly, unlike the GM-based 60:40 whey:casein formulation which was consumed in 
greater quantities than 20:80 even in the non-choice scenario, significantly so after 24 hours 
(see Chapter 3), this effect was absent in CM. This may suggest the additive effect of the more 
palatable whey:casein ratio and – as shown in Chapter 2 – the more preferred milk type (GM), 
was apparent through enhanced consumption even in the paradigm that did not involve a 
choice. 
Importantly, in cross-species milk formulation comparisons, the preference for GM over CM, 
observed with skim milks in Chapter 2, persisted somewhat with formulations with the same 
whey to casein ratio. Mice presented with the formulations derived from GM and CM with 
adjusted 60:40 ratio consumed significantly more of the GM formulation. A similar but 
nonsignificant trend for GM preference was observed with the 20:80 formulations, an 
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interesting observation as the protein composition of the 20:80 formula more closely resembles 
that of the skim milks in Chapter 2 that were not adjusted for protein content. It highlights the 
potential role of fat (both that was added in formulations and that was removed with skim 
milks) making species milks more palatable. It should be emphasised that alteration in 
whey:casein ratio supersedes preference derived from the species from which milk was 
sourced. When mice were provided with formulations of different whey and casein content, 
they displayed more avid consumption of the 60:40 GM or CM formulations over the 
alternative species 20:80 option. Most notably, whey:casein shifted the GM over CM 
preference with avid 60:40 CM formulation consumption over that of the 20:80 GM. This 
indicates the whey:casein ratio is a potent driver of consumption (and, potentially, 
overconsumption) of milk. Despite the potential synergistic effect between the milk type and 
whey:casein driving intake in non-choice paradigms, whey:casein appears to have the most 
critical impact on the preference for these solutions.  
Taking into account differences in preference for the 60:40 vs 20:80 whey:casein CM 
formulations, it is not surprising that consumption of similar amounts of each of the tastants 
resulted in a different response of brain circuitry in terms of c-Fos immunoreactivity (IR) as 
well as gene expression.  
The analysis of c-Fos IR in the hindbrain revealed that the animals given a more preferred 
60:40 whey:casein CM formulation had a higher level of neuronal activation in the rostral 
portion of the NTS (rNTS). Elevated activation of this area has been associated with oral 
delivery of flavoured tastants, e.g., sweet sucrose, bitter quinine, or sour citric acid (Harrer & 
Travers, 1996; King et al., 1999; Travers, 2002; Stratford et al., 2017), and therefore it is quite 
plausible that the 60:40 whey:casein CM elicits a more profound sensory response at the 
hindbrain level. On the other hand, c-Fos in the caudal portion of the NTS (cNTS), which 
integrates visceral input relayed by vagal efferents (Horst et al., 1989; Rinaman, 2010), was 
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lower after the 60:40 whey:casein CM intake. One can therefore speculate that the combination 
of sensory and visceral processing at the NTS level contributes to elevated intake of the 60:40 
whey:casein CM. Importantly, the combined findings from this chapter and from Chapter 3 
indicate that NTS c-Fos IR in response to the 60:40 vs 20:80 milk is the same regardless of the 
species from which the milk was derived. Therefore, the NTS may be a common denominator 
for elevated consumption of formulations with the enhanced whey content. 
Several hypothalamic regions displayed suppressed c-Fos IR after 60:40 whey:casein CM 
consumption. Most notably, it was observed in the PVN, which receives rich cNTS input and 
hosts neurons synthesising a number of anorexigenic peptides including oxytocin and CRH. 
And it was approximately five-fold lower in the ARC, which encompasses cells producing an 
appetite suppressant alpha-MSH. This might potentially link a propensity to ingest greater 
amounts of the 60:40 whey:casein CM with downregulation of mechanisms that prevent 
overeating. The 60:40 whey:casein CM also produced a less robust c-Fos response in the DMH, 
which has been linked with CCK-driven appetite suppression (Bellinger & Bernardis, 1984; 
Kobelt et al., 2006), as well as well as with the LHA which mediates cannabinoid-and orexin-
mediated hyperphagia (Thorpe et al., 2006; Perez-Morales et al., 2012) and appetite-
suppressing GABAergic signalling (Turenius et al., 2009). 
One should note that unlike the NTS c-Fos IR which was – as shown in this chapter and in 
Chapter 3 – the same in both CM and GM formulations, hypothalamic c-Fos mapping produced 
different results depending on the species from which milk was sourced. It can likely be 
contributed to the combined effect of the whey:casein ration and the unique characteristics of 
GM vs CM (as delineated in Chapter 2).  
Finally, the qPCR analysis of transcript levels in the brainstem and hypothalamus underscores 
a unique functional relationship between the feeding-relevant mechanisms and whey:casein 
ratio in the CM protein fraction. Most notably, consumption of the 60:40 whey:casein CM was 
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associated with a strong trend toward decrease in the anorexigenic MC4R expression in the 
hypothalamus and significant upregulation of the receptor for orexigenic nociceptin/orphanin 
FQ in the brain stem, which is in line with the more avid intake of the 60:40 formulation. 
Surprisingly, expression of hypothalamic NPY and orexin was lower, whereas brain stem 
MC3R was higher in the whey-enhanced formulation group, however, it may be either 
unrelated to feeding (e.g., in the case of ORX, it may be associated with wakefulness) or it may 
reflect a combined effect of species source and whey:casein content on broader post-ingestive 
peripheral mechanisms (which is likely considering some alignment between GM vs CM-
induced gene expression, e.g., in ORX and MC transcripts). 
In conclusion, laboratory mice display preference for the whey-enhanced CM formulation, and 
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General Discussion and Perspectives 
Food provides nutrients needed for the proper functioning of cells, tissues and, consequently, 
of the organism. Food intake has to therefore meet the body’s energy and nutrient requirements. 
As such, feeding behaviour is regulated by neural and endocrine activity which promotes 
consumption during energy or nutritional deficit and suppresses feeding upon meeting those 
demands. The GI tract and other secretory organs and tissues, such as the pancreas and adipose 
tissue, release hormones that – appropriate for the fed and fasted state – modify/adjust feeding 
behaviour. Peripheral factors relevant to energy balance influence brain activity through direct 
interaction with centrally expressed receptors for circulating nutrients and hormones (both 
orexigenic and anorexigenic) or through vagal projections to the hindbrain. This leads to 
upstream activity and molecular changes within central pathways which regulate feeding. 
Alongside processes regulating energy homeostasis, palatability of ingestants elicits signalling 
in the reward system, as well as, via an interconnected network, in broader feeding regulatory 
circuits targeted by projections from reward areas.  
Milk or milk-based foods are near ubiquitous in Western diets. Although milk, from an 
evolutionary point of view serves as a food during early life, it is commonly incorporated into 
adult diets, significantly contributing to daily energy intake and being a source of both nutrients 
and palatability. This can either be in close-to-natural forms of milk or in milk formulations 
and milk-based products that are modified to target certain health-related outcomes, i.e., 
lactose-free hypoallergenic milks, milk-based weight loss or high-protein sport drink diets, and 
whey-enhanced formulations. In addition to the issue that milk gets incorporated into our 
dietary repertoire in such different forms, one should consider an oftentimes neglected fact that 
the composition and physical characteristics of milks derived from different species vary, too. 
These differences are so profound that, as delineated in the Introduction to this thesis, 
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consumption of milk sourced from different species, e.g., goats versus cows, generates unique 
post-ingestive processes including digestion kinetics and endocrine responses. For example, 
comparing CM - the most commonly consumed, and therefore studied, milk type in Western 
societies – with GM, shows digestion differences related to protein fractions. While similar in 
total protein content, GM and CM vary in whey and casein (Park et al., 2007; Wendorff et al., 
2017). GM contains higher b-casein and as2-casein and reduced as1-casein concentrations 
(Grosclaude & Martin, 1997; Carillier-Jacquin et al., 2016; Wendorff et al., 2017). In gastric 
conditions, casein micelle structure collapses leading to coalescence of casein proteins into a 
curd (Jenness, 1980). Lowered as1-casein content in GM produces a looser curd (Ambrosoli et 
al., 1988), facilitating easier casein proteolysis (Barbé et al., 2013) and more rapid emptying 
of GM casein products into the intestinal lumen than CM (Maathuis et al., 2017; Hodgkinson 
et al., 2018). Variation in absorption rate influences subsequent endocrine cascade and appetite, 
with Rubio-Martín et al. (2017) reporting a GM breakfast with semi-skimmed milk, cheese and 
white bread lowering a desire to eat and hunger more so than a CM breakfast, also associated 
with altered GI GLP-1 release. 
The data obtained in the course of my experimental work show for the first time that GM is 
ingested more avidly than CM by mice and rats and that this phenomenon has physiological 
underpinnings in terms of feeding-relevant neural responses. As the studies were conducted in 
two standard laboratory species (rats and mice) and – moreover – in animals that belonged to 
distinct age categories (adolescent, adult, aged), the consistent feeding outcomes lend credence 
to generalising the conclusion regarding preference for GM over CM across key laboratory 
animal models. The set of studies in Chapter 2 (Palatability of goat’s versus cow’s milk: 
insights from the analysis of eating behaviour and gene expression in the appetite-relevant brain 
circuits in laboratory animal models) bridges some of the gaps in the current literature 
regarding how a species from which milk was sourced, specifically bovine and caprine milk, 
affects intake and preference for this milk. I found that, while both GM and CM are highly 
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palatable, GM is preferred and more readily consumed. Increased intake and preference for 
GM appears to be due to a higher hedonic value rather than impaired/delayed satiety, as 
suggested by expression of reward- and satiety-related genes. 
Both CM and GM were found to be palatable across no-choice paradigms in my experimental 
work. When presented separately in animals being in a fed or fasted state, consumption of milks 
was comparable to the palatable positive control of a sweetened solution. Consumption of these 
three palatable liquids exceeded that of the “bland” cornstarch. High palatability of milks was 
also confirmed with solid diets enriched with milk. Laboratory rodents showed elevated 
consumption of milk-containing chows compared to standard (‘bland’) chow during episodic 
presentations. Both milks were also highly palatable across the three age groups examined 
(adolescent, adult and aged) with elevated intake of CM and GM equivalent to the palatable 
sweetened water. While the aged animals exhibited slightly lowered intake of palatable 
solutions than the adult or adolescent groups, one should note that in both humans and non-
human animals, aging is associated with an increased prevalence of anhedonia (Lampe et al., 
2001), and that includes reduced consumption of palatable diets (Herrera-Pérez et al., 2008; 
Shin et al., 2012; Inui-Yamamoto et al., 2017; Sakai et al., 2017). While intake for palatability 
was indeed mildly suppressed in the aged rats and mice, they still displayed elevated intake of 
milk, which indicates that the animals retain sensitivity to the pleasant consequences of milk 
consumption despite the overall lowered hedonic responsiveness to foods during old age. 
Though the results have been obtained in animal studies, they nonetheless serve as an important 
clue for possible human interventions in that a palatable and nutritive tastant, namely milk, can 
be treated as a dietary tool helping in mitigating anhedonic consequences of aging. 
Whilst both milks were found to be palatable, this research also identified differences in the 
context of preference. In regard to relative palatability, simultaneous presentations of GM and 
CM diets (liquid formulations and solid chow) underscored a near-uniform preference for GM. 
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Preference for GM in a liquid form was higher than that for CM in mice and in rats, with the 
only exception being adolescent mice that ingested similar amounts of GM and CM. In 
simultaneous presentations of CM- and GM-enriched chows, adult and aged rats and adult mice 
preferred goat milk-enriched pellets; aged mice showed a trend toward GM preference. 
Lickometer feeding patterns strongly support the notion of the elevated GM preference, with 
four-fold increase of licks of skim GM within the first five minutes of exposure, persisting with 
a two-fold increase in the following five minutes. Licking microstructure analysis showed a 
high bout number and an extended bout length for goat milk. The observed increase in the 
initial GM intake, bout number and duration parallels licking patterns of highly palatable 
solutions (Davis & Smith, 1992; Davis & Perez, 1993; Spector et al., 1998; Glass et al., 2001), 
suggesting that heightened palatability of GM drives the intake of this milk type.  
Despite both CM and GM being common foods on a global scale our understanding of potential 
differences in palatability and acceptability of these milks is extremely limited and relies 
mainly on anecdotal evidence. It appears that, prior to this experimental work, no other 
laboratory animal study utilising CM and GM diets had directly compared preference for and 
relative intake of these milks. Nor have human studies performed any in-depth analysis of 
participants’ preferences for GM versus CM, other than providing very limited notions, such 
as that GM is perceived as novel with a unique “goaty” taste (Mowlem, 2005; Park & Haenlein, 
2013, Rubio-Martín et al., 2017; Milan et al., 2018). It should be emphasised though that in 
the context of human observations preferences are strongly biased by habituation. The 
aforementioned human studies were conducted in geographic locations in which CM is 
predominantly consumed (Western diet) and, therefore, where exposure to CM is extremely 
unlikely to constitute a new experience, whereas GM may more often be met with 
unfamiliarity. Foods with familiar gustatory perception (flavours and textures) are generally 
preferred (Torrico et al., 2019; Cheng et al., 2020). Habituation is a nearly unavoidable 
confounding factor in human study designs, needing either cohorts naïve to or with equal 
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exposure to both milk types. Considering this, the use of animal models in the current studies 
allowed us to examine whether differences in preference for GM vs CM exist at all in 
individuals (animals) whose prior exposure to both milk types could be controlled and, thus, 
devoid of the habituation bias. In fact, the very consistent preference for GM across various 
models in our experiments is so striking that – taking into account the mainly anecdotal 
evidence of a somewhat negative perception of GM in human subjects with lifetime exposure 
to primarily Western diets - it may be of interest to examine whether early-life habituation to 
CM or GM in laboratory rodents would also affect their GM-vs-CM preference later in life. 
This might be a worthwhile endeavour especially in light of the data showing that animal milk-
based formula intake in early infancy modifies later dairy preference in humans (Mennella & 
Beauchamp, 2002; Maslin et al., 2016). One might even speculate – though this hypothesis is 
quite premature - that the onset of a preference for a given milk may occur already during the 
pre-weaning phase: rodent maternal diet during lactation is known to affect food preferences 
once the pups reach adult age (Carlin et al., 2013; Gugusheff et al., 2015).  
Accordingly, it should be acknowledged animals used in this study consumed their dams milk 
as neonates. Rodent milk differs in composition from the test diets examined here, varying 
across species and strain (Treadway et al., 1986; Del Prado, et al., 1997; Bautista, et al., 2021; 
Boumahrou et al., 2009, Godbole, et al., 1981; Görs, et al., 2009; Ragueneau, 1987). 
Notability, whey:casein ratio is near the 20:80 ratio and a β-casein ratio closer to CM 
(Wendorff et al., 2017; Boumahrou et al., 2009). No controls for pre-programming of 
preferences concerning milk diets conveyed during the neonatal period are used in these 
studies. Potentially, this could be achieved with earlier postnatal interventions where manual 
milk administration replaces milk supply from dams and later life feeding patterns and 
preferences are evaluated in the offspring. This would ascertain whether preferences observed 
in these studies are indeed confounded by neonate exposure to dams’ milk. 
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The analyses of brain gene expression accompanying intake of GM and CM found disparate 
effects of the consumption of each milk type at the central level. Intake of GM induces more 
robust activation of hedonic pathways, possibly indicating that increased intake and preference 
for GM over CM is related to reward. Alongside this, in pathways involved in feeding for 
energy GM promoted expression of satiety genes and suppression of hunger-related genes, thus 
suggesting that the heightened intake of GM was not due to abnormal hunger-satiation 
processing. It is well known that reward-driven intake is mediated by interconnected regions 
activated following ingestion of palatable foods, from lower brain stem areas to higher order 
orbitofrontal cortex, ventral palladium and NAcc (Berridge & Kringelbach, 2015). Following 
palatable food intake, dopaminergic, opioid and endocannabinoid signalling in these areas is 
enhanced, and so is the expression of genes that encode relevant neurotransmitters, their 
receptors and associated signalling factors. Opioid signalling is associated with hedonic 
stimulation, especially the “liking” component of reward-driven consumption (Berridge & 
Kringelbach, 2015), and an increase in the opioid tone promotes intake of palatable tastants, 
from the simple, single-macronutrient, calorie-dilute ingestants to the preferred, highly caloric 
and nutritionally complex foods (Lynch, 1986; Giraudo et al., 1993; Levine et al., 1995; 
Weldon et al., 1996; Peciña & Berridge, 2000; Glass et al., 2001; Naleid et al., 2007; Olszewski 
et al., 2011). Dopamine signalling within the mesolimbic system (originating in the ventral 
tegmental area and encompassing ventral striatal structures including the NAcc (Pandit et al., 
2011)), produces the “wanting” of a rewarding tastant (Wyvell & Berridge, 2000), and 
connexin-36 (Cx36) mediates synchronicity within dopamine neuronal networks (Steffensen 
et al., 2011). Importantly, the results presented here show that GM consumption increased 
expression of mu (MOR) and kappa (KOR) opioid receptors in the hypothalamus, and also 
caused a trend toward their upregulation in the NAcc and brainstem. Additionally, dopamine 
receptor transcript levels were affected following GM, alongside the changes in Cx36 
expression. Auxiliary modulation of the reward system by GM might also be linked with other 
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feeding-related transcripts in the NAcc, including GHSR, PNOC and OPRL (Perelló & 
Zigman, 2012; Skibicka et al., 2013; Hardaway et al., 2016; Statnick et al., 2016; Hernandez 
et al., 2021). Thus, the response of the reward system to GM is relatively vast, involving a 
diverse repertoire of genes and, importantly, these findings are congruent with the outcomes of 
food intake experiments which found GM to be more palatable/preferred than CM.  
As mentioned above, gene expression studies indicate that GM consumption does not affect 
expression of hunger- and satiety-related genes adversely, i.e., in a manner that would suggest 
impaired hunger-satiety processing in response to GM exposure. Upregulation of anorexigenic 
melanocortin system-associated genes, MC3R and MC4R, as well as reduced expression of 
orexigenic NPY and ORX transcripts following GM intake is expected considering that milk 
provides calories (Levine et al., 2004; Nixon et al., 2012). Furthermore, elevated OXT 
expression following GM indicates both GM palatability (as OXT is typically released with 
intake of palatable food, especially that containing carbohydrates) and maintenance of a satiety 
response (Amico et al., 2005) (Miedlar et al., 2007) (Mullis et al., 2013; Herisson et al., 2014).  
Our meal microstructure lickometer analysis supports this notion of preserved satiety with GM 
intake with similar timeframes of attenuation of consumption between GM and CM suggesting 
that elevated preference for GM was not due to delayed satiation (Glass et al., 2001). In line 
with this finding, prior studies in human subjects report no deficit in satiety to GM or CM diets. 
Milan et al. (2018) reported equivalent perceived satiety and appetite as well as circulating 
levels of appetite-regulating hormones in participants given fortified GM or CM drinks. Rubio-
Martín et al. (2017) even suggest that GM-based breakfast heightens satiety compared to CM 
breakfast: the subjects in that study reported a reduced desire to eat and subjective hunger, and 
those questionnaire data were elegantly paralleled by GLP-1 and triglyceride levels. Overall, 
higher intake of GM does not stem from impaired satiety processing and can be attributed to 
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palatability and the consequences at the reward system’s level may be viewed as a promising 
parameter for possible translational applications of this finding to human dietary interventions.  
While it is clear, at least in animal models, that GM is more preferred than CM, it is important 
to reiterate the fact that Western diets rarely rely on unmodified milk, but rather utilise milk 
products that have undergone processing. These modifications are likely to affect a number of 
characteristics of milk, leading to altered palatability and acceptability. Therefore, one cannot 
declare a priori that all GM-based milk formulations are more palatable and more avidly 
consumed than CM-derived tastants. Considering this crucial caveat, I continued my work on 
feeding responses to CM and GM by focusing on formulations that had incorporated one of the 
most common compositional adjustments: the natural 20:80 whey:casein ratio found in bovine 
and caprine milks was whey-enhanced to 60:40 in order to match the typical whey:casein ratio 
of human milk. In Chapter 3 (Changes in feeding and related brain function in mouse model 
following consumption of infant formulations with variable whey and casein content) and 
Chapter 4 (Whey:casein adjustment in cow’s milk from 20:80 to 60:40 affects food intake, 
brain stem and hypothalamic gene expression and neuronal activation, and it supersedes 
preference for goat’s over cow’s milk), I furthered GM and CM comparisons with formulations 
differing in the whey:casein ratio.  
That a shift in whey:casein may significantly impact intake of milks that differ in this parameter 
seemed quite intuitive considering a disparate impact that each of the fractions has on eating-
related behavioural and physiological processes. Whey and casein fractions have unique 
digestion, with “fast” whey passing through the stomach and into the intestine whilst “slow” 
casein aggregating there. The resulting absorption features early and high peaks in plasma 
amino acids with whey and slower, lower and longer elevated levels with casein. Endocrine 
response to whey has been described as more pronounced. Long-term preliminary studies on 
whey and casein intake published prior to the commencement of this research have shown a 
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possible link with serotonergic and melanocortin signalling. Interestingly, when whey and 
casein are consumed together, GI endocrine release is unique to that seen with isolates and not 
necessarily proportional to either fraction’s contribution (Diepvens et al., 2008; Lorenzen et 
al., 2012). Studies that have examined the acute digestive, endocrine and appetitive responses 
to natural and adjusted whey:casein ratios indicate that such modifications influence satiety-
related processes. Ye et al. (2019) demonstrated in vitro that elevating casein content in CM 
increased micelle aggregate size thereby slowing 60:40 CM formula digestion. 20:80 and 60:40 
GM formulations, having similar particle size and digestion rates, differed in the rate of protein 
digestion and in amino acid plasma spikes (Dangin et al., 2001; Juvonen et al., 2011), 
particularly notable with casein (Juvonen et al., 2011). Appetite and endocrine functions 
following natural and whey-adjusted CM formulations were examined in studies by Kung et 
al. (2018) and El Khoury et al. (2019). Following formulation intake as part of a cereal-based 
breakfast, the 60:40 ratio produced a lower plasma glucose peak (Kung et al., 2018). Glycaemic 
regulation was insulin-independent, relating rather to gastric emptying speed altered by GI 
hormone release, modifying the rate of glucose absorption and thereby blood glucose levels 
(El Khoury et al., 2019). Furthermore, human subjects reported reduced appetite with the 20:80 
formulation (Kung et al., 2018).  
The observations in humans are strongly supported by the outcomes of the studies presented in 
this thesis. In the feeding studies in Chapters 3 and 4, I observed that preference was heavily 
impacted by whey:casein ratios. Chapter 3 utilised GM-based formulations with the natural 
20:80 and adjusted 60:40 whey:casein ratios whilst Chapter 4 examined response to CM-based 
formulations with the same ratios. In choice scenarios, mice avidly consumed the adjusted 
60:40 formulations over 20:80 with both GM- and CM-derived formulations. The four-fold 
increase in 60:40 intake compared to the 20:80 formulation indicates a strong influence of 
whey:casein ratio on palatability, given that in previously published choice paradigms using 
highly palatable tastants of sugar and fat, intake disparity is within 10% of the total volume 
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(Olszewski et al., 2010; Herisson et al., 2014). This high palatability of the 60:40 whey:casein 
is reaffirmed in the choice paradigms in Chapter 4. When mice were given simultaneously two 
milk formulations of the same whey:casein ratio but from a different species source (i.e. CM 
20:80 vs GM 20:80 or CM 60:40 vs GM 60:40), animals preferred GM formulations, consistent 
with preferences observed in Chapter 2 with skim milks. However, this species source-based 
milk preference was superseded by the whey:casein ratio when animals were given alternate 
ratios from two different species. Specifically, when given a choice between the CM 
formulation with the 60:40 ratio and the GM formulation with the 20:80 ratio, animals avidly 
consumed the CM formulation despite GM preference in the whey:casein matched scenarios.  
The data in the single tastant tests are largely consistent with the notion of heightened 
palatability of 60:40 milks. In Chapter 3, mice given a single bottle of GM (either 60:40 or 
20:80) for 24 hours had higher intake of the 60:40 formulation whilst in Chapter 4, though mice 
given a single bottle of either 60:40 or 20:80, CM had equal intake in the same paradigm with 
CM formulations. This suggests that palatability of GM and of the 60:40 ratio could have a 
additive effect, promoting elevated consumption above that of the two CM formulations. This 
may explain why, in the cross-source milk presentations in Chapter 4, there was the significant 
preference for 60:40 GM over 60:40 CM, while there was only a trend for 20:80 GM over 
20:80 CM preference. It is also possible, given the lack of fats in the skim milk comparisons in 
Chapter 2, that inclusion of species milk lipids or added fats in formulations may change 
palatability of these species milks.  
One of the questions that may arise based on the results of these studies is whether whey 
enhancement is therefore a desirable modification of milk content. It should be considered that 
GM is already palatable and, therefore, its intake is associated with a rewarding value that by 
itself is sufficient to promote consumption. Thus, when choosing a diet with the aim of 
elevating food intake, replacing CM with GM might be an optimal intervention. This is because 
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by combining either CM or GM with whey enhancement (and thus departing from the natural 
whey:casein ratio and elevating feeding even further), an increase in calorie intake may be so 
high that it would produce a greater risk of bringing about unwanted metabolic consequences 
through delivering a diet with more of an obesogenic potential. This issue certainly needs to be 
investigated in-depth in future studies involving long-term exposure to milks that differ in 
whey:casein ratios to assess their impact on energy homeostasis.  
One should also note that a departure from a natural 20:80 whey:casein ratio in milk is not 
without consequences for brain activation and for gene expression. Though CM and GM 
formulations were examined by me in two separate projects (Chapter 3 and 4) dedicated to 
each milk type (either CM or GM) makes direct statistical comparison impossible, there are 
clear commonalities and differences that can be attributed to whey:casein ratio and to the 
species source of a given milk, respectively. In fact, the nucleus of the solitary tract (NTS) 
appears to be a common denominator for neuronal activity changes induced by whey 
enhancement. Regardless of whether GM or CM, the intake of the whey:casein 60:40 milk 
formulation increases c-Fos IR in the rostral portion of the NTS (rNTS) and decreases the 
density of c-Fos-positive neurons in the caudal portion of this nucleus (cNTS). Given whey 
and casein fractions have such unique digestive and absorption kinetics, it is intuitive that 
adjusting the ratio would elicit activity in the cNTS as this area is responsive to visceral input 
(including vagal) as well as to the circulating nutrient status (Horst et al., 1989; Johnson & 
Gross, 1993; Rinaman, 2010). The rNTS activity is quite interesting as it aligns well with the 
findings showing differences in palatability/preference between the whey:casein ratios from 
our animal experiments as well as from some human studies utilising a formula (Kung et al., 
2018) or yoghurt (Tomaschunas et al., 2012; Cheng et al., 2019). Importantly, the rNTS 
receives gustatory and sensory input and displays reactivity to specific tastes (Harrer & 
Travers, 1996; King et al., 1999; Travers, 2002; Rinaman, 2010; Stratford et al., 2017).  
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Interestingly, the hypothalamus was the region where c-Fos mapping after 20:80 vs 60:40 
formula intake produced a differential pattern of activity that was dependent on the species 
from which a milk was sourced. In GM-fed animals, the whey-enhanced formulation affected 
c-Fos only in the SON and VMH. On the other hand, in the CM experiment, I found a change 
in neuronal activation in the PVN, LHA, DMH and ARC, and the change in activity was 
opposite depending on the species (in GM, whey enhancement caused an increase, whereas in 
CM, a decrease in c-Fos immunoreactivity). c-Fos observations are accompanied by changes 
in relative gene expression in the two studies. Transcript level changes in the hypothalamus 
between groups given 60:40 vs 20:80 milks are notably different in the CM study than in the 
GM study, whereas the brainstem profiles have at least some similarities between the two 
studies (e.g., in melanocortin receptor, orexin or dynorphin genes – showing either significance 
or trend approaching significance). Considering the role of the hypothalamus in energy 
homeostasis control, these data should be therefore viewed as an additional impetus to conduct 
long-term studies that focus on potential metabolic consequences of whey enhancement. 
Furthermore, these outcomes serve as evidence that a departure from the natural whey:casein 
ratio in milk is not a neutral change in terms of altering short-term feeding responses as well 
as the relevant central mechanisms that govern ingestive behaviour.  
5.1 Limitations 
This work has highlighted new findings regarding control of food intake following milk 
consumption, specifically variations in feeding behaviour and central processes with different 
milk types. These are the first studies to examine such outcomes of the context species source 
and common modifications in milk proteins made in manufacture of milk diets in a systematic 
way. However, it is important to note the limitations of these studies conclusions. 
Several limitations are noted including the translation of rodent studies to humans. There are 
benefits for animal models in dietary research compared to humans, such as high level of 
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control over factors impacting intake and metabolic processes such as lifestyle, genomic 
variability and diet compliance, and the availability of techniques allowing for closer 
examination physiological processes, such as invasive tissue collection. However, innate 
differences in biology between our species and that of laboratory models does limit 
extrapolation from diet and metabolic studies (Lai, et al., 2014; Chalvon-Demersay, et al., 
2017; Hintze, et al., 2018; Suleiman, et al., 2020). The use of animal models has eliminated 
the biases in preferences occurring with pre-exposure one would expect within a population 
through use of animal models. Whilst this gives methodological accuracy for unbiased milk 
species preferences, this may not necessarily translate to human populations as perceptions of 
novel foods, especially milks, are biased by what is standard within a culture (Torrico et al., 
2019; Cheng et al., 2020; Mennella & Beauchamp, 2002; Maslin et al., 2016; Mowlem, 2005; 
Park & Haenlein, 2013). Therefore, observed preferences in intake and related changes in 
neuronal activity and gene expression may not necessarily represent any given human 
population due to difference in biology between species and innate preferences of any given 
individual.  
Alongside this, the most obvious confounding factor in milk preferences studies would be 
giving rodents lactose-rich diets as they exhibit lactose intolerance following weaning (De 
Angelis, et al., 1984; Labrie, et al., 2016). Rats have displayed poor digestibility and 
intolerance of diets with higher lactose contents around 20-30% (De Angelis, et al., 1984; van 
De Heijning, et al., 2015). Given lactose content of test diets used here had high lactose content, 
rodent lactose intolerance could impact the palatability of these diets. Lactose intolerance 
studies examined chronic intake of high lactose, noting the outcomes of lower absorption, 
altered carbohydrate and lipid metabolism and increased incidence of diarrhoea (De Angelis, 
et al., 1984; Alexandre, et al., 2013; van De Heijning, et al., 2015). However, acute impact of 
short periods of lactose intake is relatively unknown. Diet studies were preceded with brief pre-
exposure to the diets to prevent hyponeophagia and milk diets were avidly consumed and 
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highly palatable, comparable to sweet sucrose solutions. This would suggest that animals did 
not experience malaise after the pre-exposure session, as they did not display aversion for the 
diets. Indeed, high palatability was observed across all age groups examined in Chapter 2, 
notable as intestinal lactase in rodents decline with age and would make the any negative post-
prandial effect more pronounced (Labrie, et al., 2016). This suggests minimal negative side 
effects from lactose intake on palatability, but this could be confirmed with conditioned taste 
avoidance studies with milk diets, ensuring no malaise results from short episodic intake. 
Another limitation to be considered in these studies is use of appropriate controls. Suitable 
control diets that account for complex macronutrient profile of milk diets as well as for 
variations that occur in naturally sourced diets are difficult to achieve. Controls used in Chapter 
2 for the preference studies included sucrose and cornstarch whilst gene expression studies 
utilised isovolumetric water intake. The former served as palatable and unpalatable caloric 
controls. Near equal intake to sucrose and higher intake than cornstarch solution was noted. 
This pattern persisted even in low energy, food deprived state, indicating that these skim milks 
were highly palatable and not just rewarding for their caloric content. Water served as a control 
for the gene expression study in Chapter 2. It serves as a non-caloric control, accounting for 
gene expression associated with intake volume, thirst abolition and gastric distension (Traub, 
et al., 1996; Sun, et al., 2006; Tang, et al., 2006; Sabbatini, et al., 2008), given its isovolumetric 
consumption. However, water as a control does not account for changes resulting from nutritive 
components of diets, where isocaloric solutions and compositionally matched diets may serve 
as better controls. These nutritive components are harder to control for, as the test diets in all 
three chapters have complex macronutrient profiles which are naturally sourced.  
An isocaloric solution of sucrose or cornstarch, or other commonly used carbohydrate solutions 
such as glucose, may provide a caloric control but would not accurately match metabolic 
outcomes of lactose (Alexandre, et al., 2013; Mohammad, et al., 2011; Roser, et al., 2009; 
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Krishna, et al., 2020) nor would these solutions, or a lactose or galactose control, account for 
the changes that would come from consumption of the other macronutrients present in the milk 
solutions. One could consider other milks or milk-based diets as controls, such as rat and human 
milks, or commercially available infant formulations and milk shake replacement diets. These 
solutions have complex blend of nutrients more closely resembling test diet composition 
compared to single nutrient solutions. However, these would not account for effects of species 
macronutrient differences or added ingredients in different milk-based diets.  
Another aspect constricting controls is the natural variability in milk composition, with changes 
in composition dependent on genetics and animal breed (Scholtens, et al., 2020; Bainbridge, et 
al., 2016; Lim, et al., 2020), health status (Al-Farha, et al., 2017; Gonçalves, et al., 2020; 
Novac & Andrei, 2020), lactation period (Zhang, et al., 2020; Kljajevic, et al., 2018), fodder 
intake and nutrient supplementation during lactation (Thoh, et al.,2017; Murney, et al., 2019; 
Muir, et al., 2015; Ariza, et al., 2019) and environmental changes (Kljajevic, et al., 2018; 
Bertocchi, et al., 2014). Accurately reflecting these variations in a macronutrient-matched 
control is near impossible.  
Given the limitations of accurate controls for milk diets, direct comparison of formulations 
were made in Chapters 3 and 4. 
Compositional variation also contributes to flaws in these studies regarding replicability and 
validity. Milks used here are pooled from multiple animals and farms which may 
counterbalance some of the aspects influencing composition described about, though may still 
vary from batch to batch. This highlights issues in study replicability faced by all naturally 
sourced diet studies. Additionally, there are some variations in test diets macronutrient 
composition used in Chapters 3 and 4. Whilst these studies aimed to manipulate whey and 
casein contents of the milk diets, there were other changes in composition such as a ~10% 
difference in fat content in the CM formulations, a ~13% and ~7% difference in total protein 
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content as well as a ~1% and ~5% carbohydrate difference in the CM and GM formulations 
respectively. Whilst these changes are smaller in comparison to the intentional changes in whey 
and casein contents of these diets (~90% and ~78% difference in whey and casein, respectively, 
in CM formulations, ~105% and ~60% difference in whey and casein, respectively, in GM 
formulations), these variations could impact brain activity and gene expression profiles (Hu, et 
al., 2018). Therefore, a role of other macronutrient variations in changes attributed to whey 
and casein manipulation cannot be discounted.  
Another component that could be influencing histological and gene expression outcomes is 
intake volume. Gastric distension influences activity in the hypothalamus and brain stem 
(Traub, et al., 1996; Sun, et al., 2006; Tang, et al., 2006; Sabbatini, et al., 2008) as will as 
caloric load (Lazzarino, et al., 2017; Lazzarino, et al., 2019; Xu, et al., 2007). There was not a 
significant difference in intake of skim milks (or water control) or of CM-based formulations 
prior to histological testing and gene expression analyses in Chapters 2 and 4. While these 
studies were not strictly calorie controlled, it is unlikely that intake volume would have greatly 
impacted the results from these chapters. However, in Chapter 3, whilst 2-hour GM-
formulation consumption for histological analyses had similar intake, the 24-hour intake of the 
60:40 formula was significantly larger than the 20:80 formula. Interestingly, higher caloric 
intake should induce higher expression of satiety-related genes, however, the 20:80 formula 
had reduced expression of anorexigenic POMC and OXT. It is unclear, then, how intake 
volume has influenced gene expression in this chapter. Follow up studies are attempting to 
control for this variability from ad libitum consumption through intragastric delivery of 
isovolumetric boli.  
5.2 Conclusions 
The overarching aim of this doctoral research was to examine whether laboratory rodents 
display different preference for GM versus CM-based diets and whether it is associated with 
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different responsiveness of brain systems controlling eating for energy and/or reward. The 
findings of these studies are: 
- GM and CM liquid and solid diets are highly palatable. 
- GM is preferred over CM by rats and mice and across different age groups (adolescent, 
adult and aged). 
- GM intake elevates expression of dopaminergic and opioidergic genes in the NAcc, 
suggesting a functional relationship between GM intake and reward. 
- GM intake also upregulates some melanocortin system genes, indicative of a link with 
satiety processing. 
- Whey enhancement is associated with elevated intake of and preference for milk 
regardless whether sourced from goats or cows.  
- Whey:casein ratio manipulation supersedes impact of a species from which the milk 
was sourced on the preference for a formulation.  
- Intake of 20:80 and 60:40 whey:casein milk formulations is accompanied by alterations 
in neuronal activity and gene expression in key regions regulating food intake 
- Both CM and GM formulations induce hindbrain activity associated with gustatory and 
visceral sensations, relating to manipulating the whey:casein ratio. 
- Differences in gene expression and activity of hypothalamic nuclei following GM or 
CM formulations indicate that a species from which the milk was sourced impacts food 




Alexandre, V., Even, P. C., Larue-Achagiotis, C., Blouin, J. M., Blachier, F., Benamouzig, R., 
Tomé, D., & Davila, A. M. (2013). Lactose malabsorption and colonic fermentations 
alter host metabolism in rats. British Journal of Nutrition, 110(4), 625-631. 
Al-Farha, A. A. B., Hemmatzadeh, F., Khazandi, M., Hoare, A., & Petrovski, K. (2017). 
Evaluation of effects of Mycoplasma mastitis on milk composition in dairy cattle from 
South Australia. BMC veterinary research, 13(1), 1-8. 
Ambrosoli, R., di Stasio, L., & Mazzocco, P. (1988). Content of αs1-casein and coagulation 
properties in goat milk. Journal of Dairy Science, 71(1), 24-28. 
Amico, J. A., Vollmer, R. R., Cai, H.-m., Miedlar, J. A., & Rinaman, L. (2005). Enhanced 
initial and sustained intake of sucrose solution in mice with an oxytocin gene deletion. 
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 
289(6), R1798-R1806. 
Ariza, J. M., Meignan, T., Madouasse, A., Beaudeau, F., & Bareille, N. (2019). Effects on milk 
quantity and composition associated with extruded linseed supplementation to dairy 
cow diets. Scientific reports, 9(1), 1-7. 
Bainbridge, M. L., Cersosimo, L. M., Wright, A. D. G., & Kraft, J. (2016). Content and 
composition of branched-chain fatty acids in bovine milk are affected by lactation stage 
and breed of dairy cow. PLoS One, 11(3), e0150386.Barbé, F., Ménard, O., Le Gouar, 
Y., Buffière, C., Famelart, M.-H., Laroche, B., Le Feunteun, S., Dupont, D., & Rémond, 
D. (2013). The heat treatment and the gelation are strong determinants of the kinetics 
of milk proteins digestion and of the peripheral availability of amino acids. Food 
Chemistry, 136(3), 1203-1212. 
Bautista, C. J., Reyes-Castro, L. A., Bautista, R. J., Ramirez, V., Elias-López, A. L., 
Hernández-Pando, R., & Zambrano, E. (2021). Different Protein Sources in the 
Maternal Diet of the Rat during Gestation and Lactation Affect Milk Composition and 
Male Offspring Development during Adulthood. Reproductive Sciences, 1-
14.Berridge, K. C., & Kringelbach, M. L. (2015). Pleasure systems in the brain. Neuron, 
86(3), 646-64. 
Bertocchi, L., Vitali, A., Lacetera, N., Nardone, A., Varisco, G., & Bernabucci, U. (2014). 
Seasonal variations in the composition of Holstein cow’s milk and temperature–
humidity index relationship. Animal, 8(4), 667-674. 
Boumahrou, N., Andrei, S., Miranda, G., Henry, C., Panthier, J. J., Martin, P., & Bellier, S. 
(2009). The major protein fraction of mouse milk revisited using proven proteomic 
tools. Journal of  Physioly and Pharmacology, 60(suppl 3), 113-118. 
Carillier-Jacquin, C., Larroque, H., & Robert-Granié, C. (2016). Including αs1casein gene 
information in genomic evaluations of French dairy goats. Genetics Selection 
Evolution, 48(1), 54. 
Carlin, J., George, R., & Reyes, T. M. (2013). Methyl donor supplementation blocks the 
adverse effects of maternal high fat diet on offspring physiology. PloS one, 8(5), 
e63549. 
Chalvon-Demersay, T., Blachier, F., Tomé, D., & Blais, A. (2017). Animal models for the 
study of the relationships between diet and obesity: a focus on dietary protein and 
estrogen deficiency. Frontiers in nutrition, 4, 5.Cheng, N., Barbano, D. M., & Drake, 
M. (2019). Effects of milk fat, casein, and serum protein concentrations on sensory 
properties of milk-based beverages. Journal of Dairy Science, 102(10), 8670-8690. 
Cheng, Z., O'Sullivan, M. G., Kerry, J. P., Drake, M. A., Miao, S., Kaibo, D., & Kilcawley, K. 
N. (2020). A cross-cultural sensory analysis of skim powdered milk produced from 
pasture and non-pasture diets. Food Research International, 138, 109749. 
 
136 
Dangin, M., Boirie, Y., Garcia-Rodenas, C., Gachon, P., Fauquant, J., Callier, P., Ballèvre, O., 
& Beaufrère, B. (2001). The digestion rate of protein is an independent regulating factor 
of postprandial protein retention. American Journal of Physiology-Endocrinology and 
Metabolism, 280(2), E340-E348. 
Davis, J. D., & Perez, M. C. (1993). Food deprivation-and palatability-induced microstructural 
changes in ingestive behavior. American Journal of Physiology-Regulatory, Integrative 
and Comparative Physiology, 264(1), R97-R103. 
Davis, J. D., & Smith, G. P. (1992). Analysis of the microstructure of the rhythmic tongue 
movements of rats ingesting maltose and sucrose solutions. Behavioral Neuroscience, 
106(1), 217-28.  
De Angelis, R. C., Giuli, G. G., Rogano, R. N., & Terra, I. C. (1984). Lactose load diet effect 
in rats. Arquivos de Gastroenterologia, 20(4), 166-169. 
Del Prado, M., Delgado, G., & Villalpando, S. (1997). Maternal lipid intake during pregnancy 
and lactation alters milk composition and production and litter growth in rats. The 
Journal of nutrition, 127(3), 458-462. 
Diepvens, K., Häberer, D., & Westerterp-Plantenga, M. (2008). Different proteins and 
biopeptides differently affect satiety and anorexigenic/orexigenic hormones in healthy 
humans. International Journal of Obesity, 32(3), 510-8. 
El Khoury, D., Vien, S., Sanchez-Hernandez, D., Kung, B., Wright, A., Goff, H. D., & 
Anderson, G. H. (2019). Increased milk protein content and whey-to-casein ratio in 
milk served with breakfast cereal reduce postprandial glycemia in healthy adults: An 
examination of mechanisms of action. Journal of Dairy Science, 102(8), 6766-6780. 
Giraudo, S., Grace, M., Welch, C., Billington, C. J., & Levine, A. S. (1993). Naloxone's 
anorectic effect is dependant upon the relative palatability of food. Pharmacology 
Biochemistry and Behavior, 46(4), 917-921. 
Glass, M. J., Grace, M. K., Cleary, J. P., Billington, C. J., & Levine, A. S. (2001). Naloxone's 
effect on meal microstructure of sucrose and cornstarch diets. American Journal of 
Physiology Regulatory, Integrative and Comparative Physiology, 281(5), R1605-12. 
Godbole, V. Y., Grundleger, M. L., Pasquine, T. A., & Thenen, S. W. (1981). Composition of 
rat milk from day 5 to 20 of lactation and milk intake of lean and preobese Zucker pups. 
The Journal of nutrition, 111(3), 480-487.  
Gonçalves, J. L., Kamphuis, C., Vernooij, H., Araújo Jr, J. P., Grenfell, R. C., Juliano, L., ... & 
Dos Santos, M. V. (2020). Pathogen effects on milk yield and composition in chronic 
subclinical mastitis in dairy cows. The Veterinary Journal, 262, 105473. 
Görs, S., Kucia, M., Langhammer, M., Junghans, P., & Metges, C. C. (2009). Milk composition 
in mice—methodological aspects and effects of mouse strain and lactation day. Journal 
of dairy science, 92(2), 632-637.Grosclaude, F., & Martin, P. (1997). Casein 
polymorphisms in the goat. In Milk protein polymorphism, Palmerston North (New 
Zealand), Feb 1997: International Dairy Federation. 
Gugusheff, J. R., Ong, Z. Y., & Muhlhausler, B. S. (2015). The early origins of food 
preferences: targeting the critical windows of development. The FASEB Journal, 29(2), 
365-373. 
Hardaway, J. A., Jensen, J., Kim, M., Mazzone, C. M., Sugam, J. A., Diberto, J. F., Lowery-
Gionta, E. G., Hwa, L. S., Pleil, K. E., Bulik, C. M., & Kash, T. L. (2016). Nociceptin 
receptor antagonist SB 612111 decreases high fat diet binge eating. Behav Brain Res, 
307, 25-34. 
Harrer, M. I., & Travers, S. P. (1996). Topographic organization of Fos-like immunoreactivity 
in the rostral nucleus of the solitary tract evoked by gustatory stimulation with sucrose 
and quinine. Brain Res, 711(1-2), 125-37. 
Herisson, F. M., Brooks, L. L., Waas, J. R., Levine, A. S., & Olszewski, P. K. (2014). 
Functional relationship between oxytocin and appetite for carbohydrates versus 
saccharin. Neuroreport, 25(12), 909-14. 
 
137 
Hernandez, J., Perez, L., Soto, R., Le, N., Gastelum, C., & Wagner, E. J. (2021). 
Nociceptin/orphanin FQ neurons in the Arcuate Nucleus and Ventral Tegmental Area 
Act via Nociceptin Opioid Peptide Receptor Signaling to Inhibit Proopiomelanocortin 
and A(10) Dopamine Neurons and Thereby Modulate Ingestion of Palatable Food. 
Physiol Behav, 228, 113183. 
Herrera-Pérez, J. J., Martínez-Mota, L., & Fernández-Guasti, A. (2008). Aging increases the 
susceptibility to develop anhedonia in male rats. Progress in Neuro-
Psychopharmacology and Biological Psychiatry, 32(8), 1798-1803.  
Hintze, K. J., Benninghoff, A. D., Cho, C. E., & Ward, R. E. (2018). Modeling the western diet 
for preclinical investigations. Advances in Nutrition, 9(3), 263-271.Hodgkinson, A. J., 
Wallace, O. A. M., Boggs, I., Broadhurst, M., & Prosser, C. G. (2018). Gastric digestion 
of cow and goat milk: Impact of infant and young child in vitro digestion conditions. 
Food Chemistry, 245, 275-281. 
Horst, G. J. T., De Boer, P., Luiten, P. G. M., & Van Willigen, J. D. (1989). Ascending 
projections from the solitary tract nucleus to the hypothalamus. A Phaseolus vulgaris 
lectin tracing study in the rat. Neuroscience, 31(3), 785-797. 
Hu, S., Wang, L., Yang, D., Li, L., Togo, J., Wu, Y., ... & Speakman, J. R. (2018). Dietary fat, 
but not protein or carbohydrate, regulates energy intake and causes adiposity in mice. 
Cell Metabolism, 28(3), 415-431. 
Inui-Yamamoto, C., Yamamoto, T., Ueda, K., Nakatsuka, M., Kumabe, S., Inui, T., & Iwai, Y. 
(2017). Taste preference changes throughout different life stages in male rats. PLOS 
ONE, 12(7), e0181650. 
Jenness, R. (1980). Composition and characteristics of goat milk: review 1968−1979. Journal 
of Dairy Science, 63(10), 1605-1630. 
Johnson, A. K., & Gross, P. M. (1993). Sensory circumventricular organs and brain 
homeostatic pathways. The FASEB Journal, 7(8), 678-686. 
Juvonen, K. R., Karhunen, L. J., Vuori, E., Lille, M. E., Karhu, T., Jurado-Acosta, A., 
Laaksonen, D. E., Mykkanen, H. M., Niskanen, L. K., Poutanen, K. S., & Herzig, K. 
H. (2011). Structure modification of a milk protein-based model food affects 
postprandial intestinal peptide release and fullness in healthy young men. British 
Journal of Nutrition, 106(12), 1890-8. 
King, C. T., Travers, S. P., Rowland, N. E., Garcea, M., & Spector, A. C. (1999). 
Glossopharyngeal nerve transection eliminates quinine-stimulated fos-like 
immunoreactivity in the nucleus of the solitary tract: implications for a functional 
topography of gustatory nerve input in rats. J Neurosci, 19(8), 3107-21. 
Kljajevic, N. V., Tomasevic, I. B., Miloradovic, Z. N., Nedeljkovic, A., Miocinovic, J. B., & 
Jovanovic, S. T. (2018). Seasonal variations of Saanen goat milk composition and the 
impact of climatic conditions. Journal of food science and technology, 55(1), 299-303. 
Krishna, M. S., Revathy, V. M., & Jaleel, A. (2020). Adipocytes utilize sucrose as an energy 
source—Effect of different carbohydrates on adipocyte differentiation. Journal of 
Cellular Physiology, 235(2), 891-899. 
Kung, B., Anderson, G. H., Paré, S., Tucker, A. J., Vien, S., Wright, A. J., & Goff, H. D. 
(2018). Effect of milk protein intake and casein-to-whey ratio in breakfast meals on 
postprandial glucose, satiety ratings, and subsequent meal intake. Journal of Dairy 
Science, 101(10), 8688-8701. 
Labrie, V., Buske, O. J., Oh, E., Jeremian, R., Ptak, C., Gasiūnas, G., ... & Petronis, A. (2016). 
Lactase nonpersistence is directed by DNA-variation-dependent epigenetic aging. 
Nature Structural & Molecular Biology, 23(6), 566-573. 
Lai, M., Chandrasekera, P. C., & Barnard, N. D. (2014). You are what you eat, or are you? The 
challenges of translating high-fat-fed rodents to human obesity and diabetes. Nutrition 
& diabetes, 4(9), e135-e135.Lampe, I. K., Kahn, R. S., & Heeren, T. J. (2001). Apathy, 
 
138 
Anhedonia, and Psychomotor Retardation in Elderly Psychiatric Patients and Healthy 
Elderly Individuals. Journal of Geriatric Psychiatry and Neurology, 14(1), 11-16. 
Lazzarino, G. P., Andreoli, M. F., Rossetti, M. F., Stoker, C., Tschopp, M. V., Luque, E. H., & 
Ramos, J. G. (2017). Cafeteria diet differentially alters the expression of feeding-related 
genes through DNA methylation mechanisms in individual hypothalamic nuclei. 
Molecular and cellular endocrinology, 450, 113-125. 
Lazzarino, G. P., Acutain, M. F., Canesini, G., Andreoli, M. F., & Ramos, J. G. (2019). 
Cafeteria diet induces progressive changes in hypothalamic mechanisms involved in 
food intake control at different feeding periods in female rats. Molecular and cellular 
endocrinology, 498, 110542. 
Levine, A., Weldon, D., Grace, M., Cleary, J., & Billington, C. (1995). Naloxone blocks that 
portion of feeding driven by sweet taste in food-restricted rats. American Journal of 
Physiology-Regulatory, Integrative and Comparative Physiology, 268(1), R248-R252. 
Levine, A. S., Jewett, D. C., Cleary, J. P., Kotz, C. M., & Billington, C. J. (2004). Our journey 
with neuropeptide Y: Effects on ingestive behaviors and energy expenditure. Peptides, 
25(3), 505-510. 
Lim, D. H., Mayakrishnan, V., Lee, H. J., Ki, K. S., Kim, T. I., & Kim, Y. (2020). A 
comparative study on milk composition of Jersey and Holstein dairy cows during the 
early lactation. Journal of Animal Science and Technology, 62(4), 565.Lorenzen, J., 
Frederiksen, R., Hoppe, C., Hvid, R., & Astrup, A. (2012). The effect of milk proteins 
on appetite regulation and diet-induced thermogenesis. European Journal of Clinical 
Nutrition, 66(5), 622-7. 
Lynch, W. C. (1986). Opiate blockade inhibits saccharin intake and blocks normal preference 
acquisition. Pharmacology Biochemistry and Behavior, 24(4), 833-836. 
Maathuis, A., Havenaar, R., He, T., & Bellmann, S. (2017). Protein digestion and quality of 
goat and cow milk infant formula and human milk under simulated infant conditions. 
Journal of Pediatric Gastroenterology and Nutrition, 65(6), 661-666. 
Maslin, K., Grundy, J., Glasbey, G., Dean, T., Arshad, S. H., Grimshaw, K., Oliver, E., Roberts, 
G., & Venter, C. (2016). Cows' milk exclusion diet during infancy: Is there a long-term 
effect on children's eating behaviour and food preferences? Pediatr Allergy Immunol, 
27(2), 141-6. 
Mennella, J. A., & Beauchamp, G. K. (2002). Flavor experiences during formula feeding are 
related to preferences during childhood. Early Human Development, 68(2), 71-82. 
Miedlar, J. A., Rinaman, L., Vollmer, R. R., & Amico, J. A. (2007). Oxytocin gene deletion 
mice overconsume palatable sucrose solution but not palatable lipid emulsions. 
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 
293(3), R1063-R1068. 
Milan, A. M., Hodgkinson, A. J., Mitchell, S. M., Prodhan, U. K., Prosser, C. G., Carpenter, 
E. A., Fraser, K., & Cameron-Smith, D. (2018). Digestive responses to fortified cow or 
goat dairy drinks: a randomised controlled trial. Nutrients, 10(10), 1492. 
Mohammad, M. A., Sunehag, A. L., Rodriguez, L. A., & Haymond, M. W. (2011). Galactose 
promotes fat mobilization in obese lactating and nonlactating women. The American 
Journal of Clinical Nutrition, 93(2), 374-381. 
Mowlem, A. (2005). Marketing goat dairy produce in the UK. Small Ruminant Research, 60(1), 
207-213. 
Muir, S. K., Ward, G. N., & Jacobs, J. L. (2015). Herbage intake and milk production of late-
lactation dairy cows offered a second-year chicory crop during summer. Journal of 
Dairy Science, 98(12), 8825-8835. 
Mullis, K., Kay, K., & Williams, D. L. (2013). Oxytocin action in the ventral tegmental area 
affects sucrose intake. Brain Res, 1513, 85-91. 
 
139 
Murney, R., Burggraaf, V., Mapp, N., Ganche, E., & King, W. (2019). The effect of cultivated 
mixed-species green fodder on intake, milk production and milk composition of housed 
dairy goats. animal, 13(12), 2802-2810. 
Naleid, A. M., Grace, M. K., Chimukangara, M., Billington, C. J., & Levine, A. S. (2007). 
Paraventricular opioids alter intake of high-fat but not high-sucrose diet depending on 
diet preference in a binge model of feeding. American Journal of Physiology-
Regulatory, Integrative and Comparative Physiology, 293(1), R99-R105. 
Nixon, J. P., Kotz, C. M., Novak, C. M., Billington, C. J., & Teske, J. A. (2012). Neuropeptides 
controlling energy balance: orexins and neuromedins. Handbook of Experimental 
Pharmacology(209), 77-109. 
Novac, C. S., & Andrei, S. (2020). The Impact of Mastitis on the Biochemical Parameters, 
Oxidative and Nitrosative Stress Markers in Goat’s Milk: A Review. Pathogens, 9(11), 
882. 
Olszewski, P. K., Alsiö, J., Schiöth, H. B., & Levine, A. S. (2011). Opioids as facilitators of 
feeding: Can any food be rewarding? Physiology & Behavior, 104(1), 105-110. 
Olszewski, P. K., Klockars, A., Olszewska, A. M., Fredriksson, R., Schiöth, H. B., & Levine, 
A. S. (2010). Molecular, immunohistochemical, and pharmacological evidence of 
oxytocin's role as inhibitor of carbohydrate but not fat intake. Endocrinology, 151(10), 
4736-44. 
Pandit, R., de Jong, J. W., Vanderschuren, L. J. M. J., & Adan, R. A. H. (2011). Neurobiology 
of overeating and obesity: The role of melanocortins and beyond. European Journal of 
Pharmacology, 660(1), 28-42. 
Park, Y. W., & Haenlein, G. F. W. (2013). Milk and Dairy Products in Human Nutrition : 
Production, Composition and Health. Somerset, UK: John Wiley & Sons, Incorporated. 
Park, Y. W., Juárez, M., Ramos, M., & Haenlein, G. F. W. (2007). Physico-chemical 
characteristics of goat and sheep milk. Small Ruminant Research, 68(1-2), 88-113. 
Peciña, S., & Berridge, K. C. (2000). Opioid site in nucleus accumbens shell mediates eating 
and hedonic ‘liking’ for food: map based on microinjection Fos plumes. Brain 
Research, 863(1), 71-86. 
Perelló, M., & Zigman, J. M. (2012). The Role of Ghrelin in Reward-Based Eating. Biological 
Psychiatry, 72(5), 347-353. 
Ragueneau, S. (1987). Early development in mice. IV: Quantity and gross composition of milk 
in five inbred strains. Physiology & Behavior, 40(4), 431-435. 
Rinaman, L. (2010). Ascending projections from the caudal visceral nucleus of the solitary 
tract to brain regions involved in food intake and energy expenditure. Brain Research, 
1350, 18-34. 
Roser, M., Josic, D., Kontou, M., Mosetter, K., Maurer, P., & Reutter, W. (2009). Metabolism 
of galactose in the brain and liver of rats and its conversion into glutamate and other 
amino acids. Journal of Neural Transmission, 116(2), 131-139. 
Rubio-Martín, E., García-Escobar, E., Ruiz de Adana, M.-S., Lima-Rubio, F., Peláez, L., 
Caracuel, A.-M., Bermúdez-Silva, F.-J., Soriguer, F., Rojo-Martínez, G., & Olveira, G. 
(2017). Comparison of the effects of goat dairy and cow dairy based breakfasts on 
satiety, appetite hormones, and metabolic profile. Nutrients, 9(8), 877. 
Sabbatini, M., Molinari, C., Grossini, E., Piffanelli, V., Mary, D. A. S. G., Vacca, G., & Cannas, 
M. (2008). GABAA receptors expression pattern in rat brain following low pressure 
distension of the stomach. Neuroscience, 152(2), 449-458. 
Sakai, M., Kazui, H., Shigenobu, K., Komori, K., Ikeda, M., & Nishikawa, T. (2017). Gustatory 
dysfunction as an early symptom of semantic dementia. Dementia and Geriatric 
Cognitive Disorders Extra, 7(3), 395-405. 
Scholtens, M., Jiang, A., Smith, A., Littlejohn, M., Lehnert, K., Snell, R., ... & Blair, H. (2020). 
Genome-wide association studies of lactation yields of milk, fat, protein and somatic 
cell score in New Zealand dairy goats. Journal of Animal Science and Biotechnology, 
 
140 
11, 1-14.Shin, Y. K., Cong, W. N., Cai, H., Kim, W., Maudsley, S., Egan, J. M., & 
Martin, B. (2012). Age-related changes in mouse taste bud morphology, hormone 
expression, and taste responsivity. J Gerontol A Biol Sci Med Sci, 67(4), 336-44. 
Skibicka, K. P., Shirazi, R. H., Rabasa-Papio, C., Alvarez-Crespo, M., Neuber, C., Vogel, H., 
& Dickson, S. L. (2013). Divergent circuitry underlying food reward and intake effects 
of ghrelin: dopaminergic VTA-accumbens projection mediates ghrelin's effect on food 
reward but not food intake. Neuropharmacology, 73, 274-83. 
Spector, A. C., Klumpp, P. A., & Kaplan, J. M. (1998). Analytical issues in the evaluation of 
food deprivation and sucrose concentration effects on the microstructure of licking 
behavior in the rat. Behavioral neuroscience, 112(3), 678. 
Statnick, M. A., Chen, Y., Ansonoff, M., Witkin, J. M., Rorick-Kehn, L., Suter, T. M., Song, 
M., Hu, C., Lafuente, C., Jiménez, A., Benito, A., Diaz, N., Martínez-Grau, M. A., 
Toledo, M. A., & Pintar, J. E. (2016). A Novel Nociceptin Receptor Antagonist 
LY2940094 Inhibits Excessive Feeding Behavior in Rodents: A Possible Mechanism 
for the Treatment of Binge Eating Disorder. J Pharmacol Exp Ther, 356(2), 493-502. 
Steffensen, S. C., Bradley, K. D., Hansen, D. M., Wilcox, J. D., Wilcox, R. S., Allison, D. W., 
Merrill, C. B., & Edwards, J. G. (2011). The role of connexin-36 gap junctions in 
alcohol intoxication and consumption. Synapse, 65(8), 695-707. 
Stratford, J. M., Thompson, J. A., & Finger, T. E. (2017). Immunocytochemical organization 
and sour taste activation in the rostral nucleus of the solitary tract of mice. The Journal 
of comparative neurology, 525(2), 271-290. 
Suleiman, J. B., Mohamed, M., & Bakar, A. B. A. (2020). A systematic review on different 
models of inducing obesity in animals: Advantages and limitations. Journal of advanced 
veterinary and animal research, 7(1), 103. 
Sun, X., Tang, M., Zhang, J., & Chen, J. D. (2006). Excitatory effects of gastric electrical 
stimulation on gastric distension responsive neurons in ventromedial hypothalamus 
(VMH) in rats. Neuroscience Research, 55(4), 451-457.    
Tang, M., Zhang, J., & Chen, J. D. Z. (2006). Central mechanisms of gastric electrical 
stimulation involving neurons in the paraventricular nucleus of the hypothalamus in 
rats. Obesity Surgery, 16(3), 344-352. 
Thoh, D., Pakdeechanuan, P., & Chanjula, P. (2017). Effect of supplementary glycerin on milk 
composition and heat stability in dairy goats. Asian-Australasian journal of animal 
sciences, 30(12), 1711.  
Tomaschunas, M., Hinrichs, J., Köhn, E., & Busch-Stockfisch, M. (2012). Effects of casein-
to-whey protein ratio, fat and protein content on sensory properties of stirred yoghurt. 
International Dairy Journal, 26(1), 31-35. 
Torrico, D. D., Fuentes, S., Gonzalez Viejo, C., Ashman, H., & Dunshea, F. R. (2019). Cross-
cultural effects of food product familiarity on sensory acceptability and non-invasive 
physiological responses of consumers. Food Research International, 115, 439-450. 
Traub, R. J., Sengupta, J. N., & Gebhart, G. F. (1996). Differential c-fos expression in the 
nucleus of the solitary tract and spinal cord following noxious gastric distention in the 
rat. Neuroscience, 74(3), 873-884. 
Travers, S. P. (2002). Quinine and citric acid elicit distinctive Fos-like immunoreactivity in the 
rat nucleus of the solitary tract. Am J Physiol Regul Integr Comp Physiol, 282(6), 
R1798-810. 
Treadway, J. L., & Lederman, S. A. (1986). The effects of exercise on milk yield, milk 
composition, and offspring growth in rats. The American journal of clinical nutrition, 
44(4), 481-488. 
van De Heijning, B. J., Kegler, D., Schipper, L., Voogd, E., Oosting, A., & Beek, E. M. (2015). 
Acute and chronic effects of dietary lactose in adult rats are not explained by residual 
intestinal lactase activity. Nutrients, 7(7), 5542-5555. 
 
141 
Weldon, D. T., O'Hare, E., Cleary, J., Billington, C. J., & Levine, A. S. (1996). Effect of 
naloxone on intake of cornstarch, sucrose, and polycose diets in restricted and 
nonrestricted rats. American Journal of Physiology-Regulatory, Integrative and 
Comparative Physiology, 270(6), R1183-R1188. 
Wendorff, W. L., Park, Y. W., & Haenlein, G. F. W. (2017). Handbook of Milk of Non-Bovine 
Mammals. Hoboken, UK: John Wiley & Sons, Incorporated. 
Wyvell, C. L., & Berridge, K. C. (2000). Intra-accumbens amphetamine increases the 
conditioned incentive salience of sucrose reward: Enhancement of reward 'wanting' 
without enhanced 'liking' or response reinforcement. Journal of Neuroscience, 20(21), 
8122-8130. 
Xu, X., Zhan, M., Duan, W., Prabhu, V., Brenneman, R., Wood, W., Firman, J., Li, H., Zhang, 
P., Ibe, C., Zonderman, A. B., Longo, D. L., Poosala, S., Becker, K. G., & Mattson, M. 
P. (2007). Gene expression atlas of the mouse central nervous system: impact and 
interactions of age, energy intake and gender. Genome biology, 8(11), 1-17. 
Ye, A., Cui, J., Carpenter, E., Prosser, C., & Singh, H. (2019). Dynamic in vitro gastric 
digestion of infant formulae made with goat milk and cow milk: Influence of protein 
composition. International Dairy Journal, 97, 76-85. 
Zhang, Y., Zheng, Z., Liu, C., & Liu, Y. (2020). Lipid profiling and microstructure 
characteristics of goat milk fat from different stages of lactation. Journal of agricultural 










6.1 Composition of CM- and GM-enriched chow 
 
 
143 
 
